| 1 |
Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer. Drugs. 1993 Sep;46(3):446-514.
|
| 2 |
T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment. Int J Mol Sci. 2023 Jul 28;24(15):12106.
|
| 3 |
Arsenic trioxide FDA Label
|
| 4 |
Azacitidine FDA Label
|
| 5 |
Bortezomib FDA Label
|
| 6 |
Busulfan FDA Label
|
| 7 |
Clofarabine FDA Label
|
| 8 |
Cyproheptadine FDA Label
|
| 9 |
Dasatinib FDA Label
|
| 10 |
Daunorubicin FDA Label
|
| 11 |
Doxorubicin FDA Label
|
| 12 |
Everolimus FDA Label
|
| 13 |
Gemcitabine FDA Label
|
| 14 |
Idarubicin FDA Label
|
| 15 |
Imatinib FDA Label
|
| 16 |
Lenalidomide FDA Label
|
| 17 |
Melphalan FDA Label
|
| 18 |
Methotrexate FDA Label
|
| 19 |
Methylprednisolone FDA Label
|
| 20 |
Mitoxantrone FDA Label
|
| 21 |
New conjugates of mycophenolic acid and their antiproliferative activity. J Asian Nat Prod Res. 2016 Nov;18(11):1057-62.
|
| 22 |
Omacetaxine mepesuccinate FDA Label
|
| 23 |
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. J Clin Oncol. 2021 Nov 1;39(31):3496-3505.
|
| 24 |
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. N Engl J Med. 2010 Dec 23;363(26):2511-21.
|
| 25 |
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study. Lancet Haematol. 2020 Mar;7(3):e196-e208.
|
| 26 |
Pentostatin FDA Label
|
| 27 |
Prednisolone FDA Label
|
| 28 |
Propofol FDA Label
|
| 29 |
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006 Apr 1;106(7):1569-80.
|
| 30 |
Tacrolimus FDA Label
|
| 31 |
Thalidomide FDA Label
|
| 32 |
Thiotepa FDA Label
|
| 33 |
Vincristine FDA Label
|
| 34 |
Cyclosporin A protects JEG-3 cells against oxidative stress-induced apoptosis by inhibiting the p53 and JNK/p38 signaling pathways. Reprod Biol Endocrinol. 2020 Oct 12;18(1):100.
|
| 35 |
Choline FDA Label
|
| 36 |
A causal mechanism for childhood acute lymphoblastic leukaemia.Nat Rev Cancer. 2018 Aug;18(8):471-484. doi: 10.1038/s41568-018-0015-6.
|
| 37 |
Development and pharmaceutical evaluation of the anticancer Anthrafuran/Cavitron complex, a prototypic parenteral drug formulation.Eur J Pharm Sci. 2017 Nov 15;109:631-637. doi: 10.1016/j.ejps.2017.09.025. Epub 2017 Sep 18.
|
| 38 |
Expression and modulation of annexin VIII in human leukemia-lymphoma cell lines.Leuk Res. 1993 Nov;17(11):949-57. doi: 10.1016/0145-2126(93)90042-j.
|
| 39 |
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.Haematologica. 2019 Apr;104(4):738-748. doi: 10.3324/haematol.2018.193631. Epub 2018 Oct 31.
|
| 40 |
The Deubiquitinating Enzyme USP14 Regulates Leukemic Chemotherapy Drugs-Induced Cell Apoptosis by Suppressing Ubiquitination of Aurora Kinase B.Cell Physiol Biochem. 2017;42(3):965-973. doi: 10.1159/000478679. Epub 2017 Jun 27.
|
| 41 |
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.Blood. 2010 Apr 29;115(17):3559-69. doi: 10.1182/blood-2009-08-236760. Epub 2010 Feb 25.
|
| 42 |
Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers.Am J Respir Crit Care Med. 2002 Sep 1;166(5):724-31. doi: 10.1164/rccm.2104010.
|
| 43 |
Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.Int J Hematol. 2018 Oct;108(4):416-422. doi: 10.1007/s12185-018-2506-3. Epub 2018 Jul 24.
|
| 44 |
Frameshift mutations in caspase-5 and other target genes in leukemia and lymphoma cell lines having microsatellite instability.Leuk Res. 2003 Apr;27(4):359-61. doi: 10.1016/s0145-2126(02)00215-1.
|
| 45 |
Immunotherapy in pediatric B-cell acute lymphoblastic leukemia.Hum Immunol. 2019 Jun;80(6):400-408. doi: 10.1016/j.humimm.2019.01.011. Epub 2019 Feb 1.
|
| 46 |
NGF inhibits human leukemia proliferation by downregulating cyclin A1 expression through promoting acinus/CtBP2 association.Oncogene. 2009 Oct 29;28(43):3825-36. doi: 10.1038/onc.2009.236. Epub 2009 Aug 10.
|
| 47 |
Multiple myeloma secondary to acute lymphoblastic leukemia: A case report.Medicine (Baltimore). 2019 Jan;98(1):e14018. doi: 10.1097/MD.0000000000014018.
|
| 48 |
CAR T cell therapy: A new era for cancer treatment (Review).Oncol Rep. 2019 Dec;42(6):2183-2195. doi: 10.3892/or.2019.7335. Epub 2019 Sep 24.
|
| 49 |
A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.Blood. 2017 Nov 30;130(22):2410-2419. doi: 10.1182/blood-2017-04-777052. Epub 2017 Oct 17.
|
| 50 |
Generation of Suicide Gene-Modified Chimeric Antigen Receptor-Redirected T-Cells for Cancer Immunotherapy.Methods Mol Biol. 2019;1895:57-73. doi: 10.1007/978-1-4939-8922-5_5.
|
| 51 |
CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients.Leukemia. 2005 Feb;19(2):301-4. doi: 10.1038/sj.leu.2403588.
|
| 52 |
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52).Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S71-S82. doi: 10.1016/j.cmi.2018.02.003. Epub 2018 Feb 12.
|
| 53 |
IL-15/IL-15R/CD80-expressing AML cell vaccines eradicate minimal residual disease in leukemic mice.Blood Adv. 2018 Nov 27;2(22):3177-3192. doi: 10.1182/bloodadvances.2018019026.
|
| 54 |
Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1.Int J Mol Med. 2016 May;37(5):1405-11. doi: 10.3892/ijmm.2016.2539. Epub 2016 Mar 24.
|
| 55 |
Strategies to re-express epigenetically silenced p15(INK4b) and p21(WAF1) genes in acute myeloid leukemia.Epigenetics. 2010 Nov-Dec;5(8):696-703. doi: 10.4161/epi.5.8.13276.
|
| 56 |
CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.Leukemia. 2019 Jul;33(7):1608-1619. doi: 10.1038/s41375-019-0382-3. Epub 2019 Jan 24.
|
| 57 |
Synergism between the mTOR inhibitor rapamycin and FAK down-regulation in the treatment of acute lymphoblastic leukemia.J Hematol Oncol. 2016 Feb 18;9:12. doi: 10.1186/s13045-016-0241-x.
|
| 58 |
Elevated NF-kappaB responses and FLIP levels in leukemic but not normal lymphocytes: reduction by salicylate allows TNF-induced apoptosis.Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12790-5. doi: 10.1073/pnas.0701437104. Epub 2007 Jul 23.
|
| 59 |
High-expressing cystic fibrosis transmembrane conductance regulator interacts with histone deacetylase 2 to promote the development of Ph+ leukemia through the HDAC2-mediated PTEN pathway.Leuk Res. 2017 Jun;57:9-19. doi: 10.1016/j.leukres.2017.02.004. Epub 2017 Feb 16.
|
| 60 |
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells.Mol Cancer. 2014 Jun 10;13:147. doi: 10.1186/1476-4598-13-147.
|
| 61 |
The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.Cytometry B Clin Cytom. 2018 May;94(3):520-526. doi: 10.1002/cyto.b.21540. Epub 2017 Aug 11.
|
| 62 |
L233P mutation in the bovine leukemia virus Tax protein depresses endothelial cell recruitment and tumorigenesis in athymic nude mice.Arch Virol. 2019 May;164(5):1343-1351. doi: 10.1007/s00705-019-04191-3. Epub 2019 Mar 8.
|
| 63 |
zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.FASEB J. 2010 Jun;24(6):1852-65. doi: 10.1096/fj.09-140459. Epub 2010 Jan 26.
|
| 64 |
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia.Int J Mol Sci. 2019 Jun 5;20(11):2764. doi: 10.3390/ijms20112764.
|
| 65 |
Blocking migration of regulatory T cells to leukemic hematopoietic microenvironment delays disease progression in mouse leukemia model.Cancer Lett. 2020 Jan 28;469:151-161. doi: 10.1016/j.canlet.2019.10.032. Epub 2019 Oct 24.
|
| 66 |
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.Cell Rep. 2019 Apr 2;27(1):238-254.e6. doi: 10.1016/j.celrep.2019.03.009.
|
| 67 |
Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.PLoS One. 2015 May 18;10(5):e0127308. doi: 10.1371/journal.pone.0127308. eCollection 2015.
|
| 68 |
Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.Pharmacol Res. 2007 Apr;55(4):343-9. doi: 10.1016/j.phrs.2007.01.003. Epub 2007 Jan 16.
|
| 69 |
Bile acids at neutral and acidic pH induce apoptosis and gene cleavages in nasopharyngeal epithelial cells: implications in chromosome rearrangement.BMC Cancer. 2018 Apr 12;18(1):409. doi: 10.1186/s12885-018-4327-4.
|
| 70 |
Alternative splicing generates a diacylglycerol kinase transcript that acts as a dominant-negative modulator of superoxide production in localized aggressive periodontitis.J Periodontol. 2014 Jul;85(7):934-43. doi: 10.1902/jop.2013.130468. Epub 2013 Oct 30.
|
| 71 |
Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells.Int J Oncol. 2013 Apr;42(4):1317-24. doi: 10.3892/ijo.2013.1831. Epub 2013 Feb 19.
|
| 72 |
Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.Carcinogenesis. 2013 Mar;34(3):667-77. doi: 10.1093/carcin/bgs386. Epub 2012 Dec 13.
|
| 73 |
Loss of Dnmt3a and Dnmt3b does not affect epidermal homeostasis but promotes squamous transformation through PPAR-.Elife. 2017 Apr 20;6:e21697. doi: 10.7554/eLife.21697.
|
| 74 |
Structural Basis of Dot1L Stimulation by Histone H2B Lysine 120Ubiquitination.Mol Cell. 2019 Jun 6;74(5):1010-1019.e6. doi: 10.1016/j.molcel.2019.03.029. Epub 2019 Apr 10.
|
| 75 |
c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals.Blood. 2017 Dec 21;130(25):2739-2749. doi: 10.1182/blood-2017-02-769463. Epub 2017 Oct 27.
|
| 76 |
Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1.Sci Rep. 2019 Aug 14;9(1):11861. doi: 10.1038/s41598-019-47891-1.
|
| 77 |
Nuclear, not cytoplasmic, PKR maneuvers in AML.Blood. 2015 Sep 24;126(13):1523-4. doi: 10.1182/blood-2015-08-661421.
|
| 78 |
Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism.Mol Cancer Ther. 2014 Mar;13(3):662-74. doi: 10.1158/1535-7163.MCT-13-0714. Epub 2013 Dec 20.
|
| 79 |
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia.Nat Commun. 2019 Nov 7;10(1):5051. doi: 10.1038/s41467-019-12960-6.
|
| 80 |
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.Cancer Cell. 2018 Feb 12;33(2):274-291.e8. doi: 10.1016/j.ccell.2018.01.006.
|
| 81 |
Blood monocyte profiles in COPD patients with PiMM and PiZZ 1-antitrypsin.Respir Med. 2019 Mar;148:60-62. doi: 10.1016/j.rmed.2019.02.001. Epub 2019 Feb 6.
|
| 82 |
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4).BMC Cancer. 2012 Jan 17;12:19. doi: 10.1186/1471-2407-12-19.
|
| 83 |
Effects of metformin on FOXM1 expression and on the biological behavior of acute leukemia cell lines.Mol Med Rep. 2014 Dec;10(6):3193-8. doi: 10.3892/mmr.2014.2629. Epub 2014 Oct 13.
|
| 84 |
Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.Front Immunol. 2019 Jul 16;10:1646. doi: 10.3389/fimmu.2019.01646. eCollection 2019.
|
| 85 |
Association of glutathione S-transferase 1-1 polymorphisms (A140D and E208K) with the expression of interleukin-8 (IL-8), transforming growth factor beta (TGF-), and apoptotic protease-activating factor 1 (Apaf-1) in humans chronically exposed to arsenic in drinking water.Arch Toxicol. 2012 Jun;86(6):857-68. doi: 10.1007/s00204-012-0802-x.
|
| 86 |
Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?.Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):481-94. doi: 10.1097/ACI.0b013e3282f1d690.
|
| 87 |
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.Leukemia. 2018 Jan;32(1):49-60. doi: 10.1038/leu.2017.174. Epub 2017 Jun 5.
|
| 88 |
Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320.Theranostics. 2019 Jul 28;9(19):5642-5656. doi: 10.7150/thno.34813. eCollection 2019.
|
| 89 |
Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth.Exp Cell Res. 2019 Sep 15;382(2):111485. doi: 10.1016/j.yexcr.2019.06.030. Epub 2019 Jun 26.
|
| 90 |
Discovery of DC_H31 as potential mutant IDH1 inhibitor through NADPH-based high throughput screening.Bioorg Med Chem. 2019 Aug 1;27(15):3229-3236. doi: 10.1016/j.bmc.2019.05.040. Epub 2019 May 28.
|
| 91 |
IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti-IL-2R therapies.Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21120-21130. doi: 10.1073/pnas.1901382116. Epub 2019 Sep 30.
|
| 92 |
Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor.Br J Haematol. 2009 Feb;144(3):376-87. doi: 10.1111/j.1365-2141.2008.07491.x. Epub 2008 Nov 13.
|
| 93 |
Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia.J Pediatr Hematol Oncol. 2017 May;39(4):e227-e232. doi: 10.1097/MPH.0000000000000770.
|
| 94 |
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.Cell Res. 2019 Jun;29(6):446-459. doi: 10.1038/s41422-019-0162-7. Epub 2019 Apr 25.
|
| 95 |
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies.Onco Targets Ther. 2019 Jan 18;12:635-645. doi: 10.2147/OTT.S189391. eCollection 2019.
|
| 96 |
Gene mutation profile and risk stratification in AML1ETOpositive acute myeloid leukemia based on nextgeneration sequencing.Oncol Rep. 2019 Dec;42(6):2333-2344. doi: 10.3892/or.2019.7375. Epub 2019 Oct 15.
|
| 97 |
Structure characterization and anti-leukemia activity of a novel polysaccharide from Angelica sinensis (Oliv.) Diels.Int J Biol Macromol. 2019 Jan;121:161-172. doi: 10.1016/j.ijbiomac.2018.09.213. Epub 2018 Oct 2.
|
| 98 |
The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development.Nat Cell Biol. 2015 May;17(5):665-77. doi: 10.1038/ncb3158. Epub 2015 Apr 27.
|
| 99 |
CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.Leukemia. 2005 May;19(5):835-40. doi: 10.1038/sj.leu.2403704.
|
| 100 |
Involvement of NF-B in mediating the anti-tumour effects of combretastatins in T cells.Invest New Drugs. 2018 Aug;36(4):523-535. doi: 10.1007/s10637-017-0543-z. Epub 2018 Feb 19.
|
| 101 |
LIFR-CT3 induces differentiation of a human acute myelogenous leukemia cell line HL-60 by suppressing miR-155 expression through the JAK/STAT pathway.Leuk Res. 2014 Oct;38(10):1237-44. doi: 10.1016/j.leukres.2014.07.004. Epub 2014 Jul 22.
|
| 102 |
Understanding PIM-1 kinase inhibitor interactions with free energy simulation.Phys Chem Chem Phys. 2019 Apr 3;21(14):7544-7558. doi: 10.1039/c9cp00070d.
|
| 103 |
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):431-440.e13. doi: 10.1016/j.clml.2019.03.015. Epub 2019 Mar 26.
|
| 104 |
Case-only study of interactions between DNA repair genes (hMLH1, APEX1, MGMT, XRCC1 and XPD) and low-frequency electromagnetic fields in childhood acute leukemia.Leuk Lymphoma. 2008 Dec;49(12):2344-50. doi: 10.1080/10428190802441347.
|
| 105 |
Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.Int J Oncol. 2014 Mar;44(3):986-92. doi: 10.3892/ijo.2013.2235. Epub 2013 Dec 30.
|
| 106 |
Mutational landscape of T-cell lymphoma in mice lacking the DNA mismatch repair gene Mlh1: no synergism with ionizing radiation.Carcinogenesis. 2019 Apr 29;40(2):216-224. doi: 10.1093/carcin/bgz013.
|
| 107 |
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations.EMBO Mol Med. 2013 Jan;5(1):38-51. doi: 10.1002/emmm.201201703. Epub 2012 Dec 11.
|
| 108 |
CAR-T "the living drugs", immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy.J Hematol Oncol. 2019 Nov 8;12(1):113. doi: 10.1186/s13045-019-0819-1.
|
| 109 |
The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.Leukemia. 2019 Dec;33(12):2817-2829. doi: 10.1038/s41375-019-0495-8. Epub 2019 May 28.
|
| 110 |
MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer.J Biol Chem. 2001 Nov 30;276(48):45137-44. doi: 10.1074/jbc.M106127200. Epub 2001 Sep 20.
|
| 111 |
[Transcription levels of the MYCN gene in blood cell subpopulations of Patients with leukemia].Mol Biol (Mosk). 2008 Mar-Apr;42(2):378-82.
|
| 112 |
MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.Anticancer Res. 2017 Nov;37(11):6203-6209. doi: 10.21873/anticanres.12070.
|
| 113 |
Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway.Leuk Res. 2018 Jun;69:39-46. doi: 10.1016/j.leukres.2018.04.004. Epub 2018 Apr 5.
|
| 114 |
A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.Oncotarget. 2014 Jul 30;5(14):5494-509. doi: 10.18632/oncotarget.2131.
|
| 115 |
The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors.Cell Cycle. 2019 Sep;18(18):2307-2322. doi: 10.1080/15384101.2019.1646068. Epub 2019 Jul 26.
|
| 116 |
Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.Oncogene. 2018 Jul;37(28):3839-3851. doi: 10.1038/s41388-018-0234-z. Epub 2018 Apr 12.
|
| 117 |
HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML.Leukemia. 2013 Jun;27(6):1358-68. doi: 10.1038/leu.2012.366. Epub 2012 Dec 18.
|
| 118 |
Semaphorins and Their Receptors in Hematological Malignancies.Front Oncol. 2019 May 9;9:382. doi: 10.3389/fonc.2019.00382. eCollection 2019.
|
| 119 |
Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.PLoS One. 2018 Aug 23;13(8):e0202677. doi: 10.1371/journal.pone.0202677. eCollection 2018.
|
| 120 |
Inhibition of oncostatin M in osteoarthritic synovial fluid enhances GAG production in osteoarthritic cartilage repair.Eur Cell Mater. 2013 Sep 11;26:80-90; discussion 90. doi: 10.22203/ecm.v026a06.
|
| 121 |
PAX5 is part of a functional transcription factor network targeted in lymphoid leukemia.PLoS Genet. 2019 Aug 5;15(8):e1008280. doi: 10.1371/journal.pgen.1008280. eCollection 2019 Aug.
|
| 122 |
SIL-TAL1 rearrangement is related with poor outcome: a study from a Chinese institution.PLoS One. 2013 Sep 9;8(9):e73865. doi: 10.1371/journal.pone.0073865. eCollection 2013.
|
| 123 |
Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression.Ann Hematol. 2018 Oct;97(10):1749-1755. doi: 10.1007/s00277-018-3463-x. Epub 2018 Aug 1.
|
| 124 |
Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through phosphatidylinositol 3-kinase-AKT pathway.Biochem Biophys Res Commun. 2004 Apr 23;317(1):198-204. doi: 10.1016/j.bbrc.2004.03.034.
|
| 125 |
Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation.Eur J Med Chem. 2019 Feb 15;164:317-333. doi: 10.1016/j.ejmech.2018.12.065. Epub 2018 Dec 26.
|
| 126 |
DNA Aptamers in the Detection of Leukemia Cells by the Thickness Shear Mode Acoustics Method.Chemphyschem. 2019 Feb 18;20(4):545-554. doi: 10.1002/cphc.201801126. Epub 2019 Feb 6.
|
| 127 |
DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.Cancers (Basel). 2019 Jun 23;11(6):877. doi: 10.3390/cancers11060877.
|
| 128 |
RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia.Hum Pathol. 2018 Oct;80:82-86. doi: 10.1016/j.humpath.2018.02.023. Epub 2018 Mar 10.
|
| 129 |
Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha.Oncotarget. 2017 Mar 21;8(12):20103-20112. doi: 10.18632/oncotarget.15384.
|
| 130 |
The cyclohexene derivative MC-3129 exhibits antileukemic activity via RhoA/ROCK1/PTEN/PI3K/Akt pathway-mediated mitochondrial translocation of cofilin.Cell Death Dis. 2018 May 29;9(6):656. doi: 10.1038/s41419-018-0689-4.
|
| 131 |
Tunicamycin promotes apoptosis in leukemia cells through ROS generation and downregulation of survivin expression.Apoptosis. 2015 Aug;20(8):1087-98. doi: 10.1007/s10495-015-1135-z.
|
| 132 |
p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia.Blood. 2011 Jun 23;117(25):6885-94. doi: 10.1182/blood-2010-10-315721. Epub 2011 Apr 28.
|
| 133 |
p38 and JNK pathways control E-selectin-dependent extravasation of colon cancer cells by modulating miR-31 transcription.Oncotarget. 2017 Jan 3;8(1):1678-1687. doi: 10.18632/oncotarget.13779.
|
| 134 |
Imatinib restores expression of CD62L in BCR-ABL-positive cells.J Leukoc Biol. 2003 May;73(5):600-3. doi: 10.1189/jlb.1002507.
|
| 135 |
Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis.Crit Rev Oncol Hematol. 2019 Jan;133:74-83. doi: 10.1016/j.critrevonc.2018.07.013. Epub 2018 Aug 3.
|
| 136 |
PI3K p110 inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.J Clin Invest. 2019 Jan 2;129(1):122-136. doi: 10.1172/JCI99386. Epub 2018 Nov 19.
|
| 137 |
Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix.Mol Cancer Res. 2006 Dec;4(12):915-26. doi: 10.1158/1541-7786.MCR-06-0184.
|
| 138 |
Megakaryocyte and polyploidization.Exp Hematol. 2018 Jan;57:1-13. doi: 10.1016/j.exphem.2017.10.001. Epub 2017 Oct 27.
|
| 139 |
Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.Leukemia. 2009 Oct;23(10):1818-24. doi: 10.1038/leu.2009.138. Epub 2009 Jul 16.
|
| 140 |
Expression of TRAIL and its receptor DR5 and their significance in acute leukemia cells.Genet Mol Res. 2015 Dec 28;14(4):18562-8.
|
| 141 |
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia.Biomed Res Int. 2015;2015:792187. doi: 10.1155/2015/792187. Epub 2015 Aug 3.
|
| 142 |
Expression and function of the transient receptor potential ion channel family in the hematologic malignancies.Curr Mol Pharmacol. 2013 Nov;6(3):137-48. doi: 10.2174/187446720603140415215431.
|
| 143 |
Glucosylceramide synthase promotes Bcl-2 expression via the ERK signaling pathway in the K562/A02 leukemia drug-resistant cell line.Int J Hematol. 2014 Dec;100(6):559-66. doi: 10.1007/s12185-014-1679-7. Epub 2014 Oct 4.
|
| 144 |
VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues.Leuk Lymphoma. 2007 Oct;48(10):2014-21. doi: 10.1080/10428190701540975.
|
| 145 |
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.JCI Insight. 2019 Oct 3;4(19):e127716. doi: 10.1172/jci.insight.127716.
|
| 146 |
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.Blood. 2017 Feb 23;129(8):981-990. doi: 10.1182/blood-2016-06-721191. Epub 2017 Jan 9.
|
| 147 |
Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia.Hum Mol Genet. 2017 Jan 15;26(2):344-353. doi: 10.1093/hmg/ddw427.
|
| 148 |
ABR, a novel inducer of transcription factor C/EBP, contributes to myeloid differentiation and is a favorable prognostic factor in acute myeloid leukemia.Oncotarget. 2017 Oct 26;8(61):103626-103639. doi: 10.18632/oncotarget.22093. eCollection 2017 Nov 28.
|
| 149 |
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).Blood. 2015 Jan 29;125(5):820-30. doi: 10.1182/blood-2014-06-583062. Epub 2014 Nov 26.
|
| 150 |
High Expression of ABL2 Suppresses Apoptosis in Gastric Cancer.Dig Dis Sci. 2018 Sep;63(9):2294-2300. doi: 10.1007/s10620-018-5111-7. Epub 2018 May 16.
|
| 151 |
Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. J Exp Clin Cancer Res. 2019 Jul 15;38(1):308. doi: 10.1186/s13046-019-1295-8.
|
| 152 |
Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression.Toxicol Appl Pharmacol. 2015 Apr 1;284(1):33-41. doi: 10.1016/j.taap.2015.02.005. Epub 2015 Feb 12.
|
| 153 |
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.Leukemia. 2014 Jul;28(7):1414-22. doi: 10.1038/leu.2014.56. Epub 2014 Feb 3.
|
| 154 |
Androgen receptor CpG island methylation status in human leukemia cancer cells.Cancer Invest. 2009 Feb;27(2):156-62. doi: 10.1080/07357900802208590.
|
| 155 |
Increased phosphorylation of eIF2 in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.Oncotarget. 2016 Nov 29;7(48):79706-79721. doi: 10.18632/oncotarget.12941.
|
| 156 |
Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase.Blood Adv. 2018 May 22;2(10):1157-1169. doi: 10.1182/bloodadvances.2017015214.
|
| 157 |
Cigarette smoke induces rat testicular injury via mitochondrial apoptotic pathway.Mol Reprod Dev. 2017 Oct;84(10):1053-1065. doi: 10.1002/mrd.22863.
|
| 158 |
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.
|
| 159 |
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737.Clin Cancer Res. 2012 Feb 1;18(3):783-95. doi: 10.1158/1078-0432.CCR-11-1166. Epub 2011 Dec 15.
|
| 160 |
Erythroblast differentiation at spleen in Q137E mutant ribosomal protein S19 gene knock-in C57BL/6J mice.Immunobiology. 2018 Jan;223(1):118-124. doi: 10.1016/j.imbio.2017.10.003. Epub 2017 Oct 5.
|
| 161 |
Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I.J Biol Chem. 2018 Jun 22;293(25):9555-9569. doi: 10.1074/jbc.RA118.002836. Epub 2018 May 16.
|
| 162 |
Cis-trimethoxy resveratrol induces intrinsic apoptosis via prometaphase arrest and prolonged CDK1 activation pathway in human Jurkat T cells.Oncotarget. 2017 Dec 22;9(4):4969-4984. doi: 10.18632/oncotarget.23576. eCollection 2018 Jan 12.
|
| 163 |
Prognostic gene alterations and clonal changes in childhood B-ALL.Leuk Res. 2019 Aug;83:106159. doi: 10.1016/j.leukres.2019.05.009. Epub 2019 Jun 8.
|
| 164 |
Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia.Blood. 2017 Jan 12;129(2):177-187. doi: 10.1182/blood-2016-05-707653. Epub 2016 Oct 24.
|
| 165 |
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia.Cancer Res. 2018 Dec 15;78(24):6762-6770. doi: 10.1158/0008-5472.CAN-18-1638. Epub 2018 Oct 22.
|
| 166 |
In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins.Clin Cancer Res. 2005 Jun 15;11(12):4495-503. doi: 10.1158/1078-0432.CCR-04-2363.
|
| 167 |
Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers.Eur J Dermatol. 2017 Dec 1;27(6):590-598. doi: 10.1684/ejd.2017.3132.
|
| 168 |
Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.Cell Physiol Biochem. 2018;51(1):262-277. doi: 10.1159/000495228. Epub 2018 Nov 19.
|
| 169 |
Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia.Cell. 2016 Sep 22;167(1):171-186.e15. doi: 10.1016/j.cell.2016.08.057. Epub 2016 Sep 15.
|
| 170 |
Transcriptional Selectivity of Epigenetic Therapy in Cancer.Cancer Res. 2017 Jan 15;77(2):470-481. doi: 10.1158/0008-5472.CAN-16-0834. Epub 2016 Nov 22.
|
| 171 |
Triazolo[4,5-d]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells.Comput Struct Biotechnol J. 2018 Sep 28;16:350-360. doi: 10.1016/j.csbj.2018.09.003. eCollection 2018.
|
| 172 |
miR?5a?p affects the proliferation, migration and apoptosis of lens epithelial cells.Mol Med Rep. 2019 Feb;19(2):1110-1116. doi: 10.3892/mmr.2018.9738. Epub 2018 Dec 11.
|
| 173 |
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Blood. 2010 Nov 4;116(18):3622-6. doi: 10.1182/blood-2010-05-283648. Epub 2010 Jul 23.
|
| 174 |
Turn It Down a Notch.Front Cell Dev Biol. 2017 Jan 18;4:151. doi: 10.3389/fcell.2016.00151. eCollection 2016.
|
| 175 |
Ffar2 expression regulates leukaemic cell growth in vivo.Br J Cancer. 2017 Oct 24;117(9):1336-1340. doi: 10.1038/bjc.2017.307. Epub 2017 Sep 5.
|
| 176 |
fgf1 is required for normal differentiation of erythrocytes in zebrafish primitive hematopoiesis.Dev Dyn. 2007 Mar;236(3):633-43. doi: 10.1002/dvdy.21056.
|
| 177 |
The role of chlorine atom on the binding between 2-phenyl-1H-benzimidazole analogues and fat mass and obesity-associated protein.J Mol Recognit. 2019 Jun;32(6):e2774. doi: 10.1002/jmr.2774. Epub 2018 Dec 21.
|
| 178 |
Cx25 contributes to leukemia cell communication and chemosensitivity.Oncotarget. 2015 Oct 13;6(31):31508-21. doi: 10.18632/oncotarget.5226.
|
| 179 |
Visualization of ligand-induced G(i)-protein activation in chemotaxing cells.FASEB J. 2017 Mar;31(3):910-919. doi: 10.1096/fj.201601102R. Epub 2016 Nov 23.
|
| 180 |
Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.Leuk Lymphoma. 2009 Jun;50(6):985-97. doi: 10.1080/10428190902878448.
|
| 181 |
Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.Haematologica. 2003 Nov;88(11):1238-44.
|
| 182 |
Immunogenicity moderation effect of interleukin-24 on myelogenous leukemia cells.Anticancer Drugs. 2018 Apr;29(4):353-363. doi: 10.1097/CAD.0000000000000606.
|
| 183 |
Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia.Cytokine Growth Factor Rev. 2018 Oct;43:1-7. doi: 10.1016/j.cytogfr.2018.06.001. Epub 2018 Jun 7.
|
| 184 |
Leukemia growth is inhibited by benzoxime without causing any harmful effect in rats bearing RBL-1 enotransplants.Oncol Lett. 2019 Feb;17(2):1934-1938. doi: 10.3892/ol.2018.9783. Epub 2018 Nov 30.
|
| 185 |
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders.Biochem Pharmacol. 2019 Sep;167:133-148. doi: 10.1016/j.bcp.2019.04.019. Epub 2019 Apr 24.
|
| 186 |
Suv4-20h1 promotes G1 to S phase transition by downregulating p21(WAF1/CIP1) expression in chronic myeloid leukemia K562 cells.Oncol Lett. 2018 May;15(5):6123-6130. doi: 10.3892/ol.2018.8092. Epub 2018 Feb 21.
|
| 187 |
Role of MSC-derived galectin 3 in the AML microenvironment.Biochim Biophys Acta Mol Cell Res. 2018 Jul;1865(7):959-969. doi: 10.1016/j.bbamcr.2018.04.005. Epub 2018 Apr 12.
|
| 188 |
CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma.Hum Vaccin Immunother. 2015;11(7):1606-11. doi: 10.1080/21645515.2015.1046658.
|
| 189 |
RNAi-mediated knockdown of MCM7 gene on CML cells and its therapeutic potential for leukemia.Med Oncol. 2017 Feb;34(2):21. doi: 10.1007/s12032-016-0878-x. Epub 2017 Jan 5.
|
| 190 |
c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells.Stem Cells. 2018 Nov;36(11):1685-1696. doi: 10.1002/stem.2897. Epub 2018 Sep 5.
|
| 191 |
Targeting neuropilin-1 in human leukemia and lymphoma.Blood. 2011 Jan 20;117(3):920-7. doi: 10.1182/blood-2010-05-282921. Epub 2010 Nov 9.
|
| 192 |
Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.Haematologica. 2014 Sep;99(9):1465-71. doi: 10.3324/haematol.2013.100917. Epub 2014 Jun 20.
|
| 193 |
Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis.Exp Hematol. 2014 May;42(5):369-379.e3. doi: 10.1016/j.exphem.2014.01.009. Epub 2014 Jan 31.
|
| 194 |
Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.Oncogene. 2017 Jan 12;36(2):254-262. doi: 10.1038/onc.2016.196. Epub 2016 Jun 6.
|
| 195 |
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth.Oncotarget. 2016 Jan 12;7(2):1765-76. doi: 10.18632/oncotarget.6426.
|
| 196 |
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.J Pediatr Surg. 2019 Jun;54(6):1206-1213. doi: 10.1016/j.jpedsurg.2019.02.029. Epub 2019 Feb 28.
|
| 197 |
Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.J Pediatr Hematol Oncol. 2019 Aug;41(6):e359-e370. doi: 10.1097/MPH.0000000000001416.
|
| 198 |
Inhibition of Ser/Thr phosphatase PPM1D induces neutrophil differentiation in HL-60 cells.J Biochem. 2017 Oct 1;162(4):303-308. doi: 10.1093/jb/mvx032.
|
| 199 |
PRAME peptide-specific CD8(+) Tcells represent the predominant response against leukemia-associated antigens in healthy individuals.Eur J Immunol. 2018 Aug;48(8):1400-1411. doi: 10.1002/eji.201747399. Epub 2018 Jul 8.
|
| 200 |
Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.J Med Chem. 2019 Feb 14;62(3):1125-1137. doi: 10.1021/acs.jmedchem.8b00513. Epub 2018 Dec 5.
|
| 201 |
Erythroleukemia cells acquire an alternative mitophagy capability.Sci Rep. 2016 Apr 19;6:24641. doi: 10.1038/srep24641.
|
| 202 |
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.J Clin Invest. 2016 Feb;126(2):585-98. doi: 10.1172/JCI83535.
|
| 203 |
Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells.Cancer Lett. 2016 Nov 28;382(2):215-230. doi: 10.1016/j.canlet.2016.08.016. Epub 2016 Sep 6.
|
| 204 |
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.Curr Pharm Des. 2017;23(32):4745-4757. doi: 10.2174/1381612823666170710125332.
|
| 205 |
Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.Oncotarget. 2016 Nov 8;7(45):73769-73780. doi: 10.18632/oncotarget.12063.
|
| 206 |
Expression and Prognosis Analyses of Runt-Related Transcription Factor Family in Human Leukemia.Mol Ther Oncolytics. 2018 Dec 18;12:103-111. doi: 10.1016/j.omto.2018.12.008. eCollection 2019 Mar 29.
|
| 207 |
S100A9 induces differentiation of acute myeloid leukemia cells through TLR4.Blood. 2017 Apr 6;129(14):1980-1990. doi: 10.1182/blood-2016-09-738005. Epub 2017 Jan 30.
|
| 208 |
Identification of a novel small molecule that inhibits deacetylase but not defatty-acylase reaction catalysed by SIRT2.Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748):20170070. doi: 10.1098/rstb.2017.0070.
|
| 209 |
Induction of heme oxygenase-1 by Na+-H+ exchanger 1 protein plays a crucial role in imatinib-resistant chronic myeloid leukemia cells.J Biol Chem. 2015 May 15;290(20):12558-71. doi: 10.1074/jbc.M114.626960. Epub 2015 Mar 23.
|
| 210 |
SET and MYND domain containing protein 3 in cancer.Am J Transl Res. 2017 Jan 15;9(1):1-14. eCollection 2017.
|
| 211 |
Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.Tumour Biol. 2014 Nov;35(11):11081-9. doi: 10.1007/s13277-014-2405-z. Epub 2014 Aug 6.
|
| 212 |
Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.Oncotarget. 2016 Sep 13;7(37):60074-60086. doi: 10.18632/oncotarget.11054.
|
| 213 |
Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development.Nucleosides Nucleotides Nucleic Acids. 2018;37(12):679-686. doi: 10.1080/15257770.2018.1478094. Epub 2018 Dec 6.
|
| 214 |
Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemia.Mol Ther. 2013 Apr;21(4):877-86. doi: 10.1038/mt.2013.11. Epub 2013 Feb 5.
|
| 215 |
Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus.Virology. 2018 Mar;516:165-175. doi: 10.1016/j.virol.2018.01.012.
|
| 216 |
Inhibition of USP10 induces degradation of oncogenic FLT3.Nat Chem Biol. 2017 Dec;13(12):1207-1215. doi: 10.1038/nchembio.2486. Epub 2017 Oct 2.
|
| 217 |
Selective induction of cancer cell death by VDAC1-based peptides and their potential use in cancer therapy.Mol Oncol. 2018 Jun;12(7):1077-1103. doi: 10.1002/1878-0261.12313. Epub 2018 May 19.
|
| 218 |
Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.Adv Exp Med Biol. 1999;457:65-70. doi: 10.1007/978-1-4615-4811-9_8.
|
| 219 |
Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.Anticancer Res. 2005 Mar-Apr;25(2A):991-8.
|
| 220 |
Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation.Blood. 2020 Feb 6;135(6):441-448. doi: 10.1182/blood.2019002320.
|
| 221 |
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657.Blood. 2003 Apr 15;101(8):3188-97. doi: 10.1182/blood-2002-06-1800. Epub 2002 Dec 19.
|
| 222 |
Chemoinformatic Approach to Assess Toxicity of Ionic Liquids.Methods Mol Biol. 2018;1800:559-571. doi: 10.1007/978-1-4939-7899-1_26.
|
| 223 |
Hydroquinone-induced FOXP3-ADAM17-Lyn-Akt-p21 signaling axis promotes malignant progression of human leukemia U937 cells.Arch Toxicol. 2017 Feb;91(2):983-997. doi: 10.1007/s00204-016-1753-4. Epub 2016 Jun 15.
|
| 224 |
Mapping transcription mechanisms from multimodal genomic data.BMC Bioinformatics. 2010 Oct 28;11 Suppl 9(Suppl 9):S2. doi: 10.1186/1471-2105-11-S9-S2.
|
| 225 |
Potent and Highly Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Act as Chemotherapeutic Potentiators in Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.J Med Chem. 2019 Apr 11;62(7):3590-3616. doi: 10.1021/acs.jmedchem.9b00090. Epub 2019 Mar 25.
|
| 226 |
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.Leukemia. 2013 Apr;27(5):1063-71. doi: 10.1038/leu.2012.372. Epub 2012 Dec 28.
|
| 227 |
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.Pharmacogenet Genomics.2014 Feb;24(2):129-32.
|
| 228 |
Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation.FEBS Lett. 2008 Oct 15;582(23-24):3263-9. doi: 10.1016/j.febslet.2008.08.030. Epub 2008 Sep 5.
|
| 229 |
Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. Biochem Biophys Res Commun. 2004 Sep 24;322(3):836-41. doi: 10.1016/j.bbrc.2004.08.002.
|
| 230 |
Growth inhibitory and proapoptotic effects of l-asparaginase from Fusarium culmorum ASP-87 on human leukemia cells (Jurkat).Fundam Clin Pharmacol. 2017 Jun;31(3):292-300. doi: 10.1111/fcp.12257. Epub 2016 Dec 30.
|
| 231 |
AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.Mol Cancer Ther. 2011 Mar;10(3):437-47. doi: 10.1158/1535-7163.MCT-10-0777. Epub 2011 Jan 24.
|
| 232 |
Inhibition of novel GCN5-ATM axis restricts the onset of acquired drug resistance in leukemia.Int J Cancer. 2018 May 15;142(10):2175-2185. doi: 10.1002/ijc.31242. Epub 2018 Jan 13.
|
| 233 |
AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.Mol Cells. 2018 May 31;41(5):444-453. doi: 10.14348/molcells.2018.2311. Epub 2018 Feb 23.
|
| 234 |
ABL regulation by AXL promotes cisplatin resistance in esophageal cancer.Cancer Res. 2013 Jan 1;73(1):331-40. doi: 10.1158/0008-5472.CAN-12-3151. Epub 2012 Nov 1.
|
| 235 |
BCAT1 restricts KG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.Nature. 2017 Nov 16;551(7680):384-388. doi: 10.1038/nature24294. Epub 2017 Nov 8.
|
| 236 |
Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer.Breast Cancer Res Treat. 2002 Mar;72(1):11-22. doi: 10.1023/a:1014904701723.
|
| 237 |
BCL11A expression in acute myeloid leukemia.Leuk Res. 2016 Feb;41:71-5. doi: 10.1016/j.leukres.2015.12.001. Epub 2015 Dec 7.
|
| 238 |
BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.Am J Clin Pathol. 2015 Apr;143(4):547-57. doi: 10.1309/AJCPO4U4VYAAOTEL.
|
| 239 |
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia. 2003 Sep;17(9):1794-805. doi: 10.1038/sj.leu.2403044.
|
| 240 |
BMX tyrosine kinase gene is expressed in granulocytes and myeloid leukaemias.Br J Haematol. 1996 Sep;94(3):455-60.
|
| 241 |
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism.Oncotarget. 2016 Jan 19;7(3):2765-79. doi: 10.18632/oncotarget.6409.
|
| 242 |
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.J Clin Invest. 2019 Feb 21;129(5):1878-1894. doi: 10.1172/JCI120654. Print 2019 May 1.
|
| 243 |
Germline Genetic Predisposition to Hematologic Malignancy.J Clin Oncol. 2017 Mar 20;35(9):1018-1028. doi: 10.1200/JCO.2016.70.8644. Epub 2017 Feb 13.
|
| 244 |
shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin.Cell Biochem Biophys. 2015 Mar;71(2):827-35. doi: 10.1007/s12013-014-0270-4.
|
| 245 |
The role of the structural domains of human BST-2 in inhibiting the release of xenotropic murine leukemia virus-related virus.Biochem Biophys Res Commun. 2012 Nov 9;428(1):17-23. doi: 10.1016/j.bbrc.2012.10.001. Epub 2012 Oct 6.
|
| 246 |
Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.Exp Hematol. 2018 Apr;60:57-62.e3. doi: 10.1016/j.exphem.2018.01.006. Epub 2018 Feb 8.
|
| 247 |
Bruton's tyrosine kinase (BTK) inhibitors in treating cancer: a patent review (2010-2018).Expert Opin Ther Pat. 2019 Apr;29(4):217-241. doi: 10.1080/13543776.2019.1594777.
|
| 248 |
CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.Haematologica. 2015 Oct;100(10):1311-9. doi: 10.3324/haematol.2015.126953. Epub 2015 Jul 2.
|
| 249 |
Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.Chem Biol Interact. 2005 May 30;153-154:187-95. doi: 10.1016/j.cbi.2005.03.023. Epub 2005 Apr 13.
|
| 250 |
Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers.Clin Cancer Res. 2001 Nov;7(11):3416-22.
|
| 251 |
Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas.Pathology. 2009;41(5):484-7. doi: 10.1080/00313020903041143.
|
| 252 |
A caspase-2-RFXANK interaction and its implication for MHC class II expression.Cell Death Dis. 2018 Jan 23;9(2):80. doi: 10.1038/s41419-017-0144-y.
|
| 253 |
Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res. 2012 Aug 15;72(16):4214-24.
|
| 254 |
CBX7 Induces Self-Renewal of Human Normal and Malignant Hematopoietic Stem and Progenitor Cells by Canonical and Non-canonical Interactions.Cell Rep. 2019 Feb 12;26(7):1906-1918.e8. doi: 10.1016/j.celrep.2019.01.050.
|
| 255 |
CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines.Oncol Rep. 2005 Oct;14(4):1055-8. doi: 10.3892/or.14.4.1055.
|
| 256 |
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment.Nature. 2016 Nov 10;539(7628):304-308. doi: 10.1038/nature20131. Epub 2016 Oct 26.
|
| 257 |
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.Eur J Haematol. 2007 Sep;79(3):210-25. doi: 10.1111/j.1600-0609.2007.00899.x. Epub 2007 Jul 26.
|
| 258 |
Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia.Oncotarget. 2018 Dec 28;9(102):37753-37765. doi: 10.18632/oncotarget.26514. eCollection 2018 Dec 28.
|
| 259 |
Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.Pathol Int. 2007 Feb;57(2):53-9. doi: 10.1111/j.1440-1827.2006.02058.x.
|
| 260 |
Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells.Ann Hematol. 2006 Jul;85(7):458-62. doi: 10.1007/s00277-005-0076-y. Epub 2006 Mar 15.
|
| 261 |
Role of CXCR4-mediated bone marrow colonization in CNS infiltration by T cell acute lymphoblastic leukemia.J Leukoc Biol. 2016 Jun;99(6):1077-87. doi: 10.1189/jlb.5MA0915-394R. Epub 2016 Mar 1.
|
| 262 |
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.J Pathol. 2012 Apr;226(5):713-22. doi: 10.1002/path.3015. Epub 2011 Dec 9.
|
| 263 |
Phenotype, genotype and cytokine production in acute leukemia involving progenitors of dendritic Langerhans' cells.Leuk Res. 1994 Jul;18(7):499-511. doi: 10.1016/0145-2126(94)90088-4.
|
| 264 |
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients.Leuk Res. 2017 Jul;58:31-38. doi: 10.1016/j.leukres.2017.04.001. Epub 2017 Apr 4.
|
| 265 |
ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.Genes Chromosomes Cancer. 2017 Aug;56(8):608-616. doi: 10.1002/gcc.22464. Epub 2017 May 5.
|
| 266 |
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model. Leukemia. 2014 Jul;28(7):1501-10.
|
| 267 |
Distinct breakpoints in band 11q23 of the t(4;11) and t(11;14) associated with leukocyte malignancy.Genes Chromosomes Cancer. 1992 Jul;5(1):50-6. doi: 10.1002/gcc.2870050108.
|
| 268 |
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.Cancer Cell. 2019 Mar 18;35(3):473-488.e6. doi: 10.1016/j.ccell.2019.02.006.
|
| 269 |
TLX homeodomain oncogenes mediate T cell maturation arrest in T-ALL via interaction with ETS1 and suppression of TCR gene expression.Cancer Cell. 2012 Apr 17;21(4):563-76. doi: 10.1016/j.ccr.2012.02.013.
|
| 270 |
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.Blood. 2017 Jul 20;130(3):297-309. doi: 10.1182/blood-2016-12-756585. Epub 2017 May 11.
|
| 271 |
Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion.Blood. 2000 Apr 15;95(8):2725-7.
|
| 272 |
CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells.Cancer Cell Int. 2018 Jul 9;18:96. doi: 10.1186/s12935-018-0587-y. eCollection 2018.
|
| 273 |
miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.J Biol Chem. 2015 Jan 16;290(3):1818-28. doi: 10.1074/jbc.M114.599191. Epub 2014 Dec 1.
|
| 274 |
Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors.Eur J Med Chem. 2018 May 25;152:264-273. doi: 10.1016/j.ejmech.2018.04.048. Epub 2018 Apr 28.
|
| 275 |
A kinase-independent role for CDK8 in BCR-ABL1(+) leukemia.Nat Commun. 2019 Oct 18;10(1):4741. doi: 10.1038/s41467-019-12656-x.
|
| 276 |
Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.Eur J Med Chem. 2018 Oct 5;158:896-916. doi: 10.1016/j.ejmech.2018.09.025. Epub 2018 Sep 13.
|
| 277 |
The natural anti-tumor compound Celastrol targets a Myb-C/EBP-p300 transcriptional module implicated in myeloid gene expression.PLoS One. 2018 Feb 2;13(2):e0190934. doi: 10.1371/journal.pone.0190934. eCollection 2018.
|
| 278 |
Antileukemia component, dehydroeburicoic acid from Antrodia camphorata induces DNA damage and apoptosis in vitro and in vivo models.Phytomedicine. 2012 Jun 15;19(8-9):788-96. doi: 10.1016/j.phymed.2012.03.014. Epub 2012 Apr 18.
|
| 279 |
Clinicopathological analysis of 46 cases with CD4(+) and/or CD56(+) immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms.Histopathology. 2017 Dec;71(6):972-984. doi: 10.1111/his.13340. Epub 2017 Oct 10.
|
| 280 |
Endoplasmic reticulum stress differentially modulates the IL-6 family of cytokines in murine astrocytes and macrophages.Sci Rep. 2019 Oct 17;9(1):14931. doi: 10.1038/s41598-019-51481-6.
|
| 281 |
Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.Clin Cancer Res. 2017 Aug 1;23(15):4450-4461. doi: 10.1158/1078-0432.CCR-16-2426. Epub 2017 Mar 7.
|
| 282 |
Intracellular storage and regulated plasma membrane expression of human complement receptor type 1 in rat basophil leukemia cell transfectants.Blood. 1998 Jul 1;92(1):300-9.
|
| 283 |
Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies.Differentiation. 1982;22(2):113-9. doi: 10.1111/j.1432-0436.1982.tb01234.x.
|
| 284 |
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.Haematologica. 2013 Apr;98(4):602-10. doi: 10.3324/haematol.2012.070664. Epub 2012 Oct 25.
|
| 285 |
Peptidomimetic blockade of MYB in acute myeloid leukemia.Nat Commun. 2018 Jan 9;9(1):110. doi: 10.1038/s41467-017-02618-6.
|
| 286 |
The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines.Genome Res. 1996 Mar;6(3):187-94. doi: 10.1101/gr.6.3.187.
|
| 287 |
Colony stimulating factor-1 and leukemia inhibitor factor expression from current-cycle cannula isolated endometrial cells are associated with increased endometrial receptivity and pregnancy.BMC Womens Health. 2017 Aug 22;17(1):63. doi: 10.1186/s12905-017-0418-7.
|
| 288 |
Ets1 Plays a Critical Role in MLL/EB1-Mediated Leukemic Transformation in a Mouse Bone Marrow Transplantation Model.Neoplasia. 2019 May;21(5):469-481. doi: 10.1016/j.neo.2019.03.006. Epub 2019 Apr 8.
|
| 289 |
Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.Blood. 2010 Feb 18;115(7):1433-43. doi: 10.1182/blood-2009-06-227413. Epub 2009 Dec 9.
|
| 290 |
Lentivirus-mediated down-regulation of CK2 inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells.Biochem Cell Biol. 2018 Dec;96(6):786-796. doi: 10.1139/bcb-2017-0345. Epub 2018 May 17.
|
| 291 |
Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas.Neurosurg Focus. 2013 Dec;35(6):E3. doi: 10.3171/2013.10.FOCUS13326.
|
| 292 |
Significance of chemokine receptor expression in aggressive NK cell leukemia.Leukemia. 2005 Jul;19(7):1169-74. doi: 10.1038/sj.leu.2403732.
|
| 293 |
Genetic polymorphism of CYP3A5 in Indian chronic myeloid leukemia patients.Mol Cell Biochem. 2010 Mar;336(1-2):49-54. doi: 10.1007/s11010-009-0268-1. Epub 2009 Oct 13.
|
| 294 |
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides.Anticancer Drugs. 2000 Apr;11(4):285-94. doi: 10.1097/00001813-200004000-00010.
|
| 295 |
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3070-5. doi: 10.1073/pnas.042702899. Epub 2002 Feb 26.
|
| 296 |
Methyltransferase DNMT3B in leukemia.Leuk Lymphoma. 2020 Feb;61(2):263-273. doi: 10.1080/10428194.2019.1666377. Epub 2019 Sep 24.
|
| 297 |
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia.Nat Med. 2017 Apr;23(4):472-482. doi: 10.1038/nm.4310. Epub 2017 Mar 20.
|
| 298 |
Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha).Blood Cells Mol Dis. 2008 Jul-Aug;41(1):77-81. doi: 10.1016/j.bcmd.2008.02.011. Epub 2008 Apr 10.
|
| 299 |
A blood pact: the significance and implications of eIF4E on lymphocytic leukemia.Physiol Res. 2018 Jul 17;67(3):363-382. doi: 10.33549/physiolres.933696. Epub 2018 Mar 12.
|
| 300 |
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.Blood. 2007 Feb 15;109(4):1701-11. doi: 10.1182/blood-2005-03-037648. Epub 2006 Sep 28.
|
| 301 |
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation.Epigenetics Chromatin. 2018 Jun 8;11(1):30. doi: 10.1186/s13072-018-0197-x.
|
| 302 |
Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.Eur J Med Chem. 2019 Jan 1;161:594-606. doi: 10.1016/j.ejmech.2018.10.042. Epub 2018 Oct 23.
|
| 303 |
Role of Ets/Id proteins for telomerase regulation in human cancer cells.Exp Mol Pathol. 2003 Dec;75(3):238-47. doi: 10.1016/s0014-4800(03)00092-3.
|
| 304 |
Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy.Cell Death Dis. 2018 Feb 14;9(2):239. doi: 10.1038/s41419-018-0266-x.
|
| 305 |
Crosstalk between BCR-ABL and protease-activated receptor 1 (PAR1) suggests a novel target in chronic myeloid leukemia.Exp Hematol. 2018 Oct;66:50-62. doi: 10.1016/j.exphem.2018.07.008. Epub 2018 Aug 1.
|
| 306 |
Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds. Leuk Lymphoma. 2006 Aug;47(8):1629-38. doi: 10.1080/10428190600625398.
|
| 307 |
High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.Int J Hematol. 2016 Feb;103(2):189-95. doi: 10.1007/s12185-015-1913-y. Epub 2015 Nov 26.
|
| 308 |
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.Leukemia. 1998 Jun;12(6):845-59. doi: 10.1038/sj.leu.2401043.
|
| 309 |
Interferon- affects leukemia cell apoptosis through regulating Fas/FasL signaling pathway.Eur Rev Med Pharmacol Sci. 2017 May;21(9):2244-2248.
|
| 310 |
Intravascular Colonization of Kaposi Sarcoma: Expanding the Spectrum of Specific Infiltrates of B-Cell Chronic Lymphocytic Leukemia.Am J Dermatopathol. 2019 Dec;41(12):940-944. doi: 10.1097/DAD.0000000000001481.
|
| 311 |
Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor.J Immunol. 1993 Dec 15;151(12):7273-83.
|
| 312 |
The breakpoint of an inversion of chromosome 14 in a T-cell leukemia: sequences downstream of the immunoglobulin heavy chain locus are implicated in tumorigenesis.Proc Natl Acad Sci U S A. 1987 Dec;84(24):9069-73. doi: 10.1073/pnas.84.24.9069.
|
| 313 |
FES/FER kinase signaling in hematopoietic cells and leukemias.Front Biosci (Landmark Ed). 2012 Jan 1;17(3):861-75. doi: 10.2741/3961.
|
| 314 |
GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes.Oncogene. 1997 Feb 27;14(8):997-1001. doi: 10.1038/sj.onc.1200898.
|
| 315 |
FMNL1 promotes proliferation and migration of leukemia cells.J Leukoc Biol. 2013 Sep;94(3):503-12. doi: 10.1189/jlb.0113057. Epub 2013 Jun 25.
|
| 316 |
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.Anticancer Drugs. 2020 Jan;31(1):67-72. doi: 10.1097/CAD.0000000000000850.
|
| 317 |
Expression profiles of signal transduction genes in ex vivo drug-resistant pediatric acute lymphoblastic leukemia.Anticancer Res. 2012 Feb;32(2):503-6.
|
| 318 |
Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis.J Cell Physiol. 2008 Apr;215(1):27-36. doi: 10.1002/jcp.21285.
|
| 319 |
MiR-29b/Sp1/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt/-catenin pathway in acute myeloid leukemia.J Exp Clin Cancer Res. 2019 May 16;38(1):200. doi: 10.1186/s13046-019-1179-y.
|
| 320 |
The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.Sci Rep. 2017 Aug 29;7(1):9822. doi: 10.1038/s41598-017-10045-2.
|
| 321 |
Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.Biochem Pharmacol. 2017 Mar 15;128:12-25. doi: 10.1016/j.bcp.2016.12.022. Epub 2016 Dec 30.
|
| 322 |
Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells.Cancer Cell Int. 2018 Jan 29;18:13. doi: 10.1186/s12935-018-0507-1. eCollection 2018.
|
| 323 |
Identification of Leukemia Subtypes from Microscopic Images Using Convolutional Neural Network.Diagnostics (Basel). 2019 Aug 25;9(3):104. doi: 10.3390/diagnostics9030104.
|
| 324 |
Role of alpha class glutathione transferases (GSTs) in chemoprevention: GSTA1 and A4 overexpressing human leukemia (HL60) cells resist sulforaphane and curcumin induced toxicity.Phytother Res. 2011 Apr;25(4):563-8. doi: 10.1002/ptr.3297. Epub 2010 Sep 20.
|
| 325 |
hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.J Cancer Res Clin Oncol. 2018 Jul;144(7):1279-1288. doi: 10.1007/s00432-018-2654-0. Epub 2018 May 8.
|
| 326 |
Coexpression of erythroid and megakaryocytic genes in acute erythroblastic (FAB M6) and megakaryoblastic (FAB M7) leukaemias.Br J Haematol. 1998 Sep;102(5):1335-7. doi: 10.1046/j.1365-2141.1998.00904.x.
|
| 327 |
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.Cell Death Dis. 2015 Feb 12;6(2):e1635. doi: 10.1038/cddis.2014.594.
|
| 328 |
The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.Oncogene. 2018 May;37(19):2559-2572. doi: 10.1038/s41388-018-0143-1. Epub 2018 Feb 22.
|
| 329 |
Immunohistochemical detection of histidine decarboxylase in neoplastic mast cells in patients with systemic mastocytosis.Hum Pathol. 2006 Apr;37(4):439-47. doi: 10.1016/j.humpath.2005.11.015. Epub 2006 Feb 7.
|
| 330 |
Expression of the putative proto-oncogene His-1 in normal and neoplastic tissues.Am J Pathol. 1997 Apr;150(4):1297-305.
|
| 331 |
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?.Cancer Res. 2008 Dec 15;68(24):10121-7. doi: 10.1158/0008-5472.CAN-08-2121.
|
| 332 |
Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis.Hum Pathol. 2013 Feb;44(2):208-17. doi: 10.1016/j.humpath.2012.02.020. Epub 2012 Aug 3.
|
| 333 |
Transcription factor expression in B-cell precursor-leukemia cell lines: preferential expression of T-bet.Leuk Res. 2005 Jul;29(7):841-8. doi: 10.1016/j.leukres.2004.12.010. Epub 2005 Feb 24.
|
| 334 |
t(7;11)(p15;p15) Chronic myeloid leukaemia developed into blastic transformation showing a novel NUP98/HOXA11 fusion.Br J Haematol. 2002 Jan;116(1):170-2. doi: 10.1046/j.1365-2141.2002.03246.x.
|
| 335 |
Lineage and stage specific expression of HOX 1 genes in the human hematopoietic system.Biochem Biophys Res Commun. 1992 Mar 31;183(3):1124-30. doi: 10.1016/s0006-291x(05)80307-9.
|
| 336 |
Effect of silencing HOXA5 gene expression using RNA interference on cell cycle and apoptosis in Jurkat cells.Int J Mol Med. 2016 Mar;37(3):669-78. doi: 10.3892/ijmm.2016.2480. Epub 2016 Feb 4.
|
| 337 |
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia.Nat Genet. 1996 Feb;12(2):154-8. doi: 10.1038/ng0296-154.
|
| 338 |
The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.
|
| 339 |
Down-regulation of 11-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosis.PLoS One. 2013 Jun 24;8(6):e67067. doi: 10.1371/journal.pone.0067067. Print 2013.
|
| 340 |
Oncogenic hijacking of the stress response machinery in T cell acute lymphoblastic leukemia.Nat Med. 2018 Aug;24(8):1157-1166. doi: 10.1038/s41591-018-0105-8. Epub 2018 Jul 23.
|
| 341 |
Neferine in the LotusPlumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro.J Food Sci. 2019 Apr;84(4):904-910. doi: 10.1111/1750-3841.14484. Epub 2019 Mar 13.
|
| 342 |
Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias.Mol Cell Biol. 2008 Sep;28(17):5494-506. doi: 10.1128/MCB.00265-08. Epub 2008 Jun 30.
|
| 343 |
HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.Exp Hematol. 2012 Jan;40(1):14-21. doi: 10.1016/j.exphem.2011.09.004. Epub 2011 Sep 10.
|
| 344 |
Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.J Biol Chem. 2002 Mar 1;277(9):7466-76. doi: 10.1074/jbc.M103946200. Epub 2001 Dec 5.
|
| 345 |
Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin.Blood. 2016 May 12;127(19):2322-6. doi: 10.1182/blood-2015-11-677708. Epub 2016 Mar 4.
|
| 346 |
The PKR-Like Endoplasmic Reticulum Kinase Promotes the Dissemination of Myc-Induced Leukemic Cells.Mol Cancer Res. 2019 Jul;17(7):1450-1458. doi: 10.1158/1541-7786.MCR-19-0002. Epub 2019 Mar 22.
|
| 347 |
IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival.Cell Death Dis. 2014 Jun 26;5(6):e1300. doi: 10.1038/cddis.2014.268.
|
| 348 |
Runx1 is essential at two stages of early murine B-cell development.Blood. 2013 Jul 18;122(3):413-23. doi: 10.1182/blood-2013-01-480244. Epub 2013 May 23.
|
| 349 |
Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.Anticancer Res. 1999 May-Jun;19(3A):1785-90.
|
| 350 |
A short report on the effect of decreased incubation time on the architectural profile of autologous conditioned serum (ACS).Cytokine. 2017 Jun;94:52-54. doi: 10.1016/j.cyto.2017.03.019. Epub 2017 Apr 11.
|
| 351 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9802-7. doi: 10.1073/pnas.171309898. Epub 2001 Aug 7.
|
| 352 |
GPI-microdomains (membrane rafts) and signaling of the multi-chain interleukin-2 receptor in human lymphoma/leukemia T cell lines.Eur J Biochem. 2002 Feb;269(4):1199-208. doi: 10.1046/j.0014-2956.2002.02759.x.
|
| 353 |
Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias.Blood Adv. 2019 Dec 10;3(23):3962-3967. doi: 10.1182/bloodadvances.2019000731.
|
| 354 |
STAT5 is essential for IL-7-mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells.Blood Adv. 2018 Sep 11;2(17):2199-2213. doi: 10.1182/bloodadvances.2018021063.
|
| 355 |
IL-7R is essential for leukemia-initiating cell activity of T-cell acute lymphoblastic leukemia.Blood. 2019 Dec 12;134(24):2171-2182. doi: 10.1182/blood.2019000982.
|
| 356 |
Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.Cell Signal. 2012 Nov;24(11):2095-101. doi: 10.1016/j.cellsig.2012.07.017. Epub 2012 Jul 20.
|
| 357 |
Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.Leukemia. 2018 Nov;32(11):2374-2387. doi: 10.1038/s41375-018-0112-2. Epub 2018 Mar 29.
|
| 358 |
The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.Arch Immunol Ther Exp (Warsz). 2000;48(2):95-100.
|
| 359 |
Cross talk between Wnt/-catenin and Irf8 in leukemia progression and drug resistance.J Exp Med. 2013 Oct 21;210(11):2239-56. doi: 10.1084/jem.20130706. Epub 2013 Oct 7.
|
| 360 |
The increased expression of integrin 6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.PLoS One. 2012;7(1):e30706. doi: 10.1371/journal.pone.0030706. Epub 2012 Jan 25.
|
| 361 |
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.Cancer Discov. 2018 May;8(5):616-631. doi: 10.1158/2159-8290.CD-17-0583. Epub 2018 Mar 1.
|
| 362 |
JMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesis.Leukemia. 2019 Jun;33(6):1400-1410. doi: 10.1038/s41375-018-0354-z. Epub 2019 Jan 8.
|
| 363 |
Expression, purification, and analysis of MOZ and MORF histone acetyltransferases.Methods. 2003 Sep;31(1):24-32. doi: 10.1016/s1046-2023(03)00084-7.
|
| 364 |
Eag1 channels as potential cancer biomarkers.Sensors (Basel). 2012;12(5):5986-95. doi: 10.3390/s120505986. Epub 2012 May 10.
|
| 365 |
Functional up-regulation of HERG K+ channels in neoplastic hematopoietic cells.J Biol Chem. 2002 May 24;277(21):18528-34. doi: 10.1074/jbc.M200592200. Epub 2002 Mar 13.
|
| 366 |
Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia.Med Oncol. 2018 Nov 13;36(1):3. doi: 10.1007/s12032-018-1226-0.
|
| 367 |
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.Blood Adv. 2019 Nov 12;3(21):3307-3321. doi: 10.1182/bloodadvances.2019030981.
|
| 368 |
Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1366-1373. doi: 10.26355/eurrev_201803_14480.
|
| 369 |
JMJD3 facilitates C/EBP-centered transcriptional program to exert oncorepressor activity in AML.Nat Commun. 2018 Aug 22;9(1):3369. doi: 10.1038/s41467-018-05548-z.
|
| 370 |
Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.Leuk Res. 2010 Jan;34(1):55-8. doi: 10.1016/j.leukres.2009.04.022. Epub 2009 May 18.
|
| 371 |
NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.Blood. 2005 May 15;105(10):4135-42. doi: 10.1182/blood-2004-10-4113. Epub 2005 Feb 1.
|
| 372 |
Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5'-flanking region.Oncogene. 2006 Nov 9;25(53):7078-85. doi: 10.1038/sj.onc.1209697. Epub 2006 May 29.
|
| 373 |
Murine pre-B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor.Blood. 2018 Nov 1;132(18):1899-1910. doi: 10.1182/blood-2017-12-815548. Epub 2018 Sep 12.
|
| 374 |
Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes.Gene Ther. 2013 Sep;20(9):949-57. doi: 10.1038/gt.2013.18. Epub 2013 Apr 25.
|
| 375 |
Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.Cancer Cell. 2008 May;13(5):432-40. doi: 10.1016/j.ccr.2008.03.005.
|
| 376 |
LncRNA expression profile of Np63 in cervical squamous cancers and its suppressive effects on LIF expression.Cytokine. 2017 Aug;96:114-122. doi: 10.1016/j.cyto.2017.04.001. Epub 2017 Apr 7.
|
| 377 |
Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia.Cancer Cell. 2012 Oct 16;22(4):524-35. doi: 10.1016/j.ccr.2012.08.028.
|
| 378 |
Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model.Sci Rep. 2019 Apr 8;9(1):5760. doi: 10.1038/s41598-019-42214-w.
|
| 379 |
A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).Genomics. 1999 Feb 15;56(1):40-50. doi: 10.1006/geno.1998.5685.
|
| 380 |
TNF- and LT- polymorphisms and the risk of leukemia: a meta-analysis.Tumori. 2017 Jan 21;103(1):53-59. doi: 10.5301/tj.5000549. Epub 2016 Sep 1.
|
| 381 |
Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function.Biochem Biophys Res Commun. 2016 Apr 15;472(4):610-6. doi: 10.1016/j.bbrc.2016.03.018. Epub 2016 Mar 8.
|
| 382 |
Detection of exon polymorphisms in the human lactoferrin gene.Biochem Cell Biol. 2002;80(1):17-22. doi: 10.1139/o01-207.
|
| 383 |
ALK-activating homologous mutations in LTK induce cellular transformation.PLoS One. 2012;7(2):e31733. doi: 10.1371/journal.pone.0031733. Epub 2012 Feb 9.
|
| 384 |
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.J Natl Cancer Inst. 2008 Jul 2;100(13):926-39. doi: 10.1093/jnci/djn188. Epub 2008 Jun 24.
|
| 385 |
ORP4L Extracts and Presents PIP(2) from Plasma Membrane for PLC3 Catalysis: Targeting It Eradicates Leukemia Stem Cells.Cell Rep. 2019 Feb 19;26(8):2166-2177.e9. doi: 10.1016/j.celrep.2019.01.082.
|
| 386 |
Expression of the MAGE gene family in human lymphocytic leukemia.Cancer Immunol Immunother. 1995 Aug;41(2):90-103. doi: 10.1007/s002620050205.
|
| 387 |
mRNA expression of MAGE-A3 gene in leukemia cells.Leuk Res. 2007 Jan;31(1):33-7. doi: 10.1016/j.leukres.2006.05.009. Epub 2006 Jun 27.
|
| 388 |
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.Cancer. 2016 Jun 15;122(12):1871-9. doi: 10.1002/cncr.29986. Epub 2016 Mar 18.
|
| 389 |
Inhibition of MEK5 by BIX02188 induces apoptosis in cells expressing the oncogenic mutant FLT3-ITD.Biochem Biophys Res Commun. 2011 Aug 26;412(2):307-12. doi: 10.1016/j.bbrc.2011.07.089. Epub 2011 Jul 28.
|
| 390 |
Doubling Down on Mutant RAS Can MEK or Break Leukemia.Cell. 2017 Feb 23;168(5):749-750. doi: 10.1016/j.cell.2017.02.013.
|
| 391 |
Interferon-alpha induces the growth inhibition of human T-cell leukaemia line Jurkat through p38alpha and p38beta.J Biochem. 2010 May;147(5):645-50. doi: 10.1093/jb/mvp213. Epub 2010 Jan 6.
|
| 392 |
HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRAS(Q61L) cells.Am J Cancer Res. 2019 Apr 1;9(4):730-739. eCollection 2019.
|
| 393 |
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11746-50. doi: 10.1073/pnas.92.25.11746.
|
| 394 |
Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.Oncogene. 2017 May 4;36(18):2589-2598. doi: 10.1038/onc.2016.416. Epub 2016 Nov 7.
|
| 395 |
Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia.Cancers (Basel). 2019 Nov 12;11(11):1779. doi: 10.3390/cancers11111779.
|
| 396 |
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.JCI Insight. 2018 Nov 2;3(21):e97941. doi: 10.1172/jci.insight.97941.
|
| 397 |
Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis.Asian Pac J Cancer Prev. 2014;15(1):355-62. doi: 10.7314/apjcp.2014.15.1.355.
|
| 398 |
Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.J Biol Chem. 2018 Oct 5;293(40):15359-15369. doi: 10.1074/jbc.RA118.002243. Epub 2018 Aug 20.
|
| 399 |
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia.Blood. 2011 Jul 14;118(2):390-400. doi: 10.1182/blood-2010-11-316760. Epub 2011 May 19.
|
| 400 |
Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.Cancer Res. 2004 Aug 1;64(15):5154-61. doi: 10.1158/0008-5472.CAN-04-0600.
|
| 401 |
Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.Clin Exp Pharmacol Physiol. 2011 Nov;38(11):755-63. doi: 10.1111/j.1440-1681.2011.05585.x.
|
| 402 |
Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells. Int J Hematol. 2009 Jun;89(5):628-35. doi: 10.1007/s12185-009-0311-8. Epub 2009 Apr 14.
|
| 403 |
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.J Clin Invest. 2011 Apr;121(4):1456-70. doi: 10.1172/JCI43242.
|
| 404 |
Altered expression of the human retinoblastoma gene in monocytic leukaemias.Br J Haematol. 1993 Mar;83(3):428-32. doi: 10.1111/j.1365-2141.1993.tb04667.x.
|
| 405 |
Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice.J Neurochem. 2016 Jul;138(1):163-73. doi: 10.1111/jnc.13616. Epub 2016 Jun 6.
|
| 406 |
Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.Int J Hematol. 2009 Sep;90(2):143-152. doi: 10.1007/s12185-009-0384-4. Epub 2009 Aug 5.
|
| 407 |
Identification of a gene element essential for leukemia-specific expression of transgenes.Leukemia. 2004 Mar;18(3):415-9. doi: 10.1038/sj.leu.2403260.
|
| 408 |
Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.Clin Chem. 2002 Aug;48(8):1265-71.
|
| 409 |
Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines.Eur J Cancer. 1998 Oct;34(11):1783-8. doi: 10.1016/s0959-8049(98)00190-7.
|
| 410 |
Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.Leuk Res. 2016 Nov;50:85-94. doi: 10.1016/j.leukres.2016.09.018. Epub 2016 Sep 26.
|
| 411 |
Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells.J Immunother. 2009 Jul-Aug;32(6):539-51. doi: 10.1097/CJI.0b013e3181987c22.
|
| 412 |
Cloning and chromosomal localization of the human P2Y1 purinoceptor.Biochem Biophys Res Commun. 1996 Jan 26;218(3):783-8. doi: 10.1006/bbrc.1996.0139.
|
| 413 |
Transforming activity of purinergic receptor P2Y, G protein coupled, 8 revealed by retroviral expression screening.Leuk Lymphoma. 2007 May;48(5):978-86. doi: 10.1080/10428190701225882.
|
| 414 |
The functional haplotype of peptidylarginine deiminase IV (S55G, A82V and A112G) associated with susceptibility to rheumatoid arthritis dominates apoptosis of acute T leukemia Jurkat cells.Apoptosis. 2007 Mar;12(3):475-87. doi: 10.1007/s10495-006-0005-0. Epub 2007 Jan 11.
|
| 415 |
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.Blood Cells Mol Dis. 2001 Sep-Oct;27(5):825-9. doi: 10.1006/bcmd.2001.0452.
|
| 416 |
Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridization.Bone Marrow Transplant. 1989 Jan;4 Suppl 1:13-5.
|
| 417 |
Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cells.J Pharmacol Sci. 2015 Dec;129(4):210-5. doi: 10.1016/j.jphs.2015.10.008. Epub 2015 Nov 6.
|
| 418 |
The poor prognosis of the primary gastric epithelioid angiosarcoma: A case report.Medicine (Baltimore). 2018 Apr;97(15):e0287. doi: 10.1097/MD.0000000000010287.
|
| 419 |
Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells.Leuk Res. 2004 Jun;28(6):631-8. doi: 10.1016/j.leukres.2003.10.028.
|
| 420 |
-catenin induces expression of prohibitin gene in acute leukemic cells.Oncol Rep. 2017 Jun;37(6):3201-3208. doi: 10.3892/or.2017.5599. Epub 2017 Apr 25.
|
| 421 |
The histone demethylase PHF8 is an oncogenic protein in human non-small cell lung cancer.Biochem Biophys Res Commun. 2014 Aug 15;451(1):119-25. doi: 10.1016/j.bbrc.2014.07.076. Epub 2014 Jul 24.
|
| 422 |
Role of PIM2 in allergic asthma.Mol Med Rep. 2017 Nov;16(5):7504-7512. doi: 10.3892/mmr.2017.7499. Epub 2017 Sep 18.
|
| 423 |
PLA2R1: expression and function in cancer.Biochim Biophys Acta. 2014 Aug;1846(1):40-4. doi: 10.1016/j.bbcan.2014.03.003. Epub 2014 Mar 22.
|
| 424 |
Nuclear phospholipase C gamma: punctate distribution and association with the promyelocytic leukemia protein.J Proteome Res. 2007 May;6(5):2027-32. doi: 10.1021/pr060684v. Epub 2007 Apr 10.
|
| 425 |
The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies.Leuk Lymphoma. 2015 Jul;56(7):2123-33. doi: 10.3109/10428194.2014.971407. Epub 2015 Jan 24.
|
| 426 |
Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukaemia PLB-985 cells differentiated toward neutrophils: cleavage of non-muscle myosin heavy chain-IIA by caspases.Br J Haematol. 2007 Aug;138(4):545-54. doi: 10.1111/j.1365-2141.2007.06692.x.
|
| 427 |
A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs.J Immunol. 1999 Nov 1;163(9):4994-5004.
|
| 428 |
Knockdown of protein phosphatase 5 (PPP5C) suppresses the growth of leukemic cell line U937.Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):27-31.
|
| 429 |
PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD(+) acute myeloid leukemia.Blood. 2019 Aug 8;134(6):548-560. doi: 10.1182/blood.2019001282. Epub 2019 Jun 19.
|
| 430 |
A novel specific cleavage of IB protein in acute myeloid leukemia cells involves protease PR3.Exp Cell Res. 2019 Sep 1;382(1):111441. doi: 10.1016/j.yexcr.2019.05.022. Epub 2019 May 22.
|
| 431 |
LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis. Blood. 2018 Jan 4;131(1):95-107.
|
| 432 |
Functional platelet-activating factor receptors in immature forms of leukemic blasts.Leuk Res. 2007 Mar;31(3):399-402. doi: 10.1016/j.leukres.2006.06.002. Epub 2006 Jul 11.
|
| 433 |
Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.BMC Cancer. 2019 Mar 6;19(1):202. doi: 10.1186/s12885-019-5411-0.
|
| 434 |
Identification of transcripts modulated by ETV6 expression.Br J Haematol. 2007 Jan;136(1):48-62. doi: 10.1111/j.1365-2141.2006.06377.x. Epub 2006 Oct 27.
|
| 435 |
The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor (Tel-PdgfR) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).J Biol Chem. 2012 Mar 9;287(11):8110-25. doi: 10.1074/jbc.M111.294884. Epub 2012 Jan 18.
|
| 436 |
Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.J Biol Chem. 2019 Aug 16;294(33):12483-12494. doi: 10.1074/jbc.RA119.008666. Epub 2019 Jun 27.
|
| 437 |
Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors.Cancer. 1993 Jun 15;71(12):3873-81. doi: 10.1002/1097-0142(19930615)71:12<3873::aid-cncr2820711214>3.0.co;2-1.
|
| 438 |
Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway.Leukemia. 2017 May;31(5):1154-1165. doi: 10.1038/leu.2016.287. Epub 2016 Oct 17.
|
| 439 |
Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.Leukemia. 1993 Feb;7(2):290-7.
|
| 440 |
Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.PLoS One. 2015 Mar 20;10(3):e0119831. doi: 10.1371/journal.pone.0119831. eCollection 2015.
|
| 441 |
Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.Mol Oncol. 2016 May;10(5):677-92. doi: 10.1016/j.molonc.2015.12.009. Epub 2015 Dec 20.
|
| 442 |
Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?.Int J Cancer. 2019 Apr 1;144(7):1664-1675. doi: 10.1002/ijc.31922. Epub 2018 Dec 18.
|
| 443 |
Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models.Haematologica. 2020 Mar;105(3):697-707. doi: 10.3324/haematol.2018.205534. Epub 2019 May 23.
|
| 444 |
Evidence of functional interaction between NuMA-RARalpha and RXRalpha in an in vivo model of acute promyelocytic leukemia.Oncogene. 2008 Aug 7;27(34):4666-77. doi: 10.1038/onc.2008.106. Epub 2008 Apr 14.
|
| 445 |
Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.Leuk Lymphoma. 2008 Jun;49(6):1123-31. doi: 10.1080/10428190802035933.
|
| 446 |
Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia.Biochim Biophys Acta. 2002 Dec 12;1579(2-3):117-23. doi: 10.1016/s0167-4781(02)00529-8.
|
| 447 |
PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage.J Pathol. 2005 May;206(1):76-86. doi: 10.1002/path.1752.
|
| 448 |
VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis.J Exp Med. 2013 Sep 23;210(10):1993-2010. doi: 10.1084/jem.20121200. Epub 2013 Sep 16.
|
| 449 |
Functional characterization of L-selectin ligands on human neutrophils and leukemia cell lines: evidence for mucinlike ligand activity distinct from P-selectin glycoprotein ligand-1.Blood. 1998 Feb 1;91(3):1067-75.
|
| 450 |
The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.Biochem Biophys Res Commun. 2008 Jul 11;371(4):823-8. doi: 10.1016/j.bbrc.2008.04.179. Epub 2008 May 12.
|
| 451 |
Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.Leuk Res. 2010 May;34(5):615-21. doi: 10.1016/j.leukres.2009.08.018. Epub 2009 Sep 12.
|
| 452 |
Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia.Leuk Res. 2000 Jul;24(7):559-65. doi: 10.1016/s0145-2126(00)00017-5.
|
| 453 |
Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.Int J Mol Sci. 2019 Feb 27;20(5):1029. doi: 10.3390/ijms20051029.
|
| 454 |
Expression and protein-binding studies of the EEN gene family, new interacting partners for dynamin, synaptojanin and huntingtin proteins.Biochem J. 2000 Jun 1;348 Pt 2(Pt 2):447-58.
|
| 455 |
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.Haematologica. 2018 Jan;103(1):80-90. doi: 10.3324/haematol.2017.176248. Epub 2017 Oct 12.
|
| 456 |
Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.Exp Hematol. 2019 Aug;76:38-48.e2. doi: 10.1016/j.exphem.2019.07.002. Epub 2019 Jul 8.
|
| 457 |
Identification of OCT6 as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias. Exp Hematol. 2002 Oct;30(10):1162-9.
|
| 458 |
Association of Leukemia Target Genes Tet2, Bcl2, and Slc23a2 in Vitamin C Pathways.Cancer Genomics Proteomics. 2019 Sep-Oct;16(5):333-344. doi: 10.21873/cgp.20138.
|
| 459 |
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.Oncotarget. 2017 Apr 4;8(14):23073-23086. doi: 10.18632/oncotarget.14981.
|
| 460 |
PCFT/SLC46A1 promoter methylation and restoration of gene expression in human leukemia cells. Biochem Biophys Res Commun. 2008 Nov 28;376(4):787-92.
|
| 461 |
Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia.Epigenetics. 2009 May 16;4(4):265-9. doi: 10.4161/epi.9137. Epub 2009 May 1.
|
| 462 |
Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.Mol Cancer. 2010 Sep 13;9:239. doi: 10.1186/1476-4598-9-239.
|
| 463 |
SMYD2 lysine methyltransferase regulates leukemia cell growth and regeneration after genotoxic stress.Oncotarget. 2017 Mar 7;8(10):16712-16727. doi: 10.18632/oncotarget.15147.
|
| 464 |
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents.Eur J Med Chem. 2019 Feb 15;164:391-398. doi: 10.1016/j.ejmech.2018.12.059. Epub 2018 Dec 24.
|
| 465 |
SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.Eur Rev Med Pharmacol Sci. 2017 Jul;21(13):3005-3011.
|
| 466 |
Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.Int J Hematol. 2008 Apr;87(3):266-75. doi: 10.1007/s12185-008-0052-0. Epub 2008 Feb 20.
|
| 467 |
E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.Cancer Res. 2016 Dec 1;76(23):6937-6949. doi: 10.1158/0008-5472.CAN-16-1899. Epub 2016 Oct 7.
|
| 468 |
SRPK1siRNA suppresses K562 cell growth and induces apoptosis via the PARPcaspase3 pathway.Mol Med Rep. 2018 Jan;17(1):2070-2076. doi: 10.3892/mmr.2017.8032. Epub 2017 Nov 13.
|
| 469 |
Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).PLoS One. 2015 Aug 5;10(8):e0134882. doi: 10.1371/journal.pone.0134882. eCollection 2015.
|
| 470 |
Stanniocalcin-1 as a novel marker to detect minimal residual disease of human leukemia.Tohoku J Exp Med. 2004 Oct;204(2):125-33. doi: 10.1620/tjem.204.125.
|
| 471 |
Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.Mutat Res. 2011 Jun 17;722(2):154-64. doi: 10.1016/j.mrgentox.2010.08.019. Epub 2010 Sep 9.
|
| 472 |
Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.J Korean Med Sci. 2013 Feb;28(2):237-46. doi: 10.3346/jkms.2013.28.2.237. Epub 2013 Jan 29.
|
| 473 |
Dysregulation of different classes of tRNA fragments in chronic lymphocytic leukemia.Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24252-24258. doi: 10.1073/pnas.1913695116. Epub 2019 Nov 13.
|
| 474 |
Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells.Cancer Biol Ther. 2007 Aug;6(8):1186-92. doi: 10.4161/cbt.6.8.4381. Epub 2007 May 4.
|
| 475 |
Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis.Life Sci. 1992;50(26):2059-65. doi: 10.1016/0024-3205(92)90572-7.
|
| 476 |
Thyroid hormone induces hypoxia-inducible factor 1alpha gene expression through thyroid hormone receptor beta/retinoid x receptor alpha-dependent activation of hepatic leukemia factor.Endocrinology. 2008 May;149(5):2241-50. doi: 10.1210/en.2007-1238. Epub 2008 Jan 31.
|
| 477 |
Analysis of Tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells.Br J Haematol. 1997 Jul;98(1):195-203. doi: 10.1046/j.1365-2141.1997.1732989.x.
|
| 478 |
The role of TRAIL death receptors in the treatment of hematological malignancies.Leuk Lymphoma. 2008 Jan;49(1):27-35. doi: 10.1080/10428190701713655.
|
| 479 |
Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.Mol Cancer Res. 2014 Apr;12(4):550-9. doi: 10.1158/1541-7786.MCR-13-0458. Epub 2014 Jan 27.
|
| 480 |
Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival.PLoS One. 2011;6(6):e20787. doi: 10.1371/journal.pone.0020787. Epub 2011 Jun 8.
|
| 481 |
Study of gene expression of CD30 variant (CD30v) and CD30 ligand (CD30L) in acute leukemia.Egypt J Immunol. 2007;14(1):11-20.
|
| 482 |
Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity.Leukemia. 2015 Feb;29(2):387-95. doi: 10.1038/leu.2014.174. Epub 2014 Jun 3.
|
| 483 |
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells.Haematologica. 2019 Oct;104(10):2006-2016. doi: 10.3324/haematol.2018.192062. Epub 2019 Feb 28.
|
| 484 |
Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity.Br J Haematol. 2004 Feb;124(4):454-62. doi: 10.1046/j.1365-2141.2003.04791.x.
|
| 485 |
Tnk1: a novel intracellular tyrosine kinase gene isolated from human umbilical cord blood CD34+/Lin-/CD38- stem/progenitor cells.Oncogene. 1996 Feb 15;12(4):903-13.
|
| 486 |
Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.Sci Signal. 2018 Jul 17;11(539):eaao5617. doi: 10.1126/scisignal.aao5617.
|
| 487 |
Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.DNA Repair (Amst). 2020 Jan;85:102747. doi: 10.1016/j.dnarep.2019.102747. Epub 2019 Nov 6.
|
| 488 |
Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone.J Biol Chem. 2002 Oct 4;277(40):37430-8. doi: 10.1074/jbc.M207413200. Epub 2002 Jul 30.
|
| 489 |
Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia.Proc Natl Acad Sci U S A. 1987 Jan;84(1):251-5. doi: 10.1073/pnas.84.1.251.
|
| 490 |
Targeting the T cell receptor -chain constant region for immunotherapy of T cell malignancies.Nat Med. 2017 Dec;23(12):1416-1423. doi: 10.1038/nm.4444. Epub 2017 Nov 13.
|
| 491 |
Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.Expert Opin Ther Targets. 2014 Oct;18(10):1177-96. doi: 10.1517/14728222.2014.940894. Epub 2014 Jul 29.
|
| 492 |
Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation.Sci Rep. 2019 Feb 7;9(1):1554. doi: 10.1038/s41598-018-37469-8.
|
| 493 |
Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells.Am J Physiol Cell Physiol. 2009 May;296(5):C1098-104. doi: 10.1152/ajpcell.00435.2008. Epub 2009 Mar 18.
|
| 494 |
A novel xenograft model to study the role of TSLP-induced CRLF2 signals in normal and malignant human B lymphopoiesis.Haematologica. 2016 Apr;101(4):417-26. doi: 10.3324/haematol.2015.125336. Epub 2015 Nov 26.
|
| 495 |
Effect of tyrosinase and caffeic acid crosslinking of turbot parvalbumin on the digestibility, and release of mediators and cytokines from activated RBL-2H3 cells.Food Chem. 2019 Dec 1;300:125209. doi: 10.1016/j.foodchem.2019.125209. Epub 2019 Jul 20.
|
| 496 |
USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia.Clin Cancer Res. 2019 Jan 1;25(1):222-239. doi: 10.1158/1078-0432.CCR-18-1740. Epub 2018 Sep 17.
|
| 497 |
The identification of novel small-molecule inhibitors targeting WDR5-MLL1 interaction through fluorescence polarization based high-throughput screening.Bioorg Med Chem Lett. 2019 Feb 15;29(4):638-645. doi: 10.1016/j.bmcl.2018.12.035. Epub 2018 Dec 17.
|
| 498 |
WEE1 is a validated target of the microRNA miR-17-92 cluster in leukemia.Cancer Genet. 2015 May;208(5):279-87. doi: 10.1016/j.cancergen.2015.01.001. Epub 2015 Jan 20.
|
| 499 |
Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.Blood. 2018 Jul 12;132(2):170-178. doi: 10.1182/blood-2017-12-819383. Epub 2018 Apr 20.
|
| 500 |
Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation.BMC Cancer. 2012 Feb 7;12:60. doi: 10.1186/1471-2407-12-60.
|
| 501 |
Inhibition of X-linked inhibitor of apoptosis protein enhances anti-tumor potency of pure total flavonoids on the growth of leukemic cells.Exp Ther Med. 2018 Feb;15(2):2020-2026. doi: 10.3892/etm.2017.5627. Epub 2017 Dec 14.
|
| 502 |
A critical role for CRM1 in regulating HOXA gene transcription in CALM-AF10 leukemias.Leukemia. 2015 Feb;29(2):423-32. doi: 10.1038/leu.2014.221. Epub 2014 Jul 16.
|
| 503 |
Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.J Cell Mol Med. 2012 Sep;16(9):2074-84. doi: 10.1111/j.1582-4934.2011.01503.x.
|
| 504 |
Base excision repair proteins couple activation-induced cytidine deaminase and endonuclease G during replication stress-induced MLL destabilization.Leukemia. 2018 Jan;32(1):159-167. doi: 10.1038/leu.2017.191. Epub 2017 Jun 19.
|
| 505 |
Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia.Br J Haematol. 2014 Nov;167(3):376-84. doi: 10.1111/bjh.13054. Epub 2014 Jul 31.
|
| 506 |
Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia.Int J Cancer. 2008 Oct 15;123(8):1824-31. doi: 10.1002/ijc.23749.
|
| 507 |
CD47 agonist peptide PKHB1 induces immunogenic cell death in T-cell acute lymphoblastic leukemia cells.Cancer Sci. 2019 Jan;110(1):256-268. doi: 10.1111/cas.13885. Epub 2018 Dec 14.
|
| 508 |
RTP801 is a novel retinoic acid-responsive gene associated with myeloid differentiation.Exp Hematol. 2007 Apr;35(4):572-8. doi: 10.1016/j.exphem.2007.01.049.
|
| 509 |
T Cells Deficient in Diacylglycerol Kinase Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia.Cancer Res. 2017 Oct 15;77(20):5676-5686. doi: 10.1158/0008-5472.CAN-17-1309. Epub 2017 Sep 15.
|
| 510 |
Functional impairment of the HIPK2 small ubiquitin-like modifier (SUMO)-interacting motif in acute myeloid leukemia.Am J Cancer Res. 2019 Jan 1;9(1):94-107. eCollection 2019.
|
| 511 |
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.J Clin Oncol. 2013 Oct 20;31(30):3782-90. doi: 10.1200/JCO.2012.47.4007. Epub 2013 Sep 16.
|
| 512 |
A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.Leukemia. 1995 Jul;9(7):1233-9.
|
| 513 |
Glycolytic Enzyme PKM2 Mediates Autophagic Activation to Promote Cell Survival in NPM1-Mutated Leukemia.Int J Biol Sci. 2019 Mar 1;15(4):882-894. doi: 10.7150/ijbs.30290. eCollection 2019.
|
| 514 |
Biotin conjugated organic molecules and proteins for cancer therapy: A review.Eur J Med Chem. 2018 Feb 10;145:206-223. doi: 10.1016/j.ejmech.2018.01.001. Epub 2018 Jan 2.
|
| 515 |
Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells.Mol Cancer Ther. 2013 Dec;12(12):2651-62. doi: 10.1158/1535-7163.MCT-13-0103-T. Epub 2013 Oct 15.
|
| 516 |
The Antitumor Activity of TCR-Mimic Antibody-Drug Conjugates (TCRm-ADCs) Targeting the Intracellular Wilms Tumor 1 (WT1) Oncoprotein.Int J Mol Sci. 2019 Aug 12;20(16):3912. doi: 10.3390/ijms20163912.
|
| 517 |
Identification of novel sarcoma risk genes using a two-stage genome wide DNA sequencing strategy in cancer cluster families and population case and control cohorts.BMC Med Genet. 2019 May 3;20(1):69. doi: 10.1186/s12881-019-0808-9.
|
| 518 |
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.Blood. 2008 Sep 1;112(5):2013-6. doi: 10.1182/blood-2008-01-128595. Epub 2008 Jun 19.
|
| 519 |
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.Cytokine. 2017 Jan;89:116-121. doi: 10.1016/j.cyto.2016.01.024. Epub 2016 Apr 16.
|
| 520 |
SLC22A4 and RUNX1: identification of RA susceptible genes.J Mol Med (Berl). 2004 Sep;82(9):558-64. doi: 10.1007/s00109-004-0547-y. Epub 2004 Jun 4.
|
| 521 |
Mouse and human ornithine decarboxylase genes. Methylation polymorphism and amplification.Biochem J. 1987 Feb 15;242(1):205-10. doi: 10.1042/bj2420205.
|
| 522 |
Targeting protein tyrosine phosphatase SHP2 for the treatment of PTPN11-associated malignancies.Mol Cancer Ther. 2013 Sep;12(9):1738-48. doi: 10.1158/1535-7163.MCT-13-0049-T. Epub 2013 Jul 3.
|
| 523 |
Determinants of sensitivity of human T-cell leukemia CCRF-CEM cells to immucillin-H.Leuk Res. 2008 Aug;32(8):1268-78. doi: 10.1016/j.leukres.2007.12.015. Epub 2008 Feb 14.
|
| 524 |
Role of ZIP8 in regulation of cisplatin sensitivity through Bcl-2. Toxicol Appl Pharmacol. 2019 Jan 1;362:52-58. doi: 10.1016/j.taap.2018.10.016. Epub 2018 Oct 17.
|
| 525 |
Polymorphic variants of GSTM1, GSTT1, and GSTP1 genes in childhood acute leukemias: A preliminary study in Argentina.Hematology. 2015 Oct;20(9):511-6. doi: 10.1179/1607845415Y.0000000007. Epub 2015 Mar 23.
|
| 526 |
Binding of a Smad4/Ets-1 complex to a novel intragenic regulatory element in exon12 of FPGS underlies decreased gene expression and antifolate resistance in leukemia.Oncotarget. 2014 Oct 15;5(19):9183-98. doi: 10.18632/oncotarget.2399.
|
| 527 |
Relapsed acute lymphoblastic leukemia-specific mutations in NT5C2 cluster into hotspots driving intersubunit stimulation.Leukemia. 2018 Jun;32(6):1393-1403. doi: 10.1038/s41375-018-0073-5. Epub 2018 Feb 25.
|
| 528 |
Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.Pharmacogenet Genomics. 2020 Jan;30(1):1-4. doi: 10.1097/FPC.0000000000000388.
|
| 529 |
ABO genotyping of various hematopoietic cell lines to select model cells for research purposes.Hum Immunol. 2019 Nov;80(11):917-922. doi: 10.1016/j.humimm.2019.08.002. Epub 2019 Aug 17.
|
| 530 |
Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.Cell Biol Toxicol. 2019 Apr;35(2):161-177. doi: 10.1007/s10565-018-9444-y. Epub 2018 Sep 15.
|
| 531 |
Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.Mol Cancer Ther. 2019 Sep;18(9):1587-1592. doi: 10.1158/1535-7163.MCT-18-1329. Epub 2019 Jun 17.
|
| 532 |
Acrylamide-induced molecular mutation spectra at HPRT locus in human promyelocytic leukaemia HL-60 and NB4 cell lines.Mutagenesis. 2008 Jul;23(4):309-15. doi: 10.1093/mutage/gen016. Epub 2008 Apr 11.
|
| 533 |
Subcellular localization of DJ-1 in human HL-60 leukemia cells in response to diallyl disulfide treatment.Mol Med Rep. 2016 Nov;14(5):4666-4672. doi: 10.3892/mmr.2016.5831. Epub 2016 Oct 12.
|
| 534 |
The anti-apoptotic PON2 protein is Wnt/-catenin-regulated and correlates with radiotherapy resistance in OSCC patients.Oncotarget. 2016 Aug 9;7(32):51082-51095. doi: 10.18632/oncotarget.9013.
|
| 535 |
5'-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia.Clin Biochem. 1998 Jun;31(4):269-72. doi: 10.1016/s0009-9120(98)00017-4.
|
| 536 |
Association of MTG8 (ETO/CDR), a leukemia-related protein, with serine/threonine protein kinases and heat shock protein HSP90 in human hematopoietic cell lines.Jpn J Cancer Res. 1999 Jan;90(1):60-8. doi: 10.1111/j.1349-7006.1999.tb00666.x.
|
| 537 |
Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia.Mol Cancer Res. 2018 Feb;16(2):279-285. doi: 10.1158/1541-7786.MCR-17-0569. Epub 2017 Nov 13.
|
| 538 |
Cloning and expression of uridine/cytidine kinase cDNA from human fibrosarcoma cells.Int J Mol Med. 2001 Sep;8(3):273-8.
|
| 539 |
A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol.Biochem Biophys Res Commun. 2006 Jul 28;346(2):454-60. doi: 10.1016/j.bbrc.2006.05.161.
|
| 540 |
Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.Leuk Lymphoma. 2014 Aug;55(8):1910-4. doi: 10.3109/10428194.2013.867492. Epub 2014 Jan 24.
|
| 541 |
The effect of paclitaxel on gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in human leukemia HL-60 cells.Food Chem Toxicol. 2002 May;40(5):705-13. doi: 10.1016/s0278-6915(01)00129-6.
|
| 542 |
A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.Genes Chromosomes Cancer. 2003 May;37(1):79-83. doi: 10.1002/gcc.10175.
|
| 543 |
Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding.Development. 1999 Oct;126(20):4603-15. doi: 10.1242/dev.126.20.4603.
|
| 544 |
Cloned hst gene from normal human leukocyte DNA transforms NIH3T3 cells.Biochem Biophys Res Commun. 1988 Mar 30;151(3):965-72. doi: 10.1016/s0006-291x(88)80460-1.
|
| 545 |
Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia.Exp Hematol. 2006 Sep;34(9):1192-201. doi: 10.1016/j.exphem.2006.04.020.
|
| 546 |
Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia.Leukemia. 2014 Nov;28(11):2165-77. doi: 10.1038/leu.2014.120. Epub 2014 Apr 4.
|
| 547 |
T-cell acute lymphoblastic leukemia with add(1)(p36) and del(12)(p11) following acute myelocytic leukemia with partial deletion of 9p.Cancer Genet Cytogenet. 2004 Apr 1;150(1):62-5. doi: 10.1016/j.cancergencyto.2003.08.003.
|
| 548 |
Nuclear pore proteins and cancer.Semin Cell Dev Biol. 2009 Jul;20(5):620-30. doi: 10.1016/j.semcdb.2009.03.003. Epub 2009 Mar 18.
|
| 549 |
Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.Am J Hematol. 2005 Dec;80(4):282-7. doi: 10.1002/ajh.20503.
|
| 550 |
Red cell ABH antigens in leukaemias and lymphomas.Vox Sang. 1978 Sep;35(3):154-9. doi: 10.1111/j.1423-0410.1978.tb02915.x.
|
| 551 |
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.J Clin Invest. 2014 Feb;124(2):580-91. doi: 10.1172/JCI71861. Epub 2014 Jan 16.
|
| 552 |
Papillomavirus can be transmitted through the blood and produce infections in blood recipients: Evidence from two animal models.Emerg Microbes Infect. 2019;8(1):1108-1121. doi: 10.1080/22221751.2019.1637072.
|
| 553 |
The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis.J Hematol Oncol. 2018 Feb 26;11(1):27. doi: 10.1186/s13045-018-0567-7.
|
| 554 |
Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.Genet Test Mol Biomarkers. 2019 Mar;23(3):176-179. doi: 10.1089/gtmb.2018.0283. Epub 2019 Feb 27.
|
| 555 |
Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias.Cancer Cell. 2019 Apr 15;35(4):664-676.e7. doi: 10.1016/j.ccell.2019.03.004.
|
| 556 |
An ARC-Regulated IL1/Cox-2/PGE2/-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.Cancer Res. 2019 Mar 15;79(6):1165-1177. doi: 10.1158/0008-5472.CAN-18-0921. Epub 2019 Jan 23.
|
| 557 |
SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.Oncogene. 2006 Aug 24;25(37):5180-6. doi: 10.1038/sj.onc.1209520. Epub 2006 Apr 24.
|
| 558 |
Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.Exp Hematol. 2019 Jun;74:42-51.e3. doi: 10.1016/j.exphem.2019.04.003. Epub 2019 May 13.
|
| 559 |
CBF-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia.Cell. 2018 Jun 28;174(1):172-186.e21. doi: 10.1016/j.cell.2018.05.048.
|
| 560 |
CytCD79a expression in acute leukemia with t(8;21): biphenotypic or myeloid leukemia?.Cancer Genet Cytogenet. 2007 Apr 1;174(1):76-7. doi: 10.1016/j.cancergencyto.2006.11.007.
|
| 561 |
Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.Pediatr Hematol Oncol. 2016 Apr;33(3):157-67. doi: 10.3109/08880018.2016.1161685.
|
| 562 |
A tool compound targeting the core binding factor Runt domain to disrupt binding to CBF in leukemic cells.Leuk Lymphoma. 2018 Sep;59(9):2188-2200. doi: 10.1080/10428194.2017.1410882. Epub 2017 Dec 18.
|
| 563 |
The proliferation associated nuclear element (PANE1) is conserved between mammals and fish and preferentially expressed in activated lymphoid cells.Gene Expr Patterns. 2004 Jul;4(4):389-95. doi: 10.1016/j.modgep.2004.01.008.
|
| 564 |
Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-B and ERK5 signaling pathway.Biochem Pharmacol. 2016 Jan 1;99:132-45. doi: 10.1016/j.bcp.2015.12.002. Epub 2015 Dec 8.
|
| 565 |
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancers.J Cancer Res Clin Oncol. 2018 Dec;144(12):2339-2349. doi: 10.1007/s00432-018-2765-7. Epub 2018 Oct 20.
|
| 566 |
Targeted therapy and disease monitoring in CNTRL-FGFR1-driven leukaemia.Pediatr Blood Cancer. 2019 Oct;66(10):e27897. doi: 10.1002/pbc.27897. Epub 2019 Jun 28.
|
| 567 |
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia.Transl Oncol. 2019 May;12(5):726-732. doi: 10.1016/j.tranon.2019.02.002. Epub 2019 Mar 13.
|
| 568 |
Two chimaeric transcription units result from an inversion breaking intron 1 of the factor VIII gene and a region reportedly affected by reciprocal translocations in T-cell leukaemia.Hum Mol Genet. 1996 Dec;5(12):1945-51. doi: 10.1093/hmg/5.12.1945.
|
| 569 |
CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27(kip1) signaling.Haematologica. 2017 Apr;102(4):707-718. doi: 10.3324/haematol.2016.151555. Epub 2017 Jan 25.
|
| 570 |
Germline factor DDX4 functions in blood-derived cancer cell phenotypes.Cancer Sci. 2017 Aug;108(8):1612-1619. doi: 10.1111/cas.13299. Epub 2017 Jul 11.
|
| 571 |
Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.Pediatr Blood Cancer. 2014 Dec;61(12):2230-5. doi: 10.1002/pbc.25221. Epub 2014 Sep 11.
|
| 572 |
AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.Mol Cell. 2010 Feb 12;37(3):429-37. doi: 10.1016/j.molcel.2010.01.026.
|
| 573 |
Feline Lymphoma and a High Correlation with Feline Leukaemia Virus Infection in Brazil.J Comp Pathol. 2019 Jan;166:20-28. doi: 10.1016/j.jcpa.2018.10.171. Epub 2018 Nov 29.
|
| 574 |
Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.Leuk Lymphoma. 2015 Jun;56(6):1856-62. doi: 10.3109/10428194.2014.974045. Epub 2014 Nov 14.
|
| 575 |
Downregulation of ENDOCAN in myeloid leukemia cells inhibits proliferation and promotes apoptosis by suppressing nuclear factorB activity.Mol Med Rep. 2019 Apr;19(4):3247-3254. doi: 10.3892/mmr.2019.9969. Epub 2019 Feb 19.
|
| 576 |
Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene.Blood. 2011 Feb 10;117(6):1899-910. doi: 10.1182/blood-2010-10-311001. Epub 2010 Dec 6.
|
| 577 |
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.Clin Cancer Res. 2005 Jun 15;11(12):4504-11. doi: 10.1158/1078-0432.CCR-05-0036.
|
| 578 |
FAM168A participates in the development of chronic myeloid leukemia via BCR-ABL1/AKT1/NFB pathway.BMC Cancer. 2019 Jul 10;19(1):679. doi: 10.1186/s12885-019-5898-4.
|
| 579 |
Synergistic Effects of PI3K and c-Myc Co-targeting in Acute Leukemia: Shedding New Light on Resistance to Selective PI3K- Inhibitor CAL-101.Cancer Invest. 2019;37(7):311-324. doi: 10.1080/07357907.2019.1651328. Epub 2019 Aug 14.
|
| 580 |
Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.Br J Haematol. 2008 Sep;142(5):745-53. doi: 10.1111/j.1365-2141.2008.07242.x. Epub 2008 Jun 3.
|
| 581 |
CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells.PLoS One. 2014 Feb 10;9(2):e85328. doi: 10.1371/journal.pone.0085328. eCollection 2014.
|
| 582 |
MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential.J Cell Physiol. 2019 Jun;234(6):8465-8486. doi: 10.1002/jcp.27776. Epub 2018 Dec 4.
|
| 583 |
GINS2 regulates matrix metallopeptidase 9 expression and cancer stem cell property in human triple negative Breast cancer.Biomed Pharmacother. 2016 Dec;84:1568-1574. doi: 10.1016/j.biopha.2016.10.032. Epub 2016 Nov 6.
|
| 584 |
Molecular pathogenesis of disease progression in MLL-rearranged AML.Leukemia. 2019 Mar;33(3):612-624. doi: 10.1038/s41375-018-0253-3. Epub 2018 Sep 12.
|
| 585 |
The Marine Natural Product Pseudopterosin Blocks Cytokine Release of Triple-Negative Breast Cancer and Monocytic Leukemia Cells by Inhibiting NF-B Signaling.Mar Drugs. 2017 Aug 23;15(9):262. doi: 10.3390/md15090262.
|
| 586 |
Glycophorin A mutations and risk of secondary leukaemia in patients treated for childhood acute lymphoblastic leukaemia.Br J Haematol. 1996 Apr;93(1):117-24. doi: 10.1046/j.1365-2141.1996.4621001.x.
|
| 587 |
Inactivation of the hypermethylated in cancer 1 tumour suppressor--not just a question of promoter hypermethylation?.Swiss Med Wkly. 2010 Nov 1;140:w13106. doi: 10.4414/smw.2010.13106. eCollection 2010.
|
| 588 |
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.Blood. 2012 Apr 12;119(15):3440-9. doi: 10.1182/blood-2011-06-357939. Epub 2012 Feb 27.
|
| 589 |
Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34(+) cells via pre-B-cell leukemia homeobox 1.Oncogene. 2020 Jan;39(2):443-453. doi: 10.1038/s41388-019-0998-9. Epub 2019 Sep 5.
|
| 590 |
The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.Oncogene. 2018 May;37(19):2532-2544. doi: 10.1038/s41388-018-0131-5. Epub 2018 Feb 20.
|
| 591 |
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.Clin Cancer Res. 2007 Sep 1;13(17):5048-55. doi: 10.1158/1078-0432.CCR-07-0919.
|
| 592 |
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl.Blood. 2008 Sep 1;112(5):2017-9. doi: 10.1182/blood-2008-01-135186. Epub 2008 Jun 19.
|
| 593 |
The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors.Mini Rev Med Chem. 2016;16(16):1344-1358. doi: 10.2174/1389557516666160609085520.
|
| 594 |
Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia.Leukemia. 2019 Jul;33(7):1583-1597. doi: 10.1038/s41375-018-0369-5. Epub 2019 Jan 24.
|
| 595 |
Bone marrow adipocytes support hematopoietic stem cell survival.J Cell Physiol. 2018 Feb;233(2):1500-1511. doi: 10.1002/jcp.26037. Epub 2017 Aug 3.
|
| 596 |
Dioncophyllines C(2), D(2), and F and Related Naphthylisoquinoline Alkaloids from the Congolese Liana Ancistrocladus ileboensis with Potent Activities against Plasmodium falciparum and against Multiple Myeloma and Leukemia Cell Lines.J Nat Prod. 2017 Feb 24;80(2):443-458. doi: 10.1021/acs.jnatprod.6b00967. Epub 2017 Jan 25.
|
| 597 |
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML.Leukemia. 2019 Nov;33(11):2628-2639. doi: 10.1038/s41375-019-0581-y. Epub 2019 Oct 1.
|
| 598 |
Histone demethylase KDM2B regulates lineage commitment in normal and malignant hematopoiesis.J Clin Invest. 2016 Mar 1;126(3):905-20. doi: 10.1172/JCI84014. Epub 2016 Jan 25.
|
| 599 |
MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.FASEB J. 2019 Apr;33(4):5268-5286. doi: 10.1096/fj.201801035R. Epub 2019 Jan 22.
|
| 600 |
The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer.Front Oncol. 2018 Nov 14;8:502. doi: 10.3389/fonc.2018.00502. eCollection 2018.
|
| 601 |
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations.Blood. 2012 Mar 8;119(10):e67-75. doi: 10.1182/blood-2011-09-380444. Epub 2012 Jan 10.
|
| 602 |
Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia.J Clin Oncol. 2011 Feb 20;29(6):682-9. doi: 10.1200/JCO.2010.31.1118. Epub 2011 Jan 4.
|
| 603 |
Activation of the Lysosome-Associated Membrane Protein LAMP5 by DOT1L Serves as a Bodyguard for MLL Fusion Oncoproteins to Evade Degradation in Leukemia.Clin Cancer Res. 2019 May 1;25(9):2795-2808. doi: 10.1158/1078-0432.CCR-18-1474. Epub 2019 Jan 16.
|
| 604 |
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.Blood Adv. 2019 May 14;3(9):1499-1511. doi: 10.1182/bloodadvances.2018026054.
|
| 605 |
Distinct pathways affected by menin versus MLL1/MLL2 in MLL-rearranged acute myeloid leukemia.Exp Hematol. 2019 Jan;69:37-42. doi: 10.1016/j.exphem.2018.10.001. Epub 2018 Oct 10.
|
| 606 |
The efficiency of murine MLL-ENL-driven leukemia initiation changes with age and peaks during neonatal development.Blood Adv. 2019 Aug 13;3(15):2388-2399. doi: 10.1182/bloodadvances.2019000554.
|
| 607 |
Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines.J Cell Biochem. 1994 Dec;56(4):559-67. doi: 10.1002/jcb.240560417.
|
| 608 |
Localization of the human c-mos gene by in situ hybridization in two cases of acute nonlymphocytic leukemia type M2.Cancer Genet Cytogenet. 1987 Jan;24(1):137-41. doi: 10.1016/0165-4608(87)90090-2.
|
| 609 |
Knockdown of immature colon carcinoma transcript1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.Oncol Rep. 2018 Mar;39(3):1269-1275. doi: 10.3892/or.2018.6185. Epub 2018 Jan 3.
|
| 610 |
A Previously Unknown Drug-Drug Interaction Is Suspected in Delayed Elimination of Plasma Methotrexate in High-Dose Methotrexate Therapy.Ann Pharmacother. 2020 Jan;54(1):29-35. doi: 10.1177/1060028019870445. Epub 2019 Aug 15.
|
| 611 |
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis.Blood. 2008 Apr 15;111(8):4322-8. doi: 10.1182/blood-2007-06-095075. Epub 2008 Jan 2.
|
| 612 |
Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population.Eur J Haematol. 2011 Mar;86(3):199-205. doi: 10.1111/j.1600-0609.2010.01562.x. Epub 2011 Jan 25.
|
| 613 |
Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia.Carcinogenesis. 2002 Apr;23(4):559-64. doi: 10.1093/carcin/23.4.559.
|
| 614 |
Flow cytometry: its applications in hematology.Haematologica. 1995 Jan-Feb;80(1):69-81.
|
| 615 |
The nuclear migration gene NudC and human hematopoiesis.Leuk Lymphoma. 2000 Nov;39(5-6):447-54. doi: 10.3109/10428190009113375.
|
| 616 |
Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway.Cancer Manag Res. 2018 Oct 8;10:4311-4323. doi: 10.2147/CMAR.S173496. eCollection 2018.
|
| 617 |
Thymic precursor cells generate acute myeloid leukemia in NUP98-PHF23/NUP98-HOXD13 double transgenic mice.Sci Rep. 2019 Nov 20;9(1):17213. doi: 10.1038/s41598-019-53610-7.
|
| 618 |
Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2020 Feb;59(2):125-130. doi: 10.1002/gcc.22808. Epub 2019 Oct 4.
|
| 619 |
Assay of OAZ1 mRNA levels in chronic myeloid leukemia combined with application of leukemia PCR array identified relevant gene changes affected by antizyme.Acta Haematol. 2014;131(3):141-7. doi: 10.1159/000353406. Epub 2013 Oct 26.
|
| 620 |
Myeloid neoplasms with eosinophilia.Blood. 2017 Feb 9;129(6):704-714. doi: 10.1182/blood-2016-10-695973. Epub 2016 Dec 27.
|
| 621 |
The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.Leukemia. 2011 Apr;25(4):655-62. doi: 10.1038/leu.2010.301. Epub 2011 Jan 25.
|
| 622 |
A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia.Haematologica. 2007 Jun;92(6):744-52. doi: 10.3324/haematol.10869.
|
| 623 |
HRAS1 and INS genes are relocated but not structurally altered as a result of the t(7;11)(p15;p15) in a clone from a patient with acute myeloid leukaemia (M4).Br J Haematol. 1989 Apr;71(4):481-6. doi: 10.1111/j.1365-2141.1989.tb06306.x.
|
| 624 |
DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells.Int J Cancer. 2007 Aug 15;121(4):706-13. doi: 10.1002/ijc.22634.
|
| 625 |
ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A.Leuk Lymphoma. 2015;56(8):2416-23. doi: 10.3109/10428194.2014.982643. Epub 2014 Dec 4.
|
| 626 |
FAS and RAS related Apoptosis defects: From autoimmunity to leukemia.Immunol Rev. 2019 Jan;287(1):50-61. doi: 10.1111/imr.12720.
|
| 627 |
S100A16 suppresses the growth and survival of leukaemia cellsand correlates with relapse and relapse free survival in adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia.Br J Haematol. 2019 Jun;185(5):836-851. doi: 10.1111/bjh.15878. Epub 2019 Mar 27.
|
| 628 |
Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome.Genes Dev. 2011 May 1;25(9):917-29. doi: 10.1101/gad.623011.
|
| 629 |
Notch signal transduction is not regulated by SEL1L in leukaemia and lymphoma cells in culture.Anticancer Res. 2002 Nov-Dec;22(6C):4211-4.
|
| 630 |
FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23).Leukemia. 2004 May;18(5):998-1005. doi: 10.1038/sj.leu.2403334.
|
| 631 |
Potent Enhancement of HIV-1 Replication by Nef in the Absence of SERINC3 and SERINC5.mBio. 2019 Jun 11;10(3):e01071-19. doi: 10.1128/mBio.01071-19.
|
| 632 |
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub.Nat Commun. 2018 Jun 6;9(1):2192. doi: 10.1038/s41467-018-04462-8.
|
| 633 |
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia.Leuk Lymphoma. 2017 Oct;58(10):2419-2425. doi: 10.1080/10428194.2017.1295142. Epub 2017 Feb 28.
|
| 634 |
CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.J Immunol Res. 2019 Apr 15;2019:6032141. doi: 10.1155/2019/6032141. eCollection 2019.
|
| 635 |
Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene.Int J Oncol. 2006 Apr;28(4):899-908.
|
| 636 |
The roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemia.Biomed Res Int. 2015;2015:347571. doi: 10.1155/2015/347571. Epub 2015 Feb 19.
|
| 637 |
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.Clin Chim Acta. 2012 Aug 16;413(15-16):1211-6. doi: 10.1016/j.cca.2012.03.020. Epub 2012 Apr 3.
|
| 638 |
Adenoviral E1B55K oncoprotein sequesters candidate leukemia suppressor sequence-specific single-stranded DNA-binding protein 2 into aggresomes.Oncogene. 2007 Jul 19;26(33):4797-805. doi: 10.1038/sj.onc.1210281. Epub 2007 Feb 19.
|
| 639 |
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.Haematologica. 2020 Jan 31;105(2):435-447. doi: 10.3324/haematol.2019.216986. Print 2020.
|
| 640 |
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.Nat Genet. 2017 Jun;49(6):866-875. doi: 10.1038/ng.3854. Epub 2017 Apr 24.
|
| 641 |
The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.Leukemia. 2018 Sep;32(9):1984-1993. doi: 10.1038/s41375-018-0046-8. Epub 2018 Mar 20.
|
| 642 |
MicroRNA-124 represses wound healing by targeting SERP1 and inhibiting the Wnt/-catenin pathway.Adv Clin Exp Med. 2019 Jun;28(6):711-718. doi: 10.17219/acem/94163.
|
| 643 |
Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties.ACS Chem Biol. 2019 Sep 20;14(9):2071-2087. doi: 10.1021/acschembio.9b00593. Epub 2019 Aug 21.
|
| 644 |
Acute myeloid leukaemia: recent data on prognostic gene mutations, in relation to stratified therapies for elderly patients.J BUON. 2019 Jul-Aug;24(4):1326-1339.
|
| 645 |
STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1 in Lymphoblastic Leukemia.Curr Mol Med. 2016;16(8):767-775. doi: 10.2174/1566524016666161018154401.
|
| 646 |
Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.Leukemia. 2015 Dec;29(12):2317-27. doi: 10.1038/leu.2015.162. Epub 2015 Jun 25.
|
| 647 |
Interferon-Inducible MicroRNA miR-128 Modulates HIV-1 Replication by Targeting TNPO3 mRNA.J Virol. 2019 Sep 30;93(20):e00364-19. doi: 10.1128/JVI.00364-19. Print 2019 Oct 15.
|
| 648 |
TNR/11q#1 trinucleotide (GCC)n repeat alleles and predisposition to acute and chronic leukemia.Ann Hum Genet. 2004 Jul;68(Pt 4):362-6. doi: 10.1046/j.1529-8817.2004.00101.x.
|
| 649 |
Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.PLoS One. 2013 Nov 27;8(11):e80193. doi: 10.1371/journal.pone.0080193. eCollection 2013.
|
| 650 |
Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-B and -catenin/TCF signaling pathways.Cell Death Dis. 2018 Apr 1;9(4):427. doi: 10.1038/s41419-018-0440-1.
|
| 651 |
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.J Hematol Oncol. 2017 Jul 11;10(1):138. doi: 10.1186/s13045-017-0507-y.
|
| 652 |
Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.Cancer Res. 2010 Jun 15;70(12):4949-60. doi: 10.1158/0008-5472.CAN-09-1962. Epub 2010 May 25.
|
| 653 |
NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.Mol Cell. 2015 Dec 17;60(6):847-59. doi: 10.1016/j.molcel.2015.10.033. Epub 2015 Nov 25.
|
| 654 |
Analysis of CD137 and CD137L expression in human primary tumor tissues.Croat Med J. 2008 Apr;49(2):192-200. doi: 10.3325/cmj.2008.2.192.
|
| 655 |
A novel somatic mutation in ACD induces telomere lengthening and apoptosis resistance in leukemia cells.BMC Cancer. 2015 Sep 7;15:621. doi: 10.1186/s12885-015-1639-5.
|
| 656 |
ADCY7 supports development of acute myeloid leukemia.Biochem Biophys Res Commun. 2015 Sep 11;465(1):47-52. doi: 10.1016/j.bbrc.2015.07.123. Epub 2015 Jul 26.
|
| 657 |
The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.Mol Cell Biol. 2012 Jul;32(13):2608-17. doi: 10.1128/MCB.00182-12. Epub 2012 Apr 30.
|
| 658 |
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m(6)A Modification.Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9. doi: 10.1016/j.stem.2017.11.016. Epub 2017 Dec 28.
|
| 659 |
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia.Cancer Discov. 2016 Jul;6(7):770-83. doi: 10.1158/2159-8290.CD-16-0058. Epub 2016 May 6.
|
| 660 |
ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.Nat Commun. 2017 May 18;8:15429. doi: 10.1038/ncomms15429.
|
| 661 |
Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.Blood. 2012 Aug 16;120(7):1473-84. doi: 10.1182/blood-2011-12-395335. Epub 2012 Jun 26.
|
| 662 |
p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells.Int J Biochem Cell Biol. 2013 Mar;45(3):531-5. doi: 10.1016/j.biocel.2012.12.017. Epub 2012 Dec 31.
|
| 663 |
Vitamin K2 and cotylenin A synergistically induce monocytic differentiation and growth arrest along with the suppression of c-MYC expression and induction of cyclin G2 expression in human leukemia HL-60 cells.Int J Oncol. 2015 Aug;47(2):473-80. doi: 10.3892/ijo.2015.3028. Epub 2015 Jun 4.
|
| 664 |
The PAF complex regulation of Prmt5 facilitates the progression and maintenance of MLL fusion leukemia.Oncogene. 2018 Jan 25;37(4):450-460. doi: 10.1038/onc.2017.337. Epub 2017 Sep 25.
|
| 665 |
CEMP1 Induces Transformation in Human Gingival Fibroblasts.PLoS One. 2015 May 26;10(5):e0127286. doi: 10.1371/journal.pone.0127286. eCollection 2015.
|
| 666 |
D40/KNL1/CASC5 and autosomal recessive primary microcephaly.Congenit Anom (Kyoto). 2017 Nov;57(6):191-196. doi: 10.1111/cga.12252. Epub 2017 Nov 1.
|
| 667 |
DDX41 Recognizes RNA/DNA Retroviral Reverse Transcripts and Is Critical for In Vivo Control of Murine Leukemia Virus Infection.mBio. 2018 Jun 5;9(3):e00923-18. doi: 10.1128/mBio.00923-18.
|
| 668 |
Five-aza-2'-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells.Sci Rep. 2015 Nov 18;5:16709. doi: 10.1038/srep16709.
|
| 669 |
Isolation and Characterization of a Phaseolus vulgaris Trypsin Inhibitor with Antiproliferative Activity on Leukemia and Lymphoma Cells.Molecules. 2017 Jan 23;22(1):187. doi: 10.3390/molecules22010187.
|
| 670 |
DACT1 overexpression inhibits proliferation, enhances apoptosis, and increases daunorubicin chemosensitivity in KG-1 cells.Tumour Biol. 2017 Oct;39(10):1010428317711089. doi: 10.1177/1010428317711089.
|
| 671 |
Comparative studies of oxaliplatin-based platinum(iv) complexes in different in vitro and in vivo tumor models.Metallomics. 2017 Mar 22;9(3):309-322. doi: 10.1039/c6mt00226a.
|
| 672 |
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor.J Med Chem. 2018 Jul 26;61(14):6110-6120. doi: 10.1021/acs.jmedchem.8b00483. Epub 2018 Jul 17.
|
| 673 |
Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.Tumour Biol. 2016 Sep;37(9):11947-11957. doi: 10.1007/s13277-016-5039-5. Epub 2016 Apr 16.
|
| 674 |
Functional Evidence of the Involvement of the Dynein Light Chain DYNLRB2 in Murine Leukemia Virus Infection.J Virol. 2017 Apr 28;91(10):e00129-17. doi: 10.1128/JVI.00129-17. Print 2017 May 15.
|
| 675 |
Effect of EPH-ephrin signaling on the growth of human leukemia cells.Anticancer Res. 2014 Jun;34(6):2913-8.
|
| 676 |
An ERG Enhancer-Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward Regulation.Cancer Res. 2019 Aug 1;79(15):3862-3876. doi: 10.1158/0008-5472.CAN-18-3215. Epub 2019 Jun 7.
|
| 677 |
Active Chest Tube Clearance After Cardiac Surgery Is Associated With Reduced Reexploration Rates.Ann Thorac Surg. 2018 Jun;105(6):1771-1777. doi: 10.1016/j.athoracsur.2018.01.002. Epub 2018 Jan 31.
|
| 678 |
Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling.Cancer Cell. 2010 Oct 19;18(4):341-52. doi: 10.1016/j.ccr.2010.09.008.
|
| 679 |
Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies.Mycoses. 2020 Jan;63(1):30-37. doi: 10.1111/myc.13002. Epub 2019 Nov 13.
|
| 680 |
MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.Cancer Cell. 2003 Feb;3(2):161-71. doi: 10.1016/s1535-6108(03)00019-9.
|
| 681 |
Direct Reprogramming of Fibroblasts Into Smooth Muscle-Like Cells With Defined Transcription Factors-Brief Report.Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2191-2197. doi: 10.1161/ATVBAHA.118.310870.
|
| 682 |
An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.Oncogene. 2017 Oct 26;36(43):5985-5994. doi: 10.1038/onc.2017.210. Epub 2017 Jun 26.
|
| 683 |
The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia.PLoS One. 2015 Jul 6;10(7):e0131716. doi: 10.1371/journal.pone.0131716. eCollection 2015.
|
| 684 |
Grb10 is involved in BCR-ABL-positive leukemia in mice.Leukemia. 2015 Apr;29(4):858-68. doi: 10.1038/leu.2014.283. Epub 2014 Sep 24.
|
| 685 |
Novel interactions between the HTLV antisense proteins HBZ and APH-2 and the NFAR protein family: Implications for the HTLV lifecycles.Virology. 2016 Jul;494:129-42. doi: 10.1016/j.virol.2016.04.012. Epub 2016 Apr 22.
|
| 686 |
BOLA-DRB3 gene polymorphisms influence bovine leukaemia virus infection levels in Holstein and HolsteinJersey crossbreed dairy cattle.Anim Genet. 2017 Aug;48(4):420-430. doi: 10.1111/age.12566. Epub 2017 May 31.
|
| 687 |
Ibrutinib: A Review in Chronic Lymphocytic Leukaemia.Drugs. 2017 Feb;77(2):225-236. doi: 10.1007/s40265-017-0695-3.
|
| 688 |
Diptoindonesin G promotes ERK-mediated nuclear translocation of p-STAT1 (Ser727) and cell differentiation in AML cells.Cell Death Dis. 2017 May 4;8(5):e2765. doi: 10.1038/cddis.2017.159.
|
| 689 |
INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia.J Exp Clin Cancer Res. 2018 Jan 17;37(1):8. doi: 10.1186/s13046-018-0675-9.
|
| 690 |
JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia.Cancer Res. 2017 Dec 1;77(23):6627-6640. doi: 10.1158/0008-5472.CAN-17-1223. Epub 2017 Sep 28.
|
| 691 |
Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia.J Biol Chem. 2015 Sep 11;290(37):22474-84. doi: 10.1074/jbc.M115.678912. Epub 2015 Jul 21.
|
| 692 |
Quantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemia.Exp Biol Med (Maywood). 2015 Jan;240(1):128-34. doi: 10.1177/1535370214543067. Epub 2014 Jul 17.
|
| 693 |
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.Mol Cancer Res. 2015 Apr;13(4):699-712. doi: 10.1158/1541-7786.MCR-14-0422. Epub 2015 Mar 31.
|
| 694 |
Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines.Biochim Biophys Acta. 2014;1839(4):265-74. doi: 10.1016/j.bbagrm.2014.02.004. Epub 2014 Feb 13.
|
| 695 |
Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance.Int Immunopharmacol. 2006 Dec 20;6(13-14):1993-2001. doi: 10.1016/j.intimp.2006.09.015. Epub 2006 Oct 17.
|
| 696 |
Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity.PLoS One. 2014 Mar 27;9(3):e92706. doi: 10.1371/journal.pone.0092706. eCollection 2014.
|
| 697 |
Activation of Wnt signaling pathway by AF1q enriches stem-like population and enhance mammosphere formation of breast cells.Biochem Biophys Res Commun. 2017 Mar 18;484(4):884-889. doi: 10.1016/j.bbrc.2017.02.018. Epub 2017 Feb 8.
|
| 698 |
Targeting MTHFD2 in acute myeloid leukemia.J Exp Med. 2016 Jun 27;213(7):1285-306. doi: 10.1084/jem.20151574. Epub 2016 Jun 20.
|
| 699 |
Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.Oncotarget. 2015 Dec 8;6(39):42300-11. doi: 10.18632/oncotarget.5982.
|
| 700 |
Role and Regulation of Myeloid Zinc Finger Protein 1 in Cancer.J Cell Biochem. 2015 Oct;116(10):2146-54. doi: 10.1002/jcb.25203.
|
| 701 |
Necdin modulates leukemia-initiating cell quiescence and chemotherapy response.Oncotarget. 2017 Sep 18;8(50):87607-87622. doi: 10.18632/oncotarget.20999. eCollection 2017 Oct 20.
|
| 702 |
DNAM-1-based chimeric antigen receptors enhance T cell effector function and exhibit in vivo efficacy against melanoma.Cancer Immunol Immunother. 2015 Apr;64(4):409-18. doi: 10.1007/s00262-014-1648-2. Epub 2014 Dec 31.
|
| 703 |
Pharmacogenetic characterization of naturally occurring germline NT5C1A variants to chemotherapeutic nucleoside analogs.Pharmacogenet Genomics. 2016 Jun;26(6):271-9. doi: 10.1097/FPC.0000000000000208.
|
| 704 |
Thiopurine-mediated impairment of hematopoietic stem and leukemia cells in Nudt15(R138C) knock-in mice.Leukemia. 2020 Mar;34(3):882-894. doi: 10.1038/s41375-019-0583-9. Epub 2019 Oct 24.
|
| 705 |
Circulating tight junction proteins mirror blood-brain barrier integrity in leukaemia central nervous system metastasis.Hematol Oncol. 2017 Sep;35(3):365-373. doi: 10.1002/hon.2289. Epub 2016 Mar 21.
|
| 706 |
RKTG overexpression inhibits proliferation and induces apoptosis of human leukemia cells via suppression of the ERK and PI3K/AKT signaling pathways.Oncol Lett. 2017 Jul;14(1):965-970. doi: 10.3892/ol.2017.6182. Epub 2017 May 17.
|
| 707 |
Tyr-94 phosphorylation inhibits pyruvate dehydrogenase phosphatase 1 and promotes tumor growth.J Biol Chem. 2014 Aug 1;289(31):21413-22. doi: 10.1074/jbc.M114.581124. Epub 2014 Jun 24.
|
| 708 |
Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development.JCI Insight. 2018 Oct 18;3(20):e123172. doi: 10.1172/jci.insight.123172.
|
| 709 |
NUP98-PHF23 is a chromatin-modifying oncoprotein that causes a wide array of leukemias sensitive to inhibition of PHD histone reader function.Cancer Discov. 2014 May;4(5):564-77. doi: 10.1158/2159-8290.CD-13-0419. Epub 2014 Feb 17.
|
| 710 |
The regulation of tumor-suppressive microRNA, miR-126, inchronic lymphocytic leukemia.Cancer Med. 2017 Apr;6(4):778-787. doi: 10.1002/cam4.996. Epub 2017 Mar 15.
|
| 711 |
The miR-17?2 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.Leuk Res. 2016 Jul;46:51-60. doi: 10.1016/j.leukres.2016.04.006. Epub 2016 Apr 16.
|
| 712 |
PPM1K Regulates Hematopoiesis and Leukemogenesis through CDC20-Mediated Ubiquitination of MEIS1 and p21.Cell Rep. 2018 May 1;23(5):1461-1475. doi: 10.1016/j.celrep.2018.03.140.
|
| 713 |
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.Blood. 2013 Aug 15;122(7):1293-304. doi: 10.1182/blood-2013-05-501072. Epub 2013 Jul 8.
|
| 714 |
High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic Lymphohistiocytosis.Hum Gene Ther. 2016 Oct;27(10):847-859. doi: 10.1089/hum.2016.065. Epub 2016 Jul 29.
|
| 715 |
Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.Leukemia. 2018 Mar;32(3):575-587. doi: 10.1038/leu.2017.259. Epub 2017 Aug 17.
|
| 716 |
Modulating the Growth and Imatinib Sensitivity of Chronic Myeloid Leukemia Stem/Progenitor Cells with Pullulan/MicroRNA Nanoparticles In Vitro.J Biomed Nanotechnol. 2015 Nov;11(11):1961-74. doi: 10.1166/jbn.2015.2147.
|
| 717 |
A maternal high-fat, high-sucrose diet alters insulin sensitivity and expression of insulin signalling and lipid metabolism genes and proteins in male rat offspring: effect of folic acid supplementation.Br J Nutr. 2017 Oct;118(8):580-588. doi: 10.1017/S0007114517002501.
|
| 718 |
Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.Breast Cancer Res. 2012 Jan 9;14(1):101. doi: 10.1186/bcr3056.
|
| 719 |
SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.Haematologica. 2014 Aug;99(8):1356-64. doi: 10.3324/haematol.2013.100230. Epub 2014 May 23.
|
| 720 |
Embryonic stem cell derived germ cells induce spermatogenesis after transplantation into the testes of an adult mouse azoospermia model.Clin Sci (Lond). 2017 Sep 8;131(18):2381-2395. doi: 10.1042/CS20171074. Print 2017 Sep 15.
|
| 721 |
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.Clin Cancer Res. 2015 Sep 15;21(18):4184-93. doi: 10.1158/1078-0432.CCR-14-2112. Epub 2015 Mar 16.
|
| 722 |
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia.Oncogene. 2015 Jan 29;34(5):631-8. doi: 10.1038/onc.2013.587. Epub 2014 Jan 27.
|
| 723 |
STAG2 loss-of-function mutation induces PD-L1 expression in U2OS cells.Ann Transl Med. 2019 Apr;7(7):127. doi: 10.21037/atm.2019.02.23.
|
| 724 |
Signalling strength determines proapoptotic functions of STING.Nat Commun. 2017 Sep 5;8(1):427. doi: 10.1038/s41467-017-00573-w.
|
| 725 |
The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.J Biol Chem. 2017 Jul 28;292(30):12528-12541. doi: 10.1074/jbc.M117.785675. Epub 2017 May 23.
|
| 726 |
Poly (ADP-ribose) polymerase inhibitors selectively induce cytotoxicity in TCF3-HLF-positive leukemic cells.Cancer Lett. 2017 Feb 1;386:131-140. doi: 10.1016/j.canlet.2016.11.021. Epub 2016 Nov 25.
|
| 727 |
Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia.PLoS One. 2016 Oct 20;11(10):e0165210. doi: 10.1371/journal.pone.0165210. eCollection 2016.
|
| 728 |
Tmem30a Plays Critical Roles in Ensuring the Survival of Hematopoietic Cells and Leukemia Cells in Mice.Am J Pathol. 2018 Jun;188(6):1457-1468. doi: 10.1016/j.ajpath.2018.02.015. Epub 2018 Mar 21.
|
| 729 |
Overexpression of feline tripartite motif-containing 25 interferes with the late stage of feline leukemia virus replication.Virus Res. 2015 Jun 2;204:88-94. doi: 10.1016/j.virusres.2015.04.017. Epub 2015 Apr 24.
|
| 730 |
Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.Leuk Lymphoma. 1999 May;33(5-6):485-97. doi: 10.3109/10428199909058453.
|
| 731 |
Expression of the Gb3/CD77 synthase gene in megakaryoblastic leukemia cells: implication in the sensitivity to verotoxins.J Biol Chem. 2002 Mar 29;277(13):11247-54. doi: 10.1074/jbc.M109519200. Epub 2002 Jan 8.
|
| 732 |
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.J Exp Med. 2013 Apr 8;210(4):805-19. doi: 10.1084/jem.20121482. Epub 2013 Mar 11.
|
| 733 |
Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.Nat Commun. 2017 May 31;8:15580. doi: 10.1038/ncomms15580.
|
| 734 |
Differential expression of protein tyrosine phosphatase genes during phorbol ester-induced differentiation of human leukemia U937 cells.Cell Growth Differ. 1993 Dec;4(12):1033-9.
|
| 735 |
Single-Molecule Sequencing Reveals Patterns of Preexisting Drug Resistance That Suggest Treatment Strategies in Philadelphia-Positive Leukemias.Clin Cancer Res. 2018 Nov 1;24(21):5321-5334. doi: 10.1158/1078-0432.CCR-18-0167. Epub 2018 Jul 24.
|
| 736 |
Defining the functions of adenosine-to-inosine RNA editing through hematology.Curr Opin Hematol. 2019 Jul;26(4):241-248. doi: 10.1097/MOH.0000000000000514.
|
| 737 |
Knockdown of Adhesion-Regulating Molecule 1 Inhibits Proliferation in HL60 Cells.Acta Haematol. 2015;134(2):88-100. doi: 10.1159/000369916. Epub 2015 Apr 21.
|
| 738 |
Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study.Br J Haematol. 2010 Feb;148(3):394-401. doi: 10.1111/j.1365-2141.2009.07966.x. Epub 2009 Nov 4.
|
| 739 |
LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.Blood. 1996 Jan 15;87(2):734-45.
|
| 740 |
Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.J Virol. 2014 Feb;88(4):2319-22. doi: 10.1128/JVI.03444-13. Epub 2013 Nov 27.
|
| 741 |
Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes.Genes Chromosomes Cancer. 2012 May;51(5):510-20. doi: 10.1002/gcc.21939. Epub 2012 Feb 15.
|
| 742 |
Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10years and future perspectives.Wien Klin Wochenschr. 2018 Sep;130(17-18):517-529. doi: 10.1007/s00508-018-1355-7. Epub 2018 Jul 13.
|
| 743 |
Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?.Expert Opin Investig Drugs. 2005 Aug;14(8):1063-6. doi: 10.1517/13543784.14.8.1063.
|
| 744 |
ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells.Biochim Biophys Acta. 2006 Sep;1762(9):828-34. doi: 10.1016/j.bbadis.2006.07.010. Epub 2006 Jul 31.
|
| 745 |
The intracellular localization of amyloid beta protein precursor (AbetaPP) intracellular domain associated protein-1 (AIDA-1) is regulated by AbetaPP and alternative splicing.J Alzheimers Dis. 2004 Feb;6(1):67-78. doi: 10.3233/jad-2004-6108.
|
| 746 |
Chronic lymphocytic leukemia disease progression is accelerated by APRIL-TACI interaction in the TCL1 transgenic mouse model.Blood. 2013 Dec 5;122(24):3960-3. doi: 10.1182/blood-2013-04-497693. Epub 2013 Oct 7.
|
| 747 |
Transcriptomic and proteomic approach to studying SNX-2112-induced K562 cells apoptosis and anti-leukemia activity in K562-NOD/SCID mice.FEBS Lett. 2009 Jun 18;583(12):1859-66. doi: 10.1016/j.febslet.2009.04.046. Epub 2009 May 8.
|
| 748 |
Methylation silencing of the Apaf-1 gene in acute leukemia. Mol Cancer Res. 2005 Jun;3(6):325-34. doi: 10.1158/1541-7786.MCR-04-0105.
|
| 749 |
Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation.Nat Genet. 2004 Mar;36(3):257-63. doi: 10.1038/ng1305. Epub 2004 Feb 8.
|
| 750 |
Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.J Mol Biol. 2009 Jan 9;385(1):65-78. doi: 10.1016/j.jmb.2008.10.043. Epub 2008 Nov 1.
|
| 751 |
Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint.Cancer Res. 2017 Sep 1;77(17):4579-4588. doi: 10.1158/0008-5472.CAN-16-3394. Epub 2017 Jun 27.
|
| 752 |
The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines. Cancer Res. 2004 Jan 15;64(2):728-35.
|
| 753 |
Species-specific restriction of apobec3-mediated hypermutation.J Virol. 2008 Feb;82(3):1305-13. doi: 10.1128/JVI.01371-07. Epub 2007 Nov 21.
|
| 754 |
Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells.Oxid Med Cell Longev. 2018 Nov 18;2018:4125297. doi: 10.1155/2018/4125297. eCollection 2018.
|
| 755 |
Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.J Biol Chem. 2004 Jul 9;279(28):28831-4. doi: 10.1074/jbc.C400105200. Epub 2004 May 13.
|
| 756 |
E2FBP1/hDril1 modulates cell growth through downregulation of promyelocytic leukemia bodies.Cell Death Differ. 2004 Jul;11(7):747-59. doi: 10.1038/sj.cdd.4401412.
|
| 757 |
Structural insight into recognition of methylated histone tails by retinoblastoma-binding protein 1.J Biol Chem. 2012 Mar 9;287(11):8531-40. doi: 10.1074/jbc.M111.299149. Epub 2012 Jan 12.
|
| 758 |
ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.J Clin Pathol. 2017 Feb;70(2):162-167. doi: 10.1136/jclinpath-2016-203804. Epub 2016 Jul 22.
|
| 759 |
Argininosuccinate synthetase gene expression in leukemias: potential diagnostic marker for blastic crisis of chronic myelocytic leukemia.Leuk Res. 1992;16(5):475-83. doi: 10.1016/0145-2126(92)90173-5.
|
| 760 |
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.J Hematol Oncol. 2019 Oct 22;12(1):104. doi: 10.1186/s13045-019-0789-3.
|
| 761 |
Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):691-700. doi: 10.1098/rstb.1999.0422.
|
| 762 |
Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 Cell.PLoS One. 2016 Jul 8;11(7):e0158761. doi: 10.1371/journal.pone.0158761. eCollection 2016.
|
| 763 |
Endoplasmic reticulum calcium transport ATPase expression during differentiation of colon cancer and leukaemia cells.Biochem Biophys Res Commun. 2004 Oct 1;322(4):1223-36. doi: 10.1016/j.bbrc.2004.08.030.
|
| 764 |
Patient mutations alter ATRX targeting to PML nuclear bodies.Eur J Hum Genet. 2008 Feb;16(2):192-201. doi: 10.1038/sj.ejhg.5201943. Epub 2007 Oct 24.
|
| 765 |
Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients.Int J Hematol. 2018 Dec;108(6):588-597. doi: 10.1007/s12185-018-2517-0. Epub 2018 Aug 27.
|
| 766 |
B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.Cell Death Dis. 2013 Jun 6;4(6):e654. doi: 10.1038/cddis.2013.186.
|
| 767 |
B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line.IUBMB Life. 2012 Nov;64(11):889-900. doi: 10.1002/iub.1080. Epub 2012 Sep 29.
|
| 768 |
Histone post-translational modifications associated to BAALC expression in leukemic cells.Biochem Biophys Res Commun. 2012 Jan 13;417(2):721-5. doi: 10.1016/j.bbrc.2011.12.013. Epub 2011 Dec 14.
|
| 769 |
Identification of IGHC-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.Genes Chromosomes Cancer. 2011 Apr;50(4):207-16. doi: 10.1002/gcc.20845. Epub 2011 Jan 13.
|
| 770 |
BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia.PLoS One. 2011;6(10):e26097. doi: 10.1371/journal.pone.0026097. Epub 2011 Oct 10.
|
| 771 |
A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene.Cancer Genet Cytogenet. 2004 Feb;149(1):72-6. doi: 10.1016/s0165-4608(03)00302-9.
|
| 772 |
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.Blood. 1993 Sep 15;82(6):1813-9.
|
| 773 |
Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.Nat Commun. 2019 Mar 22;10(1):1347. doi: 10.1038/s41467-019-09250-6.
|
| 774 |
Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.Tumour Biol. 2017 Oct;39(10):1010428317720643. doi: 10.1177/1010428317720643.
|
| 775 |
Inhibition of apoptosis by downregulation of hBex1, a novel mechanism, contributes to the chemoresistance of Bcr/Abl+ leukemic cells.Carcinogenesis. 2009 Jan;30(1):35-42. doi: 10.1093/carcin/bgn251. Epub 2008 Nov 21.
|
| 776 |
Epigenetic regulation of brain expressed X-linked-2, a marker for acute myeloid leukemia with mixed lineage leukemia rearrangements.Leukemia. 2007 Feb;21(2):374-7. doi: 10.1038/sj.leu.2404493.
|
| 777 |
JEM-1, a novel gene encoding a leucine-zipper nuclear factor upregulated during retinoid-induced maturation of NB4 promyelocytic leukaemia.Oncogene. 1997 Apr 3;14(13):1563-70. doi: 10.1038/sj.onc.1200995.
|
| 778 |
Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.Oncogene. 2003 Jul 24;22(30):4679-89. doi: 10.1038/sj.onc.1206624.
|
| 779 |
MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13.Oncogene. 1993 Nov;8(11):3085-92.
|
| 780 |
Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/-catenin signaling pathway.PLoS One. 2017 Oct 23;12(10):e0186868. doi: 10.1371/journal.pone.0186868. eCollection 2017.
|
| 781 |
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells.Cell Signal. 2015 Feb;27(2):204-14. doi: 10.1016/j.cellsig.2014.11.007. Epub 2014 Nov 15.
|
| 782 |
CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways.Breast Cancer Res Treat. 2011 Nov;130(1):19-27. doi: 10.1007/s10549-010-1274-4. Epub 2010 Dec 3.
|
| 783 |
The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.BMC Mol Biol. 2012 Mar 23;13:11. doi: 10.1186/1471-2199-13-11.
|
| 784 |
The Pluripotency Regulator PRDM14 Requires Hematopoietic Regulator CBFA2T3 to Initiate Leukemia in Mice.Mol Cancer Res. 2019 Jul;17(7):1468-1479. doi: 10.1158/1541-7786.MCR-18-1327. Epub 2019 Apr 23.
|
| 785 |
Targeting a mitochondrial potassium channel to fight cancer.Cell Calcium. 2015 Jul;58(1):131-8. doi: 10.1016/j.ceca.2014.09.006. Epub 2014 Oct 18.
|
| 786 |
WT1 regulates cyclinA1 expression in K562cells.Oncol Rep. 2019 Nov;42(5):2016-2028. doi: 10.3892/or.2019.7287. Epub 2019 Aug 21.
|
| 787 |
A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.J Exp Med. 2014 Jun 30;211(7):1363-77. doi: 10.1084/jem.20140410. Epub 2014 Jun 16.
|
| 788 |
Upregulated TCR enhances interleukin-2 production in T-cells from patients with CML.DNA Cell Biol. 2012 Nov;31(11):1628-35. doi: 10.1089/dna.2012.1798. Epub 2012 Oct 11.
|
| 789 |
TGF- regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.Immunobiology. 2019 Sep;224(5):649-658. doi: 10.1016/j.imbio.2019.07.002. Epub 2019 Aug 9.
|
| 790 |
CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/-catenin signaling pathway.Pediatr Res. 2019 Jun;85(7):1024-1031. doi: 10.1038/s41390-019-0370-3. Epub 2019 Mar 12.
|
| 791 |
Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.Genomics. 2000 Dec 15;70(3):327-34. doi: 10.1006/geno.2000.6386.
|
| 792 |
Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia.Haematologica. 2020 Apr;105(4):999-1012. doi: 10.3324/haematol.2018.207001. Epub 2019 Aug 1.
|
| 793 |
Expression and localization of the CDC34 ubiquitin-conjugating enzyme in pediatric acute lymphoblastic leukemia.Cell Growth Differ. 2001 Aug;12(8):427-33.
|
| 794 |
Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model.Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16924-9. doi: 10.1073/pnas.0604579103. Epub 2006 Oct 26.
|
| 795 |
A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.Cancer Cell. 2018 Nov 12;34(5):707-723.e7. doi: 10.1016/j.ccell.2018.10.004.
|
| 796 |
Congenital heart disease complexity and childhood cancer risk.Birth Defects Res. 2018 Oct 16;110(17):1314-1321. doi: 10.1002/bdr2.1390. Epub 2018 Oct 16.
|
| 797 |
Silencing of CHD5 gene by promoter methylation in leukemia.PLoS One. 2014 Jan 13;9(1):e85172. doi: 10.1371/journal.pone.0085172. eCollection 2014.
|
| 798 |
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma.Blood. 2012 Oct 25;120(17):3491-500. doi: 10.1182/blood-2012-02-412643. Epub 2012 Sep 6.
|
| 799 |
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).Blood. 1999 Sep 1;94(5):1820-4.
|
| 800 |
PNAS-2: a novel gene probably participating in leukemogenesis.Oncology. 2006;71(5-6):423-9. doi: 10.1159/000108576. Epub 2007 Sep 14.
|
| 801 |
Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia.Br J Haematol. 2000 Apr;109(1):64-70. doi: 10.1046/j.1365-2141.2000.01972.x.
|
| 802 |
Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.Exp Hematol. 2014 Sep;42(9):783-92.e1. doi: 10.1016/j.exphem.2014.05.007. Epub 2014 May 23.
|
| 803 |
RHOA, SEMA3B, and CKAP2 expression in leukaemia of different types: the results of a pilot experiment.Folia Biol (Praha). 2013;59(5):204-6.
|
| 804 |
Increased creatine kinase BB activity and CKB mRNA expression in patients with hematologic disorders: relation to methylation status of the CKB promoter.Clin Chim Acta. 2005 Nov;361(1-2):135-40. doi: 10.1016/j.cccn.2005.05.028.
|
| 805 |
CLCA2, a novel RUNX1 partner gene in a therapy-related leukemia with t(1;21)(p22;q22).Cancer Genet Cytogenet. 2010 Oct 15;202(2):94-100. doi: 10.1016/j.cancergencyto.2010.07.116.
|
| 806 |
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.J Allergy Clin Immunol. 2010 Mar;125(3):719-26, 726.e1-726.e4. doi: 10.1016/j.jaci.2009.10.020. Epub 2010 Jan 12.
|
| 807 |
Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.Blood. 1994 Jun 15;83(12):3689-96.
|
| 808 |
Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.Leuk Res. 2011 Jun;35(6):771-6. doi: 10.1016/j.leukres.2010.11.023. Epub 2010 Dec 18.
|
| 809 |
BCR/ABL P190 transgenic mice develop leukemia in the absence of Crkl.Oncogene. 2002 May 9;21(20):3225-31. doi: 10.1038/sj.onc.1205452.
|
| 810 |
Interactions between coilin and PIASy partially link Cajal bodies to PML bodies.J Cell Sci. 2005 Nov 1;118(Pt 21):4995-5003. doi: 10.1242/jcs.02613. Epub 2005 Oct 11.
|
| 811 |
Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial.J Clin Oncol. 2011 Jun 1;29(16):2223-9. doi: 10.1200/JCO.2010.32.0838. Epub 2011 Apr 11.
|
| 812 |
CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.BMC Cancer. 2019 May 27;19(1):499. doi: 10.1186/s12885-019-5671-8.
|
| 813 |
CSL-MAML-dependent Notch1 signaling controls T lineage-specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia.J Exp Med. 2009 Apr 13;206(4):779-91. doi: 10.1084/jem.20081922. Epub 2009 Apr 6.
|
| 814 |
Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.Cancer Res. 2009 Nov 1;69(21):8482-90. doi: 10.1158/0008-5472.CAN-09-1153. Epub 2009 Oct 13.
|
| 815 |
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.Blood. 2013 Feb 7;121(6):975-83. doi: 10.1182/blood-2012-04-426965. Epub 2012 Dec 3.
|
| 816 |
Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression.Mol Pharmacol. 2006 Sep;70(3):897-908. doi: 10.1124/mol.106.023937. Epub 2006 Jun 5.
|
| 817 |
Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.J Clin Invest. 1989 May;83(5):1570-9. doi: 10.1172/JCI114054.
|
| 818 |
Intraplatform reproducibility and technical precision of gene expression profiling in 4 laboratories investigating 160 leukemia samples: the DACH study.Clin Chem. 2008 Oct;54(10):1705-15. doi: 10.1373/clinchem.2008.108506. Epub 2008 Aug 21.
|
| 819 |
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection.J Virol. 2008 Jan;82(1):126-37. doi: 10.1128/JVI.01685-07. Epub 2007 Oct 17.
|
| 820 |
From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).Angew Chem Int Ed Engl. 2017 Jan 9;56(2):462-488. doi: 10.1002/anie.201510610. Epub 2016 Nov 15.
|
| 821 |
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.Blood. 2007 Oct 1;110(7):2569-77. doi: 10.1182/blood-2006-12-062927. Epub 2007 Apr 17.
|
| 822 |
Novel DDX41 variants in Thai patients with myeloid neoplasms.Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11.
|
| 823 |
Frequent expression of HAGE in presentation chronic myeloid leukaemias.Leukemia. 2002 Nov;16(11):2238-42. doi: 10.1038/sj.leu.2402732.
|
| 824 |
Glucocorticoid resistance in childhood leukemia.Leuk Lymphoma. 1994 Apr;13(3-4):187-201. doi: 10.3109/10428199409056282.
|
| 825 |
The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia.Leuk Res. 2002 Oct;26(10):945-54. doi: 10.1016/s0145-2126(02)00040-1.
|
| 826 |
Crosslineage TCR delta rearrangements occur shortly after the DJ joinings of the IgH genes in childhood precursor B ALL and display age-specific characteristics.Br J Haematol. 1997 Oct;99(1):115-21. doi: 10.1046/j.1365-2141.1997.3653179.x.
|
| 827 |
Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A. 1999 Nov23;96(24):13989-94.
|
| 828 |
Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.Oncol Rep. 2007 Aug;18(2):417-23.
|
| 829 |
BP1, a new homeobox gene, is frequently expressed in acute leukemias.Leukemia. 2000 Nov;14(11):1867-75. doi: 10.1038/sj.leu.2401912.
|
| 830 |
Silencing of DMBT1 in neuroblastoma cell lines is not due to methylation of CCWGG motifs on its promoter.Neoplasma. 2006;53(1):15-8.
|
| 831 |
ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia.Oncogene. 2014 Nov 27;33(48):5501-10. doi: 10.1038/onc.2013.501. Epub 2013 Dec 2.
|
| 832 |
BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.Leuk Res. 2019 Dec;87:106269. doi: 10.1016/j.leukres.2019.106269. Epub 2019 Nov 7.
|
| 833 |
DOCK2 associates with CrkL and regulates Rac1 in human leukemia cell lines.Blood. 2002 Dec 1;100(12):3968-74. doi: 10.1182/blood-2001-11-0032. Epub 2002 Jun 28.
|
| 834 |
Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia.J Cell Physiol. 2018 Sep;233(9):6604-6614. doi: 10.1002/jcp.26271. Epub 2018 Mar 14.
|
| 835 |
All-trans retinoic acid induces p62DOK1 and p56DOK2 expression which enhances induced differentiation and G0 arrest of HL-60 leukemia cells.Am J Hematol. 2006 Aug;81(8):603-15. doi: 10.1002/ajh.20667.
|
| 836 |
Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing.Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):10980-5. doi: 10.1073/pnas.0704559104. Epub 2007 Jun 20.
|
| 837 |
Characterization of a variant of PAC-1 in large granular lymphocyte leukemia.Protein Expr Purif. 2003 Nov;32(1):52-60. doi: 10.1016/S1046-5928(03)00237-7.
|
| 838 |
ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.Mol Biol Cell. 2003 Apr;14(4):1517-28. doi: 10.1091/mbc.e02-07-0394.
|
| 839 |
Increased oxidative DNA damage, inducible nitric oxide synthase, nuclear factor kappaB expression and enhanced antiapoptosis-related proteins in Helicobacter pylori-infected non-cardiac gastric adenocarcinoma.World J Gastroenterol. 2004 Aug 1;10(15):2232-40. doi: 10.3748/wjg.v10.i15.2232.
|
| 840 |
Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.Blood. 2010 Mar 25;115(12):2412-9. doi: 10.1182/blood-2009-05-222208. Epub 2010 Jan 8.
|
| 841 |
Megakaryocyte-derived excessive transforming growth factor 1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.Exp Hematol. 2018 Apr;60:40-46.e2. doi: 10.1016/j.exphem.2017.12.010. Epub 2018 Jan 4.
|
| 842 |
Electrochemical branched-DNA assay for polymerase chain reaction-free detection and quantification of oncogenes in messenger RNA.Anal Chem. 2008 Dec 15;80(24):9402-10. doi: 10.1021/ac801263r.
|
| 843 |
Knockdown of eukaryotic translation initiation factor 3 subunit D (eIF3D) inhibits proliferation of acute myeloid leukemia cells.Mol Cell Biochem. 2018 Jan;438(1-2):191-198. doi: 10.1007/s11010-017-3127-5. Epub 2017 Aug 12.
|
| 844 |
A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.Open Biol. 2014 Nov;4(11):140180. doi: 10.1098/rsob.140180.
|
| 845 |
The LEM domain proteins emerin and LAP2alpha are dispensable for human immunodeficiency virus type 1 and murine leukemia virus infections.J Virol. 2008 Jun;82(12):5860-8. doi: 10.1128/JVI.00076-08. Epub 2008 Apr 9.
|
| 846 |
Realgar transforming solution as a novel arsenic agent with a lower risk of cardiotoxicity.J Pharmacol Sci. 2019 Jun;140(2):162-170. doi: 10.1016/j.jphs.2019.06.003. Epub 2019 Jun 15.
|
| 847 |
Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells.Leukemia. 2014 May;28(5):1081-91. doi: 10.1038/leu.2013.316. Epub 2013 Oct 29.
|
| 848 |
ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.Exp Hematol. 2016 Apr;44(4):269-81.e1. doi: 10.1016/j.exphem.2015.12.010. Epub 2016 Jan 14.
|
| 849 |
Measurement of separase proteolytic activity in single living cells by a fluorogenic flow cytometry assay.PLoS One. 2015 Aug 12;10(8):e0133769. doi: 10.1371/journal.pone.0133769. eCollection 2015.
|
| 850 |
The ETS factor TEL2 is a hematopoietic oncoprotein.Blood. 2006 Feb 1;107(3):1124-32. doi: 10.1182/blood-2005-03-1196. Epub 2005 Oct 18.
|
| 851 |
Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.Blood. 2010 Feb 25;115(8):1610-20. doi: 10.1182/blood-2009-07-232249. Epub 2009 Dec 14.
|
| 852 |
Disparate effects of Shb gene deficiency on disease characteristics in murine models of myeloid, B-cell, and T-cell leukemia.Tumour Biol. 2018 Apr;40(4):1010428318771472. doi: 10.1177/1010428318771472.
|
| 853 |
EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.Cancer Sci. 2016 Dec;107(12):1745-1754. doi: 10.1111/cas.13080. Epub 2016 Nov 25.
|
| 854 |
Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.Hum Mol Genet. 2004 Nov 15;13(22):2753-65. doi: 10.1093/hmg/ddh298. Epub 2004 Sep 22.
|
| 855 |
Discussing and managing hematologic germ line variants.Blood. 2016 Nov 24;128(21):2497-2503. doi: 10.1182/blood-2016-06-716704.
|
| 856 |
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.Cell Oncol. 2008;30(4):299-306. doi: 10.3233/clo-2008-0426.
|
| 857 |
Loss of FBXO9 Enhances Proteasome Activity and Promotes Aggressiveness in Acute Myeloid Leukemia.Cancers (Basel). 2019 Nov 3;11(11):1717. doi: 10.3390/cancers11111717.
|
| 858 |
Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells.Blood. 2002 Sep 15;100(6):2138-44. doi: 10.1182/blood-2001-12-0340.
|
| 859 |
Over-expression of GFP-FEZ1 causes generation of multi-lobulated nuclei mediated by microtubules in HEK293 cells.Exp Cell Res. 2008 Jun 10;314(10):2028-39. doi: 10.1016/j.yexcr.2008.02.012. Epub 2008 Mar 4.
|
| 860 |
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functions.J Exp Med. 2017 Mar 6;214(3):719-735. doi: 10.1084/jem.20161087. Epub 2017 Feb 15.
|
| 861 |
The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.J Biol Chem. 2002 Oct 4;277(40):37045-53. doi: 10.1074/jbc.M203336200. Epub 2002 Jul 26.
|
| 862 |
FIP1L1 presence in FIP1L1-RARA or FIP1L1-PDGFRA differentially contributes to the pathogenesis of distinct types of leukemia.Ann Hematol. 2014 Sep;93(9):1473-81. doi: 10.1007/s00277-014-2085-1. Epub 2014 Apr 25.
|
| 863 |
Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.Biochimie. 2020 Jan;168:1-9. doi: 10.1016/j.biochi.2019.10.005. Epub 2019 Oct 15.
|
| 864 |
Frat2 mediates the oncogenic activation of Rac by MLL fusions.Blood. 2012 Dec 6;120(24):4819-28. doi: 10.1182/blood-2012-05-432534. Epub 2012 Oct 16.
|
| 865 |
Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.Cancer Genet Cytogenet. 2007 Sep;177(2):143-6. doi: 10.1016/j.cancergencyto.2007.05.021.
|
| 866 |
The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia.Leukemia. 2019 Jul;33(7):1700-1712. doi: 10.1038/s41375-018-0358-8. Epub 2019 Jan 11.
|
| 867 |
Methylation status of the promoter region of the human frizzled 9 gene in acute myeloid leukemia.Mol Med Rep. 2016 Aug;14(2):1339-44. doi: 10.3892/mmr.2016.5387. Epub 2016 Jun 10.
|
| 868 |
Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations.Leukemia. 2017 Jun;31(6):1415-1422. doi: 10.1038/leu.2016.326. Epub 2016 Nov 14.
|
| 869 |
Gadd45a deficiency accelerates BCR-ABL driven chronic myelogenous leukemia.Oncotarget. 2017 Feb 14;8(7):10809-10821. doi: 10.18632/oncotarget.14580.
|
| 870 |
Gata2 deficiency delays leukemogenesis while contributing to aggressive leukemia phenotype in Cbfb-MYH11 knockin mice.Leukemia. 2020 Mar;34(3):759-770. doi: 10.1038/s41375-019-0605-7. Epub 2019 Oct 17.
|
| 871 |
Reduced expression but not deficiency of GFI1 causes a fatal myeloproliferative disease in mice.Leukemia. 2019 Jan;33(1):110-121. doi: 10.1038/s41375-018-0166-1. Epub 2018 Jun 20.
|
| 872 |
A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.Dev Biol. 2016 Mar 15;411(2):277-286. doi: 10.1016/j.ydbio.2016.02.002. Epub 2016 Feb 3.
|
| 873 |
Expression of human GIPC1 in normal tissues, cancer cell lines, and primary tumors.Int J Mol Med. 2002 May;9(5):509-13.
|
| 874 |
CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.Br J Haematol. 2019 Feb;184(3):337-347. doi: 10.1111/bjh.15725. Epub 2018 Dec 28.
|
| 875 |
Cloning and functional characterization of GMPR2, a novel human guanosine monophosphate reductase, which promotes the monocytic differentiation of HL-60 leukemia cells.J Cancer Res Clin Oncol. 2003 Feb;129(2):76-83. doi: 10.1007/s00432-002-0413-7. Epub 2003 Mar 1.
|
| 876 |
Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy.Leuk Res. 2017 Dec;63:15-21. doi: 10.1016/j.leukres.2017.10.007. Epub 2017 Oct 26.
|
| 877 |
Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK.Acta Haematol. 2002;108(1):13-8. doi: 10.1159/000063061.
|
| 878 |
The small oligomerization domain of gephyrin converts MLL to an oncogene.Blood. 2004 May 15;103(10):3876-82. doi: 10.1182/blood-2003-11-3817. Epub 2004 Jan 29.
|
| 879 |
ITR?84 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.Oncol Rep. 2018 Jan;39(1):383-391. doi: 10.3892/or.2017.6090. Epub 2017 Nov 9.
|
| 880 |
Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers.Cancer Res. 2004 Apr 1;64(7):2411-7. doi: 10.1158/0008-5472.can-03-0164.
|
| 881 |
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors.Mol Cancer Ther. 2018 Aug;17(8):1694-1704. doi: 10.1158/1535-7163.MCT-18-0028. Epub 2018 May 10.
|
| 882 |
Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.Eur J Pharmacol. 2017 Mar 15;799:143-153. doi: 10.1016/j.ejphar.2017.02.014. Epub 2017 Feb 10.
|
| 883 |
Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.Br J Haematol. 2004 Aug;126(4):612-21. doi: 10.1111/j.1365-2141.2004.05083.x.
|
| 884 |
E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.Mol Cell. 2007 Jul 6;27(1):107-19. doi: 10.1016/j.molcel.2007.05.030.
|
| 885 |
EDAG-1 promotes proliferation and invasion of human thyroid cancer cells by activating MAPK/Erk and AKT signal pathways.Cancer Biol Ther. 2016 Apr 2;17(4):414-21. doi: 10.1080/15384047.2016.1156259. Epub 2016 Mar 2.
|
| 886 |
New germline mutations in the hypervariable minisatellite CEB1 in the parents of children with leukaemia.Br J Cancer. 2007 Apr 23;96(8):1265-71. doi: 10.1038/sj.bjc.6603706. Epub 2007 Mar 27.
|
| 887 |
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.Cancer. 2013 Oct 1;119(19):3555-62. doi: 10.1002/cncr.28256. Epub 2013 Jul 16.
|
| 888 |
Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.Sci Rep. 2017 Apr 28;7:45960. doi: 10.1038/srep45960.
|
| 889 |
The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.Cancer Cell. 2019 Dec 9;36(6):630-644.e9. doi: 10.1016/j.ccell.2019.10.004. Epub 2019 Nov 14.
|
| 890 |
The homeodomain region controls the phenotype of HOX-induced murine leukemia.Blood. 2012 Nov 8;120(19):4018-27. doi: 10.1182/blood-2011-10-384685. Epub 2012 Sep 18.
|
| 891 |
Expression of selected human HOX-2 genes in B/T acute lymphoid leukemia and interleukin-2/interleukin-1 beta-stimulated natural killer lymphocytes.Blood. 1992 Jul 1;80(1):185-93.
|
| 892 |
Downregulation of Prdm16 mRNA is a specific antileukemic mechanism during HOXB4-mediated HSC expansion in vivo.Blood. 2014 Sep 11;124(11):1737-47. doi: 10.1182/blood-2013-10-534735. Epub 2014 Jul 31.
|
| 893 |
HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4.J Mol Endocrinol. 2012 Jan 25;48(1):61-75. doi: 10.1530/JME-11-0078. Print 2012 Feb.
|
| 894 |
Differentiation and cell-type-restricted expression of HOXC4, HOXC5 and HOXC6 in myeloid leukemias and normal myeloid cells.Leukemia. 1998 Nov;12(11):1724-32. doi: 10.1038/sj.leu.2401106.
|
| 895 |
Fas signaling and blockade of Bcr-Abl kinase induce apoptotic Hrk protein via DREAM inhibition in human leukemia cells.Haematologica. 2002 Sep;87(9):903-7.
|
| 896 |
Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients.Exp Hematol. 2007 Jul;35(7):1091-9. doi: 10.1016/j.exphem.2007.03.015.
|
| 897 |
Molecular cloning of six novel Krppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB.J Biol Chem. 1999 Dec 10;274(50):35741-8. doi: 10.1074/jbc.274.50.35741.
|
| 898 |
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.Nat Genet. 2005 Mar;37(3):265-74. doi: 10.1038/ng1521. Epub 2005 Feb 20.
|
| 899 |
Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes.Cancer Res. 2009 Oct 1;69(19):7518-23. doi: 10.1158/0008-5472.CAN-09-1428. Epub 2009 Sep 22.
|
| 900 |
Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins.Biol Cell. 2017 Feb;109(2):94-112. doi: 10.1111/boc.201600034. Epub 2016 Oct 26.
|
| 901 |
RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.Leukemia. 2020 May;34(5):1354-1363. doi: 10.1038/s41375-019-0656-9. Epub 2019 Nov 25.
|
| 902 |
Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.Blood Cells Mol Dis. 2011 Apr 15;46(4):321-6. doi: 10.1016/j.bcmd.2011.02.005. Epub 2011 Mar 17.
|
| 903 |
Insulin-like growth factor-binding protein 4 in children with acute lymphoblastic leukemia.Int J Hematol. 2005 Aug;82(2):137-42. doi: 10.1532/IJH97.E0429.
|
| 904 |
Incontinentia pigmenti with ultrastructurally disordered leucocytes.J Clin Pathol. 2010 Jul;63(7):657-9. doi: 10.1136/jcp.2009.074203.
|
| 905 |
CD8?innate-type lymphocytes in the intestinal epithelium mediate mucosal immunity.Immunity. 2014 Sep 18;41(3):451-464. doi: 10.1016/j.immuni.2014.08.010. Epub 2014 Sep 11.
|
| 906 |
INV(12) (p13q11) and dicentric chromosomes in a secondary leukaemia with basophilia.Haematologica. 1990 Sep-Oct;75(5):473-6.
|
| 907 |
The role of IRF1 and IRF2 transcription factors in leukaemogenesis.Curr Gene Ther. 2006 Oct;6(5):543-50. doi: 10.2174/156652306778520683.
|
| 908 |
Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies.PLoS One. 2014 Sep 10;9(9):e106788. doi: 10.1371/journal.pone.0106788. eCollection 2014.
|
| 909 |
JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.Int J Hematol. 2015 Jul;102(1):76-85. doi: 10.1007/s12185-015-1797-x. Epub 2015 May 5.
|
| 910 |
The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor.Biochem J. 2003 Aug 15;374(Pt 1):165-73. doi: 10.1042/BJ20030087.
|
| 911 |
HBO1 is required for the maintenance of leukaemia stem cells.Nature. 2020 Jan;577(7789):266-270. doi: 10.1038/s41586-019-1835-6. Epub 2019 Dec 11.
|
| 912 |
Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis.Cancer Res. 2017 Apr 1;77(7):1753-1762. doi: 10.1158/0008-5472.CAN-16-2374. Epub 2017 Feb 15.
|
| 913 |
KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.Mol Immunol. 2008 Aug;45(13):3631-8. doi: 10.1016/j.molimm.2008.04.016. Epub 2008 Jun 16.
|
| 914 |
Survey and evaluation of mutations in the human KLF1 transcription unit.Sci Rep. 2018 Apr 26;8(1):6587. doi: 10.1038/s41598-018-24962-3.
|
| 915 |
TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway.Int J Mol Med. 2017 Mar;39(3):569-578. doi: 10.3892/ijmm.2017.2889. Epub 2017 Feb 13.
|
| 916 |
Hypoxia selects for a quiescent, CML stem/leukemia initiating-like population dependent on CBP/catenin transcription.Curr Mol Pharmacol. 2013 Nov;6(3):204-10. doi: 10.2174/1874467207666140219121219.
|
| 917 |
The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6).J Biol Chem. 2003 Apr 25;278(17):15412-20. doi: 10.1074/jbc.M300592200. Epub 2003 Feb 14.
|
| 918 |
miR-155 Controls Lymphoproliferation in LAT Mutant Mice by Restraining T-Cell Apoptosis via SHIP-1/mTOR and PAK1/FOXO3/BIM Pathways.PLoS One. 2015 Jun 29;10(6):e0131823. doi: 10.1371/journal.pone.0131823. eCollection 2015.
|
| 919 |
New targets for Ph+ leukaemia therapy.Best Pract Res Clin Haematol. 2009 Sep;22(3):445-54. doi: 10.1016/j.beha.2009.08.002.
|
| 920 |
LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.Mol Cell Biol. 2015 Nov 23;36(3):488-506. doi: 10.1128/MCB.00901-15. Print 2016 Feb 1.
|
| 921 |
Pinch-1 was up-regulated in leukemia BMSC and its possible effect.Clin Exp Med. 2013 Feb;13(1):21-7. doi: 10.1007/s10238-012-0176-7. Epub 2012 Feb 5.
|
| 922 |
The cell fate determinant Llgl1 influences HSC fitness and prognosis in AML.J Exp Med. 2013 Jan 14;210(1):15-22. doi: 10.1084/jem.20120596. Epub 2012 Dec 31.
|
| 923 |
Clinical significance of LMO1 in gastric cancer tissue and its association with apoptosis of cancer cells.Oncol Lett. 2017 Dec;14(6):6511-6518. doi: 10.3892/ol.2017.7102. Epub 2017 Sep 28.
|
| 924 |
ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9.Genes Chromosomes Cancer. 2016 Mar;55(3):242-50. doi: 10.1002/gcc.22327. Epub 2015 Nov 6.
|
| 925 |
Methylation pattern of the putative tumor-suppressor gene LRRC3B promoter in clear cell renal cell carcinomas.Mol Med Rep. 2012 Feb;5(2):509-12. doi: 10.3892/mmr.2011.681. Epub 2011 Nov 16.
|
| 926 |
The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.Haematologica. 2012 Sep;97(9):1405-13. doi: 10.3324/haematol.2011.059030. Epub 2012 Apr 4.
|
| 927 |
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.PLoS One. 2012;7(9):e44979. doi: 10.1371/journal.pone.0044979. Epub 2012 Sep 27.
|
| 928 |
MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily.Gene. 2001 Apr 18;267(2):173-82. doi: 10.1016/s0378-1119(01)00406-1.
|
| 929 |
The molecular basis of leukemia.Hematology Am Soc Hematol Educ Program. 2004:80-97. doi: 10.1182/asheducation-2004.1.80.
|
| 930 |
The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.Haematologica. 2006 Jun;91(6):765-71.
|
| 931 |
Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines.Br J Cancer. 1998 Jun;77(12):2076-80. doi: 10.1038/bjc.1998.350.
|
| 932 |
Cancer-associated expression of minichromosome maintenance 3 gene in several human cancers and its involvement in tumorigenesis.Clin Cancer Res. 2004 Dec 15;10(24):8386-95. doi: 10.1158/1078-0432.CCR-04-1029.
|
| 933 |
Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2.PLoS One. 2010 Sep 2;5(9):e12520. doi: 10.1371/journal.pone.0012520.
|
| 934 |
Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.EBioMedicine. 2016 Jun;8:173-183. doi: 10.1016/j.ebiom.2016.04.038. Epub 2016 May 13.
|
| 935 |
Meis2 as a critical player in MN1-induced leukemia.Blood Cancer J. 2017 Sep 29;7(9):e613. doi: 10.1038/bcj.2017.86.
|
| 936 |
Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ.Nucleic Acids Res. 2003 Jun 1;31(11):2735-44. doi: 10.1093/nar/gkg401.
|
| 937 |
Triptolide induces apoptosis in human leukemia cells through caspase-3-mediated ROCK1 activation and MLC phosphorylation.Cell Death Dis. 2013 Dec 5;4(12):e941. doi: 10.1038/cddis.2013.469.
|
| 938 |
NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.PLoS Genet. 2019 Nov 1;15(11):e1008463. doi: 10.1371/journal.pgen.1008463. eCollection 2019 Nov.
|
| 939 |
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia.Nat Commun. 2018 May 2;9(1):1770. doi: 10.1038/s41467-018-04180-1.
|
| 940 |
ChREBP promotes the differentiation of leukemia-initiating cells to inhibit leukemogenesis through the TXNIP/RUNX1 pathways.Oncotarget. 2016 Jun 21;7(25):38347-38358. doi: 10.18632/oncotarget.9520.
|
| 941 |
A MENage Trois in leukemia.Cancer Cell. 2008 Jul 8;14(1):3-5. doi: 10.1016/j.ccr.2008.06.009.
|
| 942 |
Nuclear Repositioning of the Non-Translocated HLXB9 Allele in the Leukaemia Cell Line GDM-1 Harbouring a t(6;7)(q23;q36).Cytogenet Genome Res. 2017;153(1):10-17. doi: 10.1159/000480745. Epub 2017 Sep 29.
|
| 943 |
Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.J Biol Chem. 2010 May 7;285(19):14346-55. doi: 10.1074/jbc.M110.109314. Epub 2010 Mar 9.
|
| 944 |
Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):158-165. doi: 10.26355/eurrev_201801_14113.
|
| 945 |
Ecotropic viral integration site 1 regulates the progression of acute myeloid leukemia via MS4A3-mediated TGF/EMT signaling pathway.Oncol Lett. 2018 Aug;16(2):2701-2708. doi: 10.3892/ol.2018.8890. Epub 2018 Jun 4.
|
| 946 |
Epigenetic analysis of childhood acute lymphoblastic leukemia.Epigenetics. 2009 Apr 1;4(3):185-93. doi: 10.4161/epi.4.3.8752. Epub 2009 Apr 12.
|
| 947 |
Refined solution structure and backbone dynamics of 15N-labeled C12A-p8MTCP1 studied by NMR relaxation.J Biomol NMR. 1999 Dec;15(4):271-88. doi: 10.1023/a:1008336418418.
|
| 948 |
Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.J Cancer Res Clin Oncol. 2007 Nov;133(11):875-93. doi: 10.1007/s00432-007-0274-1. Epub 2007 Aug 2.
|
| 949 |
Tax oncoprotein trans-represses endogenous B-myb promoter activity in human T cells.AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1629-32. doi: 10.1089/08892220050193065.
|
| 950 |
NAIP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukemia cells.Leuk Res. 2002 Sep;26(9):857-62. doi: 10.1016/s0145-2126(02)00016-4.
|
| 951 |
Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.Nucleic Acids Res. 2010 Sep;38(16):5384-95. doi: 10.1093/nar/gkq307. Epub 2010 Apr 28.
|
| 952 |
Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia.BMC Cancer. 2013 Oct 5;13:457. doi: 10.1186/1471-2407-13-457.
|
| 953 |
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.Int J Hematol. 2014 Jan;99(1):21-31. doi: 10.1007/s12185-013-1466-x. Epub 2013 Nov 21.
|
| 954 |
Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential.Blood. 2013 May 2;121(18):3714-7. doi: 10.1182/blood-2012-11-465641. Epub 2013 Feb 20.
|
| 955 |
The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.Biochem Biophys Res Commun. 1999 Nov 2;264(3):871-7. doi: 10.1006/bbrc.1999.1605.
|
| 956 |
Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.Blood. 2007 Jan 1;109(1):323-30. doi: 10.1182/blood-2005-08-027979. Epub 2006 Aug 29.
|
| 957 |
Regulation of the human leukaemia inhibitory factor (LIF) promoter in HEC-1B endometrial adenocarcinoma cells.Mol Hum Reprod. 1997 Sep;3(9):789-93. doi: 10.1093/molehr/3.9.789.
|
| 958 |
Chromosome band 16q22-linked familial AML: exclusion of candidate genes, and possible disease risk modification by NQO1 polymorphisms.Genes Chromosomes Cancer. 2004 Nov;41(3):278-82. doi: 10.1002/gcc.20084.
|
| 959 |
Selective activation of NFAT by promyelocytic leukemia protein.Oncogene. 2008 Jun 19;27(27):3821-30. doi: 10.1038/onc.2008.2. Epub 2008 Feb 4.
|
| 960 |
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.Blood. 2019 Apr 18;133(16):1766-1777. doi: 10.1182/blood-2018-09-875047. Epub 2019 Feb 12.
|
| 961 |
Disruption of TCBA1 associated with a de novo t(1;6)(q32.2;q22.3) presenting in a child with developmental delay and recurrent infections.J Med Genet. 2006 Feb;43(2):143-7. doi: 10.1136/jmg.2004.029660. Epub 2005 May 20.
|
| 962 |
Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.Leuk Res. 2002 Jun;26(6):569-76. doi: 10.1016/s0145-2126(01)00171-0.
|
| 963 |
Establishment of a myeloid leukemia cell line, TRL-01, with MLL-ENL fusion gene.Cancer Genet Cytogenet. 2006 Aug;169(1):1-11. doi: 10.1016/j.cancergencyto.2005.09.008.
|
| 964 |
NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes.J Immunol. 2003 Jul 1;171(1):299-306. doi: 10.4049/jimmunol.171.1.299.
|
| 965 |
Superoxide-Generating Nox5 Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.J Virol. 2015 Sep;89(17):9080-9. doi: 10.1128/JVI.00983-15. Epub 2015 Jun 24.
|
| 966 |
NRARP displays either pro- or anti-tumoral roles in T-cell acute lymphoblastic leukemia depending on Notch and Wnt signaling.Oncogene. 2020 Jan;39(5):975-986. doi: 10.1038/s41388-019-1042-9. Epub 2019 Oct 4.
|
| 967 |
Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.Mol Cell Biol. 2008 Mar;28(6):2023-34. doi: 10.1128/MCB.02130-07. Epub 2008 Jan 2.
|
| 968 |
Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha.Oncogene. 2004 Jan 22;23(3):665-78. doi: 10.1038/sj.onc.1207073.
|
| 969 |
Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia.Mol Cancer. 2010 Aug 27;9:226. doi: 10.1186/1476-4598-9-226.
|
| 970 |
The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.Exp Hematol. 2017 Nov;55:76-85.e3. doi: 10.1016/j.exphem.2017.07.009. Epub 2017 Jul 28.
|
| 971 |
Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.Oncogene. 2014 Apr 24;33(17):2169-78. doi: 10.1038/onc.2013.169. Epub 2013 Jun 3.
|
| 972 |
Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig.Br J Haematol. 2000 Aug;110(2):343-50. doi: 10.1046/j.1365-2141.2000.02192.x.
|
| 973 |
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.Int J Cancer. 2006 Apr 15;118(8):1945-53. doi: 10.1002/ijc.21584.
|
| 974 |
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet. 2012 Nov 1;21(21):4793-804.
|
| 975 |
The functional polymorphisms of LIS1 are associated with acute myeloid leukemia risk in a Han Chinese population.Leuk Res. 2017 Mar;54:7-11. doi: 10.1016/j.leukres.2016.12.007. Epub 2017 Jan 2.
|
| 976 |
Fluctuation of gene expression for poly(ADP-ribose) synthetase during hemin-induced erythroid differentiation of human leukemia K562 cells and its reversion process.Biochim Biophys Acta. 1991 Mar 26;1088(3):359-64. doi: 10.1016/0167-4781(91)90125-6.
|
| 977 |
PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.Int J Cancer. 2017 Jul 15;141(2):324-335. doi: 10.1002/ijc.30739. Epub 2017 May 8.
|
| 978 |
Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.Genes Chromosomes Cancer. 2011 Dec;50(12):1043-53. doi: 10.1002/gcc.20922. Epub 2011 Aug 24.
|
| 979 |
The leucine zipper motif of the Drosophila AF10 homologue can inhibit PRE-mediated repression: implications for leukemogenic activity of human MLL-AF10 fusions.Mol Cell Biol. 2003 Jan;23(1):119-30. doi: 10.1128/MCB.23.1.119-130.2003.
|
| 980 |
Synergistic antitumoral efficacy of a novel replicative adenovirus SG611-PDCD5 and daunorubicin in human leukemic cells.Onco Targets Ther. 2018 Aug 23;11:5121-5132. doi: 10.2147/OTT.S167868. eCollection 2018.
|
| 981 |
LIM-domain-only proteins in cancer.Nat Rev Cancer. 2013 Feb;13(2):111-22. doi: 10.1038/nrc3418. Epub 2013 Jan 10.
|
| 982 |
The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia.Acta Biochim Pol. 2002;49(1):99-107.
|
| 983 |
The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies.Oncotarget. 2017 Jul 1;8(39):65445-65456. doi: 10.18632/oncotarget.18920. eCollection 2017 Sep 12.
|
| 984 |
Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage.Exp Hematol. 2001 Jan;29(1):93-103. doi: 10.1016/s0301-472x(00)00620-2.
|
| 985 |
PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia.Blood. 2019 Apr 18;133(16):1729-1741. doi: 10.1182/blood-2018-07-860726. Epub 2019 Feb 12.
|
| 986 |
Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity.Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3837-42. doi: 10.1073/pnas.0712250105. Epub 2008 Mar 3.
|
| 987 |
The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.Cancer Res. 2012 May 1;72(9):2275-84. doi: 10.1158/0008-5472.CAN-11-3159. Epub 2012 Mar 9.
|
| 988 |
Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid Cancers.Front Genet. 2019 Jan 15;9:721. doi: 10.3389/fgene.2018.00721. eCollection 2018.
|
| 989 |
Protein kinase D2: a versatile player in cancer biology.Oncogene. 2018 Mar;37(10):1263-1278. doi: 10.1038/s41388-017-0052-8. Epub 2017 Dec 20.
|
| 990 |
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.Br J Haematol. 2008 Feb;140(3):344-7. doi: 10.1111/j.1365-2141.2007.06920.x. Epub 2007 Dec 5.
|
| 991 |
The putative BH3 mimetic S1 sensitizes leukemia to ABT-737 by increasing reactive oxygen species, inducing endoplasmic reticulum stress, and upregulating the BH3-only protein NOXA.Apoptosis. 2014 Jan;19(1):201-9. doi: 10.1007/s10495-013-0910-y.
|
| 992 |
Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors.Mol Carcinog. 2001 Sep;32(1):44-53. doi: 10.1002/mc.1063.
|
| 993 |
Human CAP10-Like Protein 46kDa Gene Promotes Malignancy in Colorectal Cancer.OMICS. 2017 May;21(5):266-274. doi: 10.1089/omi.2017.0037.
|
| 994 |
The N-terminus of murine leukaemia virus p12 protein is required for mature core stability.PLoS Pathog. 2014 Oct 30;10(10):e1004474. doi: 10.1371/journal.ppat.1004474. eCollection 2014 Oct.
|
| 995 |
POU4F1 is associated with t(8;21) acute myeloid leukemia and contributes directly to its unique transcriptional signature.Leukemia. 2010 May;24(5):950-7. doi: 10.1038/leu.2010.61. Epub 2010 Apr 8.
|
| 996 |
Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells.Proc Natl Acad Sci U S A. 1987 May;84(9):2868-71. doi: 10.1073/pnas.84.9.2868.
|
| 997 |
siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53. Leuk Res. 2009 Sep;33(9):1243-8. doi: 10.1016/j.leukres.2009.02.016. Epub 2009 Mar 18.
|
| 998 |
Expression and distribution of PPP2R5C gene in leukemia.J Hematol Oncol. 2011 May 6;4:21. doi: 10.1186/1756-8722-4-21.
|
| 999 |
The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.Genomics. 1996 Oct 1;37(1):24-8. doi: 10.1006/geno.1996.0516.
|
| 1000 |
PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature.J Clin Invest. 2018 Aug 1;128(8):3250-3264. doi: 10.1172/JCI99862. Epub 2018 Jul 23.
|
| 1001 |
Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia.Tohoku J Exp Med. 2002 Mar;196(3):193-201. doi: 10.1620/tjem.196.193.
|
| 1002 |
Leukemogenic properties of NUP98-PMX1 are linked to NUP98 and homeodomain sequence functions but not to binding properties of PMX1 to serum response factor.Oncogene. 2008 Oct 9;27(46):6056-67. doi: 10.1038/onc.2008.210. Epub 2008 Jul 7.
|
| 1003 |
Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia.J Vis Exp. 2019 Sep 5;(151):10.3791/59593. doi: 10.3791/59593.
|
| 1004 |
AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia.Blood. 2011 Dec 1;118(23):6132-40. doi: 10.1182/blood-2011-01-323147. Epub 2011 Oct 14.
|
| 1005 |
Human NUP98-HOXA9 promotes hyperplastic growth of hematopoietic tissues in Drosophila.Dev Biol. 2017 Jan 1;421(1):16-26. doi: 10.1016/j.ydbio.2016.11.003. Epub 2016 Nov 10.
|
| 1006 |
GATA4 is highly expressed in childhood acute lymphoblastic leukemia, promotes cell proliferation and inhibits apoptosis by activating BCL2 and MDM2.Mol Med Rep. 2017 Nov;16(5):6290-6298. doi: 10.3892/mmr.2017.7369. Epub 2017 Aug 28.
|
| 1007 |
From oncogene to tumor suppressor: the dual role of Myc in leukemia.Cell Cycle. 2012 May 1;11(9):1757-64. doi: 10.4161/cc.19883. Epub 2012 May 1.
|
| 1008 |
Mechanisms involved in the induced differentiation of leukemia cells.Pharmacol Ther. 2003 Dec;100(3):257-90. doi: 10.1016/j.pharmthera.2003.09.002.
|
| 1009 |
Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.Cell Signal. 2014 Oct;26(10):2202-9. doi: 10.1016/j.cellsig.2014.05.015. Epub 2014 May 29.
|
| 1010 |
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.Cell Rep. 2018 Jun 12;23(11):3127-3136. doi: 10.1016/j.celrep.2018.05.034.
|
| 1011 |
In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity.Leukemia. 2014 Jun;28(6):1316-25. doi: 10.1038/leu.2013.374. Epub 2013 Nov 13.
|
| 1012 |
Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma. PLoS One. 2013 Nov 6;8(11):e79863. doi: 10.1371/journal.pone.0079863. eCollection 2013.
|
| 1013 |
Rap1GAP alters leukemia cell differentiation, apoptosis and invasion invitro.Oncol Rep. 2012 Aug;28(2):622-8. doi: 10.3892/or.2012.1825. Epub 2012 May 18.
|
| 1014 |
The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.Acta Pharmacol Sin. 2011 Jan;32(1):99-107. doi: 10.1038/aps.2010.185. Epub 2010 Dec 13.
|
| 1015 |
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias.Mol Cancer. 2009 Jul 1;8:42. doi: 10.1186/1476-4598-8-42.
|
| 1016 |
Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity.J Biol Chem. 2008 Sep 26;283(39):26820-8. doi: 10.1074/jbc.M802315200. Epub 2008 Jul 30.
|
| 1017 |
A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia.Blood. 2007 Jul 1;110(1):323-33. doi: 10.1182/blood-2006-10-052282. Epub 2007 Mar 14.
|
| 1018 |
Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma.Br J Haematol. 2008 Apr;141(2):212-5. doi: 10.1111/j.1365-2141.2007.06956.x.
|
| 1019 |
RALBP1/RLIP76 mediates multidrug resistance.Int J Oncol. 2007 Jan;30(1):139-44.
|
| 1020 |
Intestinal folate transport: identification of a cDNA involved in folate transport and the functional expression and distribution of its mRNA.Biochim Biophys Acta. 1996 Jun 11;1281(2):164-72. doi: 10.1016/0005-2736(96)00005-3.
|
| 1021 |
Genomic c-Myc quadruplex DNA selectively kills leukemia.Mol Cancer Ther. 2012 Jan;11(1):66-76. doi: 10.1158/1535-7163.MCT-11-0515. Epub 2011 Nov 14.
|
| 1022 |
Identification of RHOXF2 (PEPP2) as a cancer-promoting gene by expression cloning.Int J Oncol. 2012 Jan;40(1):93-8. doi: 10.3892/ijo.2011.1173. Epub 2011 Aug 19.
|
| 1023 |
Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.Immunity. 1997 Jun;6(6):773-82. doi: 10.1016/s1074-7613(00)80452-5.
|
| 1024 |
Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3901-6. doi: 10.1073/pnas.1301045110. Epub 2013 Feb 14.
|
| 1025 |
Breakpoints at 1p36.3 in three MDS/AML(M4) patients with t(1;3)(p36;q21) occur in the first intron and in the 5' region of MEL1.Genes Chromosomes Cancer. 2003 Mar;36(3):313-6. doi: 10.1002/gcc.10176.
|
| 1026 |
Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.Leukemia. 2012 May;26(5):927-33. doi: 10.1038/leu.2011.322. Epub 2011 Nov 18.
|
| 1027 |
Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies.Ann Oncol. 2019 Apr 1;30(4):528-541. doi: 10.1093/annonc/mdz045.
|
| 1028 |
The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.Leukemia. 2013 Jul;27(7):1461-8. doi: 10.1038/leu.2013.42. Epub 2013 Feb 13.
|
| 1029 |
Persistent detection of a novel MLL-SACM1L rearrangement in the absence of leukemia.Leuk Res. 2010 Oct;34(10):1398-401. doi: 10.1016/j.leukres.2010.05.001.
|
| 1030 |
The Study of SALL4 Gene and BMI-1 Gene Expression in Acute Myeloid Leukemia Patients.Lab Med. 2020 May 6;51(3):265-270. doi: 10.1093/labmed/lmz056.
|
| 1031 |
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.Nat Commun. 2019 Aug 2;10(1):3475. doi: 10.1038/s41467-019-11413-4.
|
| 1032 |
Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice.AIDS. 2000 Dec 22;14(18):2813-22. doi: 10.1097/00002030-200012220-00002.
|
| 1033 |
High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.Genes Chromosomes Cancer. 2012 Feb;51(2):196-206. doi: 10.1002/gcc.20944. Epub 2011 Nov 10.
|
| 1034 |
Blocking the proliferation of human tumor cell lines by peptidase inhibitors from Bauhinia seeds.Planta Med. 2013 Mar;79(3-4):227-35. doi: 10.1055/s-0032-1328156. Epub 2013 Jan 23.
|
| 1035 |
Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.FEBS J. 2010 Apr;277(8):1832-42. doi: 10.1111/j.1742-4658.2010.07609.x. Epub 2010 Mar 4.
|
| 1036 |
Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.J Neurol Sci. 2013 Dec 15;335(1-2):134-8. doi: 10.1016/j.jns.2013.09.014. Epub 2013 Sep 17.
|
| 1037 |
Methylation of SFRP5 is related to multidrug resistance in leukemia cells.Cancer Gene Ther. 2014 Feb;21(2):83-9. doi: 10.1038/cgt.2013.87. Epub 2014 Jan 17.
|
| 1038 |
Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.Ann Hematol. 2002 Aug;81(8):441-7. doi: 10.1007/s00277-002-0490-3. Epub 2002 Jul 20.
|
| 1039 |
PCR testing for HCV in anti-HCV negative blood donors involved in the so called HCV +ve post-transfusion hepatitis.Transfus Sci. 2000 Jun;22(3):161-4. doi: 10.1016/s0955-3886(00)00043-6.
|
| 1040 |
The coiled-coil domain is the structural determinant for mammalian homologues of Drosophila Sina-mediated degradation of promyelocytic leukemia protein and other tripartite motif proteins by the proteasome.J Biol Chem. 2004 Feb 13;279(7):5374-9. doi: 10.1074/jbc.M306407200. Epub 2003 Nov 25.
|
| 1041 |
The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.J Immunol. 2004 Dec 1;173(11):6841-9. doi: 10.4049/jimmunol.173.11.6841.
|
| 1042 |
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.Haematologica. 2008 Nov;93(11):1728-33. doi: 10.3324/haematol.13044. Epub 2008 Sep 11.
|
| 1043 |
Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.Blood. 2000 Jun 15;95(12):3945-50.
|
| 1044 |
Epigenetic control of SPI1 gene by CTCF and ISWI ATPase SMARCA5.PLoS One. 2014 Feb 3;9(2):e87448. doi: 10.1371/journal.pone.0087448. eCollection 2014.
|
| 1045 |
Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes. Nat Genet. 2017 May;49(5):742-752. doi: 10.1038/ng.3833. Epub 2017 Apr 3.
|
| 1046 |
Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia.Leuk Lymphoma. 2018 Oct;59(10):2423-2430. doi: 10.1080/10428194.2017.1387906. Epub 2017 Oct 18.
|
| 1047 |
Epigenetic regulator Smchd1 functions as a tumor suppressor.Cancer Res. 2013 Mar 1;73(5):1591-9. doi: 10.1158/0008-5472.CAN-12-3019. Epub 2012 Dec 26.
|
| 1048 |
Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias.Blood. 2008 May 1;111(9):4716-22. doi: 10.1182/blood-2007-10-113068. Epub 2008 Feb 25.
|
| 1049 |
PML a target of translocations in APL is a regulator of cellular senescence.Leukemia. 2002 Oct;16(10):1918-26. doi: 10.1038/sj.leu.2402722.
|
| 1050 |
Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II.J Biol Chem. 1999 Jul 30;274(31):21981-5. doi: 10.1074/jbc.274.31.21981.
|
| 1051 |
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia.Cell Res. 2018 Feb;28(2):172-186. doi: 10.1038/cr.2017.146. Epub 2017 Nov 17.
|
| 1052 |
SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.Cancer Res. 2015 Jun 1;75(11):2387-99. doi: 10.1158/0008-5472.CAN-14-3625. Epub 2015 Apr 9.
|
| 1053 |
Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.Cancer Sci. 2019 Jun;110(6):1931-1946. doi: 10.1111/cas.14021. Epub 2019 May 3.
|
| 1054 |
SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.Mol Cell. 2016 Mar 17;61(6):859-73. doi: 10.1016/j.molcel.2016.02.024.
|
| 1055 |
Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.Mod Pathol. 2010 Jan;23(1):105-12. doi: 10.1038/modpathol.2009.140. Epub 2009 Oct 2.
|
| 1056 |
SOX12: a novel potential target for acute myeloid leukaemia.Br J Haematol. 2017 Feb;176(3):421-430. doi: 10.1111/bjh.14425. Epub 2016 Nov 18.
|
| 1057 |
SOX6 blocks the proliferation of BCR-ABL1(+) and JAK2V617F(+) leukemic cells.Sci Rep. 2019 Mar 4;9(1):3388. doi: 10.1038/s41598-019-39926-4.
|
| 1058 |
Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.Blood. 2015 Jun 18;125(25):3928-36. doi: 10.1182/blood-2014-06-580993. Epub 2015 May 4.
|
| 1059 |
Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).Genes Chromosomes Cancer. 2015 Jul;54(7):401-8. doi: 10.1002/gcc.22251. Epub 2015 May 7.
|
| 1060 |
Combined high-resolution array-based comparative genomic hybridization and expression profiling of ETV6/RUNX1-positive acute lymphoblastic leukemias reveal a high incidence of cryptic Xq duplications and identify several putative target genes within the commonly gained region.Leukemia. 2007 Oct;21(10):2137-44. doi: 10.1038/sj.leu.2404879. Epub 2007 Aug 9.
|
| 1061 |
The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia.Oncotarget. 2017 Jun 6;8(23):37104-37114. doi: 10.18632/oncotarget.16183.
|
| 1062 |
ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.Exp Hematol. 2019 May;73:50-63.e2. doi: 10.1016/j.exphem.2019.03.004. Epub 2019 Apr 12.
|
| 1063 |
Sorcin, an important gene associated with multidrug-resistance in human leukemia cells.Leuk Res. 2006 Apr;30(4):469-76. doi: 10.1016/j.leukres.2005.08.024. Epub 2005 Oct 6.
|
| 1064 |
Expression of SSX genes in human tumors.Int J Cancer. 1998 Jul 3;77(1):19-23. doi: 10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2.
|
| 1065 |
STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia.Cell Rep. 2018 Sep 11;24(11):3045-3060.e5. doi: 10.1016/j.celrep.2018.08.030.
|
| 1066 |
SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin.Mol Cell Biol. 2005 Jun;25(12):5095-105. doi: 10.1128/MCB.25.12.5095-5105.2005.
|
| 1067 |
The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.J Cancer. 2019 Jan 1;10(3):721-729. doi: 10.7150/jca.28254. eCollection 2019.
|
| 1068 |
N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia.J Biol Chem. 2006 Sep 22;281(38):28122-30. doi: 10.1074/jbc.M512391200. Epub 2006 May 12.
|
| 1069 |
Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19635-19645. doi: 10.1073/pnas.1908998116. Epub 2019 Sep 5.
|
| 1070 |
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.Haematologica. 2016 Aug;101(8):951-8. doi: 10.3324/haematol.2016.143875. Epub 2016 May 5.
|
| 1071 |
Expression of transcobalamin II receptors by human leukemia K562 and HL-60 cells.Blood. 1990 Oct 1;76(7):1380-6.
|
| 1072 |
The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties.Blood. 1996 Jun 1;87(11):4607-17.
|
| 1073 |
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo.Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):806-13.
|
| 1074 |
A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML.Blood. 2014 Apr 17;123(16):2530-9. doi: 10.1182/blood-2013-07-512194. Epub 2014 Mar 7.
|
| 1075 |
Identification and characterization of a soluble suppressor factor(s) in the serum of AKR mice bearing lymphocytic leukemia.Cell Immunol. 1983 Nov;82(1):163-73. doi: 10.1016/0008-8749(83)90150-8.
|
| 1076 |
Promoter analysis of TFPT (FB1), a molecular partner of TCF3 (E2A) in childhood acute lymphoblastic leukemia.Biochem Biophys Res Commun. 2001 Nov 16;288(5):1250-7. doi: 10.1006/bbrc.2001.5906.
|
| 1077 |
Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells.Blood. 2001 Nov 1;98(9):2714-9. doi: 10.1182/blood.v98.9.2714.
|
| 1078 |
Epigenetic regulation of putative tumor suppressor TGFBI in human leukemias.Chin Med J (Engl). 2014;127(9):1645-50.
|
| 1079 |
A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5.Leukemia. 2013 Apr;27(4):932-40. doi: 10.1038/leu.2012.283. Epub 2012 Oct 3.
|
| 1080 |
Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.J Exp Med. 1996 May 1;183(5):2283-91. doi: 10.1084/jem.183.5.2283.
|
| 1081 |
TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.J Hematol Oncol. 2016 Nov 25;9(1):128. doi: 10.1186/s13045-016-0360-4.
|
| 1082 |
Synthesis of New Derivatives of Benzofuran as Potential Anticancer Agents.Molecules. 2019 Apr 18;24(8):1529. doi: 10.3390/molecules24081529.
|
| 1083 |
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041.
|
| 1084 |
The promyelocytic leukemia protein represses A20-mediated transcription.J Biol Chem. 2002 Aug 30;277(35):31734-9. doi: 10.1074/jbc.M201648200. Epub 2002 Jun 21.
|
| 1085 |
Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.Blood. 2010 May 20;115(20):4061-70. doi: 10.1182/blood-2008-06-163386. Epub 2010 Mar 11.
|
| 1086 |
TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11).Oncogene. 1991 Oct;6(10):1887-93.
|
| 1087 |
TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice.Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16600-5. doi: 10.1073/pnas.0407541101. Epub 2004 Nov 15.
|
| 1088 |
Somatic mutation of TRAF3 gene is rare in common human cancers and acute leukemias.Acta Oncol. 2008;47(8):1615-7. doi: 10.1080/02841860802195277.
|
| 1089 |
TRIM32 promotes neural differentiation through retinoic acid receptor-mediated transcription.J Cell Sci. 2011 Oct 15;124(Pt 20):3492-502. doi: 10.1242/jcs.088799. Epub 2011 Oct 7.
|
| 1090 |
HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor.J Biol Chem. 2004 Feb 27;279(9):8181-9. doi: 10.1074/jbc.M306751200. Epub 2003 Dec 8.
|
| 1091 |
Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function.Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6200-5. doi: 10.1073/pnas.0609174104. Epub 2007 Mar 30.
|
| 1092 |
Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia.Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):115-127.e15. doi: 10.1016/j.clml.2014.07.011. Epub 2014 Aug 12.
|
| 1093 |
Quantitative analysis and modeling of glucocorticoid-controlled gene expression.Pharmacogenomics. 2010 Nov;11(11):1545-60. doi: 10.2217/pgs.10.125.
|
| 1094 |
Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL).Leuk Res. 2006 Jul;30(7):883-9. doi: 10.1016/j.leukres.2005.11.012. Epub 2006 Jan 6.
|
| 1095 |
Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.Cell Stem Cell. 2015 Aug 6;17(2):152-164. doi: 10.1016/j.stem.2015.06.006. Epub 2015 Jul 23.
|
| 1096 |
Single nucleotide polymorphism of the JWA gene is associated with risk of leukemia: a case-control study in a Chinese population.J Toxicol Environ Health A. 2007 Jun;70(11):895-900. doi: 10.1080/15287390701285956.
|
| 1097 |
Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.PLoS One. 2010 Jul 2;5(7):e11418. doi: 10.1371/journal.pone.0011418.
|
| 1098 |
Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera.Int J Hematol. 2012 Aug;96(2):268-73. doi: 10.1007/s12185-012-1112-z. Epub 2012 Jun 4.
|
| 1099 |
FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients.Leuk Res. 2012 Nov;36(11):1339-46. doi: 10.1016/j.leukres.2012.06.011. Epub 2012 Aug 16.
|
| 1100 |
Posterior column ataxia with retinitis pigmentosa coexisting with sensory-autonomic neuropathy and leukemia due to the homozygous p.Pro221Ser FLVCR1 mutation.Am J Med Genet B Neuropsychiatr Genet. 2017 Oct;174(7):732-739. doi: 10.1002/ajmg.b.32570. Epub 2017 Aug 2.
|
| 1101 |
The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue.Cancer Biomark. 2016;16(1):191-202. doi: 10.3233/CBM-150555.
|
| 1102 |
GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome.Cancer Med. 2017 Jan;6(1):267-274. doi: 10.1002/cam4.984. Epub 2016 Nov 28.
|
| 1103 |
KDM3B shows tumor-suppressive activity and transcriptionally regulates HOXA1 through retinoic acid response elements in acute myeloid leukemia.Leuk Lymphoma. 2018 Jan;59(1):204-213. doi: 10.1080/10428194.2017.1324156. Epub 2017 May 25.
|
| 1104 |
Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents.Comput Biol Chem. 2018 Jun;74:294-303. doi: 10.1016/j.compbiolchem.2018.04.006. Epub 2018 Apr 10.
|
| 1105 |
Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer.Onco Targets Ther. 2018 Mar 5;11:1215-1222. doi: 10.2147/OTT.S157914. eCollection 2018.
|
| 1106 |
The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells.Nat Med. 2017 Nov;23(11):1369-1376. doi: 10.1038/nm.4416. Epub 2017 Sep 18.
|
| 1107 |
Relation of "lymphoid" phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia.Cancer. 1979 Feb;43(2):426-34. doi: 10.1002/1097-0142(197902)43:2<426::aid-cncr2820430204>3.0.co;2-h.
|
| 1108 |
Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.Cytogenet Genome Res. 2016;149(3):165-170. doi: 10.1159/000448447. Epub 2016 Sep 9.
|
| 1109 |
Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.Mol Cancer Ther. 2017 Jul;16(7):1401-1411. doi: 10.1158/1535-7163.MCT-17-0099. Epub 2017 Apr 26.
|
| 1110 |
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies.Cancer Res. 2008 Jun 1;68(11):4116-22. doi: 10.1158/0008-5472.CAN-08-0085.
|
| 1111 |
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia.Cancer Discov. 2017 Nov;7(11):1336-1353. doi: 10.1158/2159-8290.CD-17-0267. Epub 2017 Oct 3.
|
|
|
|
|
|
|
